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ABSTRACT 
In the aquatic environment fish and other aquatic organism are likely to be 
exposed and impacted by different chemicals like pharmaceuticals and personal care 
products (PPCPs). Nevertheless, organisms have detoxification mechanisms that play a 
key role in the response to anthropogenic chemicals. Therefore, characterising these 
detoxification systems is of high ecotoxicological importance as a step towards 
understanding species-specific sensitivity and the chemical’s mode of action. Fish and 
other vertebrate have developed different defences that biotransform (phase I and II 
biotransformation enzymes and antioxidant enzymes) and eliminates (phase 0 and III 
ATP-Binding Cassette (ABC) proteins) potentially toxic chemicals impacting their effects, 
accumulation and excretion. However, some compounds can constrain the efflux 
transporters inhibiting or decreasing the multixenobiotic resistance mechanism (MXR) 
activity leading to an increase in the accumulation of xenobiotics normally effluxed from 
the cells, in a process called chemosensitisation. It is also important to understand the 
regulation of genes encoding for these proteins involved in the detoxification system. In 
mammals, several nuclear receptors (NRs) have been identified as regulators of these 
defence mechanisms, but in fish little is known about its regulation. Given the importance 
of the detoxification system and their regulation by NRs as well as the potential 
chemosentisation effect of numerous environmental chemicals, this study was designed to 
better understand the interaction of emerging compounds with these defence 
mechanisms. This was approached using a) in vivo exposure of Danio rerio embryos with 
two highly prescribed pharmaceuticals (simvastatin, SIM and fluoxetine, FLU); and, b) in 
vitro assays with recombinant Abcb4 zebrafish protein exposure to different classes of 
pharmaceuticals and PCPs.   
The transcription of genes encoding for NRs, biotransformation and antioxidant 
enzymes and ABC efflux transporters in zebrafish embryos, was determined in different 
development stages. With the exception of abcc2, mRNA levels of all target genes were 
detected at all development stages and therefore seem to be from maternal origin. 
The development of zebrafish embryo was disrupted by FLU at environmentally 
relevant concentrations, while SIM showed to be more toxic to zebrafish embryo in the 
presence of ABC transporters inhibitors. 
To assess the effect of SIM and FLU in the detoxification system, transcription of 
NRs (raraa, rarab, rarga, pparαa, pparβ1, pparγ, pxr, rxraa, rxrab, rxrbb, rxrga, rxrgb and 
ahr2), ABC proteins (abcb4, abcc1, abcc2, abcg2a), biotransformation (cyp1a1, cyp3a65, 
gstπ) and antioxidant enzymes (Cu/Zn sod, cat) was evaluated after embryo exposure. 
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After 80 h exposure pxr and ahr were down regulated by SIM, while rarab was up 
regulated. Transcription of abcb4, abcc1, gstπ and Cu/Zn sod were up regulated and 
cyp3a65 and cat were down regulated. FLU exposure led to a down regulation of all NRs, 
biotransformation and antioxidant enzymes and efflux protein genes with exception of pxr 
and rxrga. The activity of EROD, GST, SOD and CAT was also evaluated. Exposure to 
SIM increased EROD and GST activity and decreased SOD and CAT activity, while FLU 
also decreased SOD but increased CAT activity. These results show an effect of these 
pharmaceuticals in the transcription of NRs, especially pxr and ahr known to regulate 
expression of genes involved in the detoxification mechanism, mainly biotransformation 
genes and consequently its enzyme activity, as shown by the increased EROD activity 
after SIM exposure. NRs are regulators of embryo development and the disruption of their 
expression, as observed in the presence of these pharmaceuticals could be linked to the 
abnormal development and increased mortality observed. To evaluate if SIM and FLU act 
in conserved pathways between fish and mammals, specific interactions with lipid and 
neurotransmitters systems were also evaluated. SIM changed the transcription of ppars 
nonetheless it did not affect the total Chol levels. FLU decreases the transcription of 
important neurotransmitters transporters and receptors (sert, dat, 5-ht2c, drd2b adra2b 
and adra2c) even at concentrations found in the environment. 
The chemosensitisation potential of different classes of PPCPs was evaluated by 
measuring the MXR activity on embryos and the ATPase activity of recombinant zebrafish 
Abcb4. The ATPase assay is a highly specific and artificial assay that examine chemical 
interaction with Abcb4, distinguishing between substrates and inhibitors whereas the 
accumulation of Rhodamine 123 - RH123, a fluorescent ABC protein substrate, is a less 
specific assay since RH123 is substrate to different efflux transporters. Despite being less 
specific the MXR assay is an in vivo assay therefore gives more information about 
relevant effect concentrations. Sertraline, fluoxetine, diclofenac, simvastatin and 
isoeugenol inhibited Abcb4 ATPase activity. Musk xylene, nerol, isoeugenol, α-
amylcinnamaldehyde and α-hexylcinnamaldehyde and simvastatin demonstrated Abcb4 
substrates properties. Most of the PPCPs tested displayed an interaction with the MXR 
mechanism and inhibited ABC proteins, although at different concentrations. Importantly, 
isoeugenol inhibited the MXR system at environmentally relevant concentrations. Overall, 
to try to identify which efflux proteins are being inhibited the accumulation assay and 
ATPase assay should be used together. Accumulation assays should be used for initial 
monitoring, followed by ATPase assay where specific interactions between the chemicals 
and ABC proteins can be observed to establish the mode of action of these chemicals.  
 xvii 
Taken together, the results highlight the key protective role of the detoxification 
mechanism against xenobiotic insults in fish. The disruption of defence genes 
transcription led to development abnormalities and mortality of zebrafish embryos. Our 
results also provide further insights on the modulation of NRs by PPCPs and impact on 
transcription of detoxification genes, mainly modulation of pxr and ahr by SIM and FLU 
impacting cyps mRNA expression. PPCPs also disturb zebrafish MXR activity, and some 
exhibited chemosensitising potential.  
The results demonstrate the importance of monitoring of the presence of PPCPs in 
the aquatic environments since: the increase in development abnormalities and mortality 
by PPCPs can have an impact in organisms at population level; the deregulation of 
important systems can affect the development, feeding, foraging or matting behaviours 
that have implications on the population survival; also the energy expenditure used by the 
organisms to metabolize and eliminate these compounds may decrease the animal fitness 
and their capability to reproduce, grow or survive in polluted environments.  
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RESUMO 
No meio aquático peixes e outros organismos são susceptíveis de estar expostos 
a diferentes químicos como fármacos e produtos de uso pessoal (PPCPs). Todavia, estes 
organismos possuem mecanismos de destoxificação que desempenham um papel 
fundamental na resposta contra químicos antropogénicos. Portanto, a caracterização 
destes sistemas de destoxificação é de grande importância ecotoxicológica sendo mais 
um passo para a compreensão espécie-sensibilidade específica e o modo de ação dos 
químicos. Peixes e outros vertebrados desenvolveram diferentes defesas que 
biotransformam (enzimas de biotransformação de fase I e II e enzimas antioxidantes) e 
eliminam (proteínas ATP-Binding Cassette (ABC) de fase 0 e III) químicos potencialmente 
tóxicos tendo impacto nos seus efeitos, acumulação e excreção. Contudo, alguns 
compostos podem constranger os transportadores de efluxo inibindo ou diminuindo a 
actividade deste mecanismo de resistência multi-xenobiótica (MXR) tornando possível a 
acumulação de xenobióticos que normalmente são efluxados das células, num processo 
chamado de quimiosensibilização. De igual forma é importante entender a regulação de 
genes que codificam proteínas envolvidas no sistema de destoxificação. Em mamíferos, 
muitos recetores nucleares (NRs) foram identificados como reguladores destes 
mecanismos de defesa, mas nos peixes pouco se sabe sobra a sua regulação. Dada a 
importância do sistema de destoxificação e a sua regulação por NRs assim como o 
potencial efeito de quimiosensibilização de inúmeros químicos ambientais, este estudo foi 
delineado para melhor se entender a interacção entre compostos emergentes e estes 
mecanismos de defesa. Para isto a) exposições in vivo de embriões de Danio rerio a dois 
fármacos altamente prescritos (sinvastatina, SIM e fluoxetina, FLU; e b) ensaios in vitro 
com proteína recombinante Abcb4 de peixe zebra com exposição a diferentes classes de 
fármacos e PCPs. 
A transcrição de genes que codificam para os NRs, enzimas de biotransformação 
e antioxidantes e os transportadores de efluxo ABC em embriões de peixe zebra foram 
determinados em diferentes estádios de desenvolvimento. Com a exeção do abcc2, foi 
detetado mRNA de todos os genes alvo em todas as fases de desenvolvimento e por isso 
parecem ser de origem materna. 
O desenvolvimento dos embriões de peixe zebra foi afectado pela FLU em 
concentrações que são ambientalmente relevantes, enquanto a SIM mostrou ser mais 
tóxica para os embriões na presença de inibidores dos transportadores ABC.  
Para avaliar os efeitos da SIM e da FLU no sistema de destoxificação, a 
transcrição dos NRs (raraa, rarab, rarga, pparαa, pparβ1, pparγ, pxr, rxraa, rxrab, rxrbb, 
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rxrga, rxrgb e ahr2), proteínas ABC (abcb4, abcc1, abcc2, abcg2a), enzimas de 
biotransformação (cyp1a1, cyp3a65, gstπ) e antioxidantes (Cu/Zn sod, cat) foi avaliada 
em embriões após a exposição. Após 80 h de exposição à SIM, a expressão génica do 
pxr e ahr foi diminuída, enquanto que se observou um aumento do rarab. A transcrição de 
abcb4, abcc1, gstπ e Cu/Zn sod foi aumentada e a do cyp3a65 e da cat decresceu. A 
exposição à FLU levou à diminuição dos níveis de expressão de todos os genes que 
codificam para NRs, enzimas de biotransformação e antioxidantes e das proteínas de 
efluxo com a exceção do pxr e do rxrga. A atividade das enzimas EROD, GST, SOD e 
CAT também foi avaliada. A exposição à SIM aumentou a actividade da EROD e da GST 
e diminuiu a actividade da SOD e da CAT, enquanto a presença da FLU também diminuiu 
a atividade da SOD mas aumentou a atividade da CAT. Estes resultados mostram um 
efeito destes fármacos na transcrição de NRs, especialmente pxr e ahr reconhecidos por 
modular a expressão de genes envolvidos no mecanismo de destoxificação. 
Principalmente ao nível da expressão dos genes de biotransformação e subsequente 
actividade enzimática, conforme observado pelo aumento da actividade da EROD. Os 
NRs são reguladores do desenvolvimento embrionário e a disrupção da expressão 
observada na presença destes fármacos podem estar correlacionadas com o 
desenvolvimento anormal e aumento de mortalidade observada nos embriões. Para 
avaliar o efeito da SIM e da FLU nas vias conservadas entre peixes e mamíferos, foram 
avaliadas interações específicas com o sistema lipídico e neurotransmissor. A SIM 
alterou a transcrição dos ppars contudo não afetou o níveis totais de colesterol. A FLU 
diminuiu a transcrição de importantes transportadores e receptores neurotransmissores 
(sert, dat, 5-ht2c, drd2b adra2b and adra2c) mesmo em concentrações encontradas no 
meio ambiente. 
O potencial de quimiosensibilização das diferentes classes de PPCPs foi avaliada 
medindo a actividade de MXR nos embriões e a atividade de ATPase com proteína 
recombinante Abcb4 de peixe zebra. O ensaio da ATPase é um ensaio muito específico e 
artificial que avalia a interacção com a Abcb4, distinguindo entre substratos e inibidores 
enquanto que a acumulação de Rodamina 123 - RH123, um substrato fluorescente das 
proteínas ABC, é um ensaio menos especifico uma vez que a RH123 é substrato de 
diferentes transportadores de efluxo. Apesar de ser menos específico o ensaio MXR é um 
ensaio in vivo e por isso é mais informativo sobre a relevância das concentrações de 
efeito. Sertraline, fluoxetine, diclofenac, simvastatin e isoeugenol inibiram a atividade da 
Abcb4 ATPase. Musk xylene, nerol, isoeugenol, α-amylcinnamaldehyde, α-
hexylcinnamaldehyde demonstraram propriedades de substrato para a Abcb4. A maioria 
dos PPCPs testados mostraram a capacidade de interagir com o mecanismo MXR e 
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inibiram proteínas ABC embora em concentrações diferentes. Um resultado relevante foi 
a capacidade do isoeugenol inibir o sistema MXR em concentrações ambientalmente 
relevantes. No geral, para tentar identificar quais proteínas de efluxo estão a ser inibidas 
ensaios de acumulação e ATPase devem ser usados em simultâneo. Os ensaios de 
acumulação devem ser usados para uma monotorização inicial, seguidos dos ensaios de 
ATPase onde interacções mais específicas entre os químicos e as proteínas ABC podem 
ser detectadas e o modo de acção destes químicos estabelecido.  
Em conjunto, estes resultados destacam o papel importante do mecanismo de 
destoxificação nos efeitos dos xenobióticos em peixes. A disrupção da transcrição dos 
genes de defesa levaram ao desenvolvimento de anomalias e aumento da mortalidade 
nos embriões de peixe zebra. Os nossos dados também fornecem novas perspetivas 
sobre a modulação dos NRs pelos PPCPs e o seu impacto na transcrição nos genes de 
destoxificação, principalmente na modulação do pxr e ahr pela SIM e FLU e o seu efeito 
na expressão génica dos cyps. Os PPCPs também alteraram a atividade de MXR dos 
peixes zebra, e que alguns exibem potencial de quimiosensibilização.  
Os resultados demonstram a importância de monitorização da presença de 
PPCPs no meio aquático uma vez que: o aumento de anomalias no desenvolvimento e 
mortalidade dos organismos pelos PPCPs pode ter impacto a nível populacional; a 
desregulação de sistemas vitais pode afetar o desenvolvimento, comportamentos de 
alimentação, procura e de acasalamento, que tem implicações na sobrevivência da 
população; também o dispêndio de energia usada pelo organismo para metabolizar e 
eliminar estes compostos pode decrescer o fitness do animal e a sua capacidade de 
reproduzir, crescer ou sobreviver em ambientes poluídos. 
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OUTLINE OF THE THESIS  
 
The thesis is organized in 8 chapters.  
 
Chapter I is an introduction to contextualize the state of art of the key topics within the 
thesis.  
Chapter II comprises the aims of the thesis and explains how these articulate with the 
subsequent experimental results presented. 
Chapter III to VII contain the main studies performed, including materials, methods, results 
and discussion. For each study, information concerning the journal and date of publication 
(for published papers) / co-authors is provided. 
Chapters VIII include a general discussion and main conclusions of the thesis, highlighting 
the most relevant achievements and also the presenting prospects for future work. 
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1.1 General introduction  
The aquatic environment is constantly being loaded with different chemicals, 
exposing the organisms to their possible deleterious effects. These chemicals appear in 
the environment from several routes such as surface runoff and treated and non-treated 
waste waters from households and industry that are directed into streams. Even though 
waste waters are mostly treated in sewage treatment plants, the elimination of many 
contaminants, such as pharmaceuticals compounds and personal care products (PPCPs), 
is still an incomplete process (Zuccato et al., 2006, Larsen et al., 2004, Soares et al., 
2008). Once these compounds reach the aquatic ecosystem, the main concern is how 
these xenobiotics will impact aquatic organisms. This will depend on the physico-chemical 
and toxicological properties of the compounds but also the organisms ability to deal with 
these compounds and its defences. To contradict the unwanted effects of these 
chemicals, vertebrate organisms have well developed cellular detoxification mechanisms. 
Proteins involved in these detoxification processes include efflux transporters (ATP – 
binding cassette (ABC) transporters), phase I (cytochrome P450 family, eg. CYP1A, 
CYP3A) and phase II (glutathione-S-transferase, (GST), UDP-glucuronlytransferases 
(UGTs), Sulfotransferases (SULTs)) biotransformation enzymes, and antioxidant enzymes 
(superoxide dismutase (SOD), catalase (CAT)) (Van der Oost et al., 2003; Bard, 2000; 
Stegeman et al., 1992; Lopez-Torres et al., 1993). In addition to these defence systems it 
is also relevant to understand the regulation of genes encoding for the proteins involved in 
the detoxification system. Nuclear receptors (NRs) are a family of key regulators, 
modulating several biological pathways including cellular detoxification, lipid metabolism, 
reproduction or development (Xu et al., 2005; Chai et al., 2013). In mammals pregnane X 
receptor (PXR), peroxisome proliferated activated receptor (PPAR), liver X receptor 
(LXR), farnesoid X receptor (FXR), retinoid X receptor (RXR), constitutive androstane 
receptor (CAR) and glucocorticoid receptor (GR), among others, have been identified as 
key regulators of this important defence mechanism (Xu et al., 2005; Pavek and Smutny, 
2014). Nonetheless, in fish there is still scarce information on NRs and their role in 
regulation of the detoxification system even though the evidences points to similar 
regulatory mechanisms as in mammals. There are numerous contaminants typically 
present in complex environmental mixtures that might interfere with regulatory 
mechanisms or NRs. These interactions can disturb the regulation of different defence 
and metabolic processes which can impair fish survival and ecosystems regeneration for 
long term. For this reason is of crucial importance to study the mode of action of emerging 
environmental contaminants, like pharmaceuticals (Fent et al., 2006), personal care 
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products (PCP) (Peck, 2006) and hazard and noxious substances (HNS), being the last 
two the least studied. Testing the toxicity of contaminants requires the use of vertebrates 
and particularly fish, when it concerns aquatic toxicology. For ethical reasons, the 
replacement of animal testing will be required nevertheless various alternative approaches 
for predicting environmental risks of chemicals are available, including analyses of 
structure-activity relationships or toxicity tests with cell-based systems and fish embryos 
(Scholz et al., 2008). In contrast to cellular replacement methods, such as fish cell lines 
(Schirmer, 2006), the embryo model offers a complex, multicellular system integrating the 
interaction of various tissues and differentiation processes. According to current European 
Union legislation for the protection of animal used for experimental and other scientific 
purposes, the use of embryonic stages of vertebrates is not regulated (Commission of the 
European Communities Council, Directive 2010/63/EU). Hence, experiments with 
embryos are considered as alternative to animal experiments (Fleming, 2007). Zebrafish, 
Danio rerio, is widely accepted as an ecotoxicological model specie, showing interesting 
features such as short life-cycle, embryo transparency and fully sequenced genome 
(Baker and Hardiman, 2014). 
1.2 Pharmaceuticals and personal care products origins in the aquatic environment 
New and unknown chemicals reach the aquatic systems and risk assessment has 
to be performed in order to protect the organisms, aquatic communities and the 
ecosystem. In recent years as a consequence of new and better analytical chemistry and 
technology advances, many emergent compounds have been detected and identified in 
water at low concentrations (ranging from ng/L to μg/L), including pharmaceuticals and 
personal care products (PPCPs) (Kim et al., 2009; Lapworth et al., 2012; Stuart et al., 
2012; Jiang et al., 2013; Díaz-Cruz and Barceló, 2015). These compounds are called 
emerging pollutants because are usually found in low concentrations and only in the last 
decades have been detected in the environment, have high production and daily 
consumption and pose a risk to health and the environment. PPCPs found in the 
environment result from agricultural activities, household and industrial effluents, 
pharmaceutical production, and hospital, veterinary and aquaculture waste treatment 
stations. Waste waters ultimately will undergo purification in waste water treatment plants 
(WWTP), however a complete and efficient removal of contaminants is not guaranteed 
and PPCPs can end up in effluents, groundwater and surface water and also in drinking 
water (Santos et al., 2010; Lapworth et al., 2012; Jiang et al., 2013). The growing data 
about the presence of these compounds in aquatic ecosystems increased the number of 
studies focusing on the effects in non-target organisms and their environmental fate, 
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demonstrating their detrimental effects which make it important to further research their 
impact and effects on these organisms, trophic populations and the overall affected 
aquatic ecosystem (Ferrari et al., 2003; Brausch and Rand, 2011). 
1.2.1 Pharmaceuticals  
Pharmaceuticals are detected mostly in WWTPs effluents but also in surface and 
ground waters (Heberer, 2002; Santos et al., 2010; Verlicchi et al., 2012). Different 
classes of therapeutic drugs have been detected in water, including analgesic, anti-
inflammatory drugs, β-blockers, antibiotics, hypolipidemics, antiepileptics and 
psychopharmaceuticals (Santos et al., 2010) (Fig. 1.1). Pharmaceuticals are designed to 
act and target metabolic pathways in humans, nonetheless, they can have the same effect 
in aquatic organisms with conserved pathways (Bound and Voulvoulis, 2004; Castro and 
Santos, 2014). The manufactures of these drugs are subject to various safety controls and 
approval processes, but studies with non-target organisms are often not included. 
Mortality, anomalies, reproduction and behavioural effects (Ferrari et al., 2003; Fent et al. 
2006; Corcoran et al. 2010; Ribeiro et al., 2015; Ortiz de García et al., 2014) are 
detrimental effects already associated with exposure to pharmaceuticals. Ethinyl estradiol, 
a synthetic estrogen used in contraceptive pills, caused one of the most alarming effects 
which included feminization of fish (Folmar et al., 1996; Larsson et al., 1999; Jobling et al., 
2002), also TBT can cause masculinization in female invertebrates (Matthiessen et al., 
1998; Santos et al., 2005) as examples of reproductive disruption. Other example is the 
exposure to diclofenac, a non-steroid anti-inflammatory that had a lethal toxicological 
impact in the vulture’s community in India (Oaks et al., 2004; Swan et al., 2006). Taking 
this information into account and the lack of studies with certain classes of 
pharmaceuticals, in this study the ones selected were based on their increasing 
consumption, detection in aquatic environments and their expected effects on conserved 
pathways. Thus, diclofenac (Non-steroidal anti-inflammatory drug), simvastatin 
(hypolipidemic drug), sertraline and fluoxetine (antidepressants) were chosen for this 
study (Table1). 
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Non-steroidal anti-inflammatory drugs (NSAIDs) are prescribed to reduce 
inflammation and manage pain. They act by the inhibition of prostaglandin synthesis by 
inhibiting cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) reducing pain and 
inflammation. Diclofenac is one of the most prescribed NSAIDs drugs and maybe the first 
one to be detected in the aquatic environment (Buser et al., 1998). NSAIDs that enter 
WWTPs are poorly eliminated and have been detected in water systems worldwide 
(Carballa et al., 2004; Santos et al., 2010). Portugal is not different from other countries 
and diclofenac is also one of the NSAIDs identified in water systems ranging from 3.1 to 
1597 ng/L (Sousa et al., 2011; Pereira et al., 2015). In aquatic organisms, invertebrates 
and vertebrates, diclofenac has demonstrated the ability to induce deleterious effects like 
tissue damage, impaired reproduction, abnormal embryo development or oxidative stress 
(Schwaiger et al., 2004; Mehinto et al., 2010; Ribeiro et al., 2015; Guiloski et al., 2015; 
González-Ortegón et al., 2015). The changes on these parameters can in the long term 
compromise aquatic organisms survival, and to what extent those impacts will damage 
ecosystems services is yet to be determined. 
Antidepressant drugs are an important group of pharmaceuticals and Selective 
Serotonin Reuptake Inhibitors (SSRIs) are a common class used to treat human 
depression, anxiety, obsessive-compulsive disorders, and panic disorders (Silverstone, 
2004). SSRIs like, fluoxetine (FLU) and sertraline (SER) inhibit the reuptake of serotonin 
Figure 1.1: Pharmaceutical classes detected in the environment. Adapted from Santos et al., 2010. Classes 
at bold represent the pharmaceuticals studied in this thesis 
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Table 1 Names, molecular structure, molecular weights, CAS numbers, log Kow values, aqueous solubility of test pharmaceuticals 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Compound Molecular 
structure 
MW CAS number Log Kow Aqueous solubility (mg/L) 
[chemspider.com] 
diclofenac 
 
318.1 15307-79-6 0.7 15906.5 
fluoxetine 
 
345.8 56296-78-7 4.17 3457.9 
sertraline 
 
342.7 79559-97-0 5.15 1713.5 
simvastatin 
 
418.6 79902-63-9 4.68 0.7653 
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by their carriers (serotonin transporter or SERT) in the presynaptic membrane, increasing 
serotonin concentration in the synaptic clefts, stimulating serotonergic neurotransmission 
(Kreke and Dietrich, 2008; Valenti et al., 2012). FLU and SER are commonly prescribed 
psychopharmaceuticals that can be found at low concentrations in aquatic environments 
(Santos et al., 2010; Metcalfe et al., 2010; Silva et al., 2014). In Portugal FLU has been 
detected in influents and effluents of different WWTPs in concentrations ranging from 4 to 
157.4 ng/L (Silva et al., 2014). Despite the low concentrations found, studies evaluating 
the effect of this drug in non-target organisms are important as it prescription is increasing 
worldwide (Silva et al., 2012). Fish exposure to psychopharmaceuticals revealed 
behavioural changes such as decreased aggressiveness and feeding responses however 
it also impaired reproduction and mortality have been overserved (Lister et al., 2009; 
Santos et al., 2010; Schultz et al., 2011). Furthermore, behavioural changes in 
invertebrates has been reported, like reduced locomotor activity or camouflage ability 
impairing their ability to escape or to foraging (Fong et al., 2014; Chen et al., 2015) and in 
addition it was also shown to be embryotoxic (Minguez et al., 2014; Di Poi et al., 2014). 
Behavioural changes can have a significant impact in population dynamics that ultimately 
could alter the functioning of the ecosystem. 
Hypolipidemic drugs are divided in two groups, statins and fibrates. Statins are one 
of the most prescribed pharmaceuticals for reduction of cholesterol. It acts by inhibiting 3-
hydroxy-3-methylglutaryl-coenzymeA reductase (HMG-CoA) limiting the HMG-CoA 
conversion into mevalonate and increasing low density lipoproteins cholesterol (LDL-C) 
receptors and LDL-C uptake (reviewed in Fent et al., 2006).  
Simvastatin (SIM) is one statin frequently prescribed to reduce mortality and 
morbidity from coronary heart diseases (Yang et al., 2011) and the use of this 
pharmaceutical is increasing in western societies due to feeding and sedentary habits. In 
aquatic environments SIM has been found at low concentrations in the order of ng/L 
(Santos et al., 2010; Ottmar et al., 2012). In Portugal SIM concentration levels found in the 
aquatic environment are similar to those found in other European countries ranging from 
0.7 to 2052 ng/L (Sousa et al., 2011; Pereira et al., 2015). Only a few studies have 
addressed statins toxicity in aquatic organisms (Key et al., 2008; Ellesat et al., 2011; 
Neuparth et al., 2014; Ribeiro et al., 2015). Nevertheless, in fish SIM showed toxic effects, 
causing abnormalities in zebrafish embryos and cytotoxicity in hepatocyte cultures of 
marine fish (Ellesat et al., 2011; Ribeiro et al., 2015). Also to aquatic invertebrates SIM 
displayed toxic effects impairing growth, reproduction and gonad maturation (Neuparth et 
INTRODUCTION 
 
9 
al 2014; Key et al., 2008).  The impairing of organisms development and overall survival 
can in the long term compromise aquatic populations and damage ecosystems. 
1.2.2 Personal care products 
Personal care products (PCPs) are synthetic organic compounds present in 
different common products such as lotions, tooth paste, detergents, cosmetics, 
(Daughton, 2004; Ellis, 2006; Brausch and Rand, 2011). PCPs reach the aquatic 
environment mainly through household’s waste waters. WWTPs usually are not prepared 
to eliminate these chemicals hence PCPs can enter the water systems (Daughton, 2004; 
Ellis, 2006). Some studies indicate that these compounds once present in surface waters 
can be eliminated naturally through volatilization, photolysis, biodegradation and/or 
sorption (Buerge et al., 2003, Chase et al., 2012). Nonetheless, PCPs have been detected 
in aquatic ecosystems (Button and Juttner, 1989; Peck and Hornbuckle, 2004; Díaz-Cruz 
and Barceló, 2015) and the EU Water Framework Directive has identified some of these 
chemicals as future emerging priority candidates for regulation and monitoring (EPA, 
2012; European Comission, 2012). Additionally, some studies demonstrated that PCPs 
may lead to toxicity effects, and some mimic natural hormones, which can induce 
endocrine-disruption in aquatic organisms (Daughton and Jones-Lepp, 2001; Daughton, 
2004; Ternes et al., 2004; Grung et al., 2007; Brausch and Rand, 2011), highlighting the 
need for a more extensive monitoring of their biological impacts.  
The PCPs selected for this study were chosen based on their increasing 
consumption, detection in aquatic environments and lack of risk assessment information; 
synthetic musks (celestolide, musk xylene, musk ketone), essential oils (nerol, citronellol, 
isoeugenol, camphene, α-amylcinnamaldehyd, α-hexylcinnamaldehyd) and preservatives 
(propylparaben) (Table 2). 
 
CHAPTER I 
 
10 
                              Table 2 Names, molecular structure, molecular weights, CAS numbers, log Kow values, aqueous solubility of test PCPs. 
Compound Molecular structure MW CAS number Log Kow Aqueous solubility 
(mg/L) 
[chemspider.com] 
propylparabene 
 
180.2 94-13-3 2.71 529.3 
α-amylcinnamaldehyde 
 
202.2 122-40-7 4.33 9 
α-hexylcinnamaldehyde 
 
216.3 101-86-0 4.82 2.75 
citronellol 
 
156.3 106-22-6 3.91 105.5 
camphene 
 
136.2 79-92-5 4.22 6 
isouegenol 
 
164.2 97-54-1 3.04 165.9 
nerol 
 
154.2 106-25-2 3.47 255.8 
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musk xylene 
 
297.3 81-15-2 2.25 61.35 
musk ketone 
 
294.3 81-14-1 2.11 83.59 
celestolide 
 
244.4 13171-00-1 5.93 0.22 
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Synthetic musks are widely used fragrances and fixative compounds found mostly 
in detergents, air fresheners and cosmetic and hygienic products (Luckenbach and Epel, 
2005; Mottaleb et al., 2012). These musks are divided into polycyclic, nitro, macrocyclic 
and alicyclic musks (Arbulu et al., 2011), and although they are structurally distinct 
molecules, they all have the same typical musk odour. Nitro musks (such as musk xylene, 
musk ketone) consist of dinitro- and trinitro- substituted benzene derivatives. In Europe 
musk xylene and musk ketone usage is restricted but it is allowed in North America, 
although excluded from products for oral uptake (Luckenbach and Epel, 2005). Polycyclic 
musks (e.g. Celestolide) comprise indane and tetraline derivatives substituted mainly by 
methyl groups. Macrocyclic musks are more recent fragrances with large ringed ketones 
and lactones and are chemically similar to animal and plant musk odorants (Sumner et al., 
2010). Alicyclic musks are also a novel class of musks and are trisubstituted cyclopentene 
derivative that differ from the other musk classes because they are modified akyl esters 
(Eh, 2004). Studies showed the presence of synthetic musks in aquatic environments 
ranging from 0.02 up to 5000 ng/L, as well as in aquatic species tissues such as 
cetaceans, fish and invertebrate organisms (Gattermann et al., 2002; Nakata, 2005; Chen 
et al., 2007; Chase et al., 2012; Paxeus, 1996; Peck and Hornbuckle, 2004). Studies in 
fish revealed musks can inhibit components of cell detoxification mechanisms, such as 
MXR and biotransformation enzymes (Fischer et al., 2013; Fernandes et al., 2013). In 
invertebrates, musks impaired larval development, reduced the growth rate and 
compromised multixenobiotic defence systems (Breitholtz et al., 2003; Luckenbach et al., 
2004; Gooding et al., 2006).  
Essential oils are concentrated, hydrophobic chemicals containing volatile aromatic 
compounds from several components of plants and exert diverse biological and 
pharmacological properties, such as antimicrobial activity (Teixeira et al., 2013). These 
compounds can be easily obtained by simple processes of maceration and water solution 
or steam distillation and are used in food preservation, fragrance industry and 
aromatherapy (Brophy and Doran 1996). The most important active compounds are 
included in two chemical groups: terpenoids (nerol, citronellol, camphene) and 
phenylpropanoids (isoeugenol, α-amylcinnamaldehyd, α-hexylcinnamaldehyd). Essential 
oils have been detected in aquatic environments in concentrations ranging from 0.38 to 
121 x 103 ng/L (Button and Juttner, 1989; Belknap et al., 2006; Švestková and Vávrová, 
2015). Not many studies were performed evaluating the effects of essential oils in non-
target organisms, even though some results showed that these chemicals exhibited 
toxicity levels in Daphnia magna or Artemia salina (Conti et al., 2014; Rodrigues et al., 
2013). 
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Parabens are antimicrobial preservatives of large spectrum, high solubility in water 
and stability across a wide pH range and are found in creams, lotion, shampoos, 
pharmaceuticals and food products (Brausch and Rand, 2011; Yamamoto et al., 2011). 
Some parabens species are rapidly absorbed through the skin and can accumulate in 
fatty components of tissues like other lipophilic compounds (Darbre et al., 2004; Tavares 
et al., 2009) and due to this some studies related the prolonged dermal exposure to 
parabens with breast cancer (Darbre et al., 2004). Among paraben species, 
propylparaben is one of the most commonly used in cosmetics (Brausch and Rand, 2011) 
and is frequently detected in the aquatic environment ranging from 7.9 to 20000 ng/L 
(González-Mariño et al., 2012; Albero et al., 2012; Haman et al., 2015). In aquatic 
organisms some studies reported a potential estrogenic activity of parabens (Yamamoto 
et al., 2011; Albero et al., 2012). 
The frequent detection and presence of these PPCPs in the aquatic environment 
as well as the toxic effects already reported highlight the need for further studies regarding 
their effects in aquatic organisms.  
1.3 Nuclear receptors and AhR – pathways for homeostasis and cellular 
detoxification 
Aquatic organisms as other vertebrate have developed a complex biochemical 
defence that biotransform and eliminate potentially toxic chemicals in order to minimise 
associated deleterious effects (van der Oost et al., 2003; Bard, 2000; Stegeman et al., 
1992; Lopez-Torres et al., 1993). Crucial to the regulation of genes involved in these 
detoxification mechanisms are a number of ligand-activated nuclear receptors (NRs) and 
the Aryl hydrocarbon receptor (AhR) (Xu et al., 2005; Chai et al., 2013). The NRs can 
regulate key biological functions such as development, reproduction, homeostasis, 
metabolism and immune function (Francis et al, 2003; Xu et al., 2005). In mammals 
several important regulators (xenobiotics receptors) of the detoxification system have 
been identified, such as, nuclear factor-erythroid 2 p45- related factor (Nrf2), pregnane X 
receptor (PXR), peroxisome proliferated activated receptor (PPAR), liver X receptor 
(LXR), farnesoid X receptor (FXR), retinoid X receptor (RXR), constitutive androstane 
receptor (CAR) and glucocorticoid receptor (GR) (Xu et al., 2005; Ferreira et al., 2014). In 
fish the information is still scarce but there are some studies that indicate some of these 
NRs are related with downstream genes and their role in detoxification mechanism, 
nevertheless more studies have to be performed to understand which NRs regulate which 
defence protein (Corcoran et al., 2012; Aleksunes and Klaassen, 2012; Chang et al., 
2013; Wassmur et al., 2010; Cocci et al., 2013) 
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In humans NRs have been identified which are activated by endogenous and 
exogenous compounds like sex hormones, fatty acids, vitamins and drugs (le Maire et al, 
2010) and since many pathways are conserved in fish one can assume that the same 
occurs in these organisms. NRs are divided in subfamilies depending on their dimerization 
and DNA-binding properties (Mangelsdorf et al., 1995; Laudet, 1997). However, they all 
share a common domain structure that comprehends three main domains: an N-terminal 
A/B domain, a central DNA-binding C-domain (DBD), linked via a hinge region to a C-
terminal ligand-binding E domain (LBD) (Aranda and Pascual, 2001) (Fig. 1.2).  The A/B 
domains are relatively low conserved and it has been suggested to have a transactivation 
function, activation function (AF-1) in many receptors (Juge-Aubry et al., 1999; 
Chamberlain et al., 1996; Sturm et al., 2010). The DBD domain is a highly conserved 
region composed of two zinc finger structures (Huckaby et al., 1987; Luisi et al., 1991) 
that mediate the binding of the NRs to a specific DNA sequence, termed response 
element, a prerequisite for the regulation of target genes by NRs (Mangelsdorf et al., 
1995). 
 
The first zinc finger is responsible for the high-affinity recognition of the "core half-
site" of the response element while the second zinc finger mediates the receptor 
dimerization and nuclear localization of the receptor (reviewed in Jiang, 2004). NRs can 
bind to DNA as heterodimers, homodimers, or monomers, depending on the class (Franco 
et al., 2003). The hinge region is located between DBD and LBD and seems to function in 
association of coregulatory proteins (cofactors) with the ligand binding region in several 
nuclear hormone receptors. LBD domain has the second ligand (AF-2) whose role in 
receptor activation is dependent on a conformational change of the LBD, induced by 
interactions with an activating ligand (reviewed in Jiang, 2004). Has been reported that 
deletion of AF-2 leads to a constitutively active receptor, scientists assume that AF-1 
functions in a ligand-independent manner (Hollenberg et al, 1987; Tora et al, 1989). 
Figure 1.2: Schematic structure of a nuclear receptor 
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Moreover LBD contacts both coactivator and co-repressor proteins when active and 
inactive conformations, and together with the DBD has a role in dimerization. 
In this study we focused our attention to some of the known mammalian 
xenobiotics receptors that have been identified in different fish species, such as PXR, 
PPAR, RXR and RAR as well as AhR, and with evidences pointing to a role in the 
regulation of genes from the detoxification mechanism (Corcoran et al., 2012; Aleksunes 
and Klaassen, 2012; Chang et al., 2013; Wassmur et al., 2010; Cocci et al., 2013; Hessel 
and Lampen, 2010; Stromskaya et al., 1998). 
1.3.1 Pregnane X receptor (PXR) 
PXR (NR1I2) in mammals mediates biological functions such as immune and 
inflammatory responses or lipid metabolism (di Masi et al., 2009; Smutny et al., 2013; Ma 
et al., 2015). This NR has been commonly designated as a xenobiotic sensor that 
regulates a variety of genes involved in metabolism and elimination of exogenous 
chemicals and endogenous molecules (Xu et al., 2005; Wang et al., 2012). It has been 
identified in several vertebrates like mammals, birds, fish and amphibians (Reschly & 
Krasowski 2006), and in mammals PXR is predominantly expressed in liver, intestine and 
kidney (Kliewer et al., 1998). PXR requires heterodimerization with RXR for high-affinity to 
pregnane x receptor response element (PXRRE) and modulate the transcription of 
adjacent genes (di Masi et al., 2009). Due to it large LBD this NR demonstrate a high 
flexibility during ligand-binding allowing it to be activated by a wide range of ligands which 
include bile acids, steroid hormones or synthetic drugs (di Masi et al., 2009). In fish PXR 
has been associated to the modulatation of key genes from the detoxification system, like 
cyp3a, gst, abcb1 or abcc2, when exposed to different xenobiotics (Wassmur et al., 2010; 
Corcoran et al., 2012; Kubota et al., 2015). 
1.3.2 Peroxisome proliferated activated receptor (PPAR) 
PPARs are members of the nuclear receptor superfamily with functions in lipid, 
carbohydrate and protein metabolism, adipogenesis, development, inflammatory response 
and xenobiotics metabolism (Janani and Ranjitha Kumari, 2015; Ipseiz et al., 2014; Xu et 
al., 2005). These NRs include three subtypes members (PPARα, PPARβ and PPARγ) 
and where identified in several species such as fish, birds and amphibians (Krey et al., 
1993; Diot and Douaire, 1999; Andersen et al., 2000). PPARs also need to heterodimerize 
with RXR to bind to the peroxisome proliferator responsive elements (PPREs) and 
regulate transcription of their target genes (Marcus et al., 1993). The LBD of PPAR is 
unusually large making this receptor relatively promiscuous and activated by different 
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natural or synthetic ligands, such as fatty acids, eicosanoids, synthetic hypolipidemic and 
antidiabetic agents (O’Sullivan, 2007). In mammals PPAR/RXR regulates the transcription 
of phase I and II biotransformation genes and antioxidant genes but also genes involved 
in lipid metabolism inflammatory and immune homeostasis (Xu et al., 2005; Janani and 
Ranjitha Kumari, 2015). Previous studies found interactions between xenobiotics and 
PPARs, like TBT and phthalates, suggesting that peroxisome proliferation could be used 
as a biomarker of environmental pollution (Cajaraville et al., 2003; Desvergne et al., 
2009). In a recent study, with juvenile sole exposed to 4-nonyphenol pparα mRNA was 
associated with cyp1a1 and cyp3a4 mRNA, suggesting that PPARα can modulate phase I 
biotransformation enzymes (Cocci et al., 2013). 
1.3.3 Retinoid acid receptor (RAR) and retinoid x receptors (RXR) 
There are two families of retinoid receptors: RAR and RXR with a similar structure 
that consist in three isotypes α, β and γ. RXRs are unique NRs because they can form 
heterodimers with PXR, PPAR and RAR but also form homodimers, hence participate in 
several regulatory pathways depending on the partner (reviewed in Lengqvist et al., 
2004). There are two types of heterodimers: nonpermissive, where the complex is 
activated only by the other partner’s ligand (Kurokawa et al., 1994) or permissive, where 
ligands from both NRs can activate the complex (Kliewer et al., 1992). RAR requires 
binding to RXR to regulate transcriptional activity, but generally the RXR activity is 
silenced (Theodosiou et al., 2010). RARs have high affinity to retinoid acid (RA) in the all-
trans conformation, whereas RXR can be activated by RA but also other natural and 
synthetic ligands such as phytanic acid or methoprene (Giguére, 1999). Detoxification 
genes, like efflux proteins (mdr1 and abcg2) and phase I (cyps) where found to be 
induced via RAR/RXR in mammals (Stromskaya et al., 1998; Howel et al., 1998; Hessel 
and Lampen, 2010). The presence of these NRs in fish is already recognized, however 
the modulation of downstream genes via RAR/RXR is not well understood. Nonetheless, 
RXR seem to be involved, through the RXR-NRs complex, in the regulation of several 
biotransformation and elimination genes (Traber, 2004; Xu et al., 2005; Pérez et al., 
2012). 
1.3.4 Aryl hydrocarbon receptor (AhR) 
AhR is related to functions, such as the regulation of immune response, cell cycle, 
proliferation and tumour promotion (Vondracek et al., 2011). In mammals AhR modulates 
many genes responsible for cellular detoxification, like phase I, II, antioxidant enzymes 
and efflux transporters (Xu et al., 2005; Kawajiri and Fujii-Kuriyama, 2007; Tompkins et 
al., 2010). Their high-affinity to polycyclic aromatic hydrocarbon compounds (PAH) is the 
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best characterized but it is also activated by other chemicals like aflatoxins or omeprazole 
(Stegeman and Hahn, 1994; Denison et al., 2011). In mammals, it is mainly expressed in 
lungs, placenta, spleen and ovaries (Yamamoto et al., 2004). The inactive AhR is located 
in the cytosol as a multi-protein complex with chaperone proteins (e.g. heat shock protein 
90) (Beischlag et al., 2008; Denison et al., 2011). After ligand binding AhR suffers a 
conformational change facilitating the translocation of the complex into the nucleus and 
heterodimerize with the aryl hydrocarbon receptor nuclear translocator (ARNT). This 
heterodimer (AhR-ARNT) then binds to xenobiotic response elements (XRE) in the 
promoter region of target genes, activating their transcription (Beischlag et al., 2008; 
Denison et al., 2011). In fish, both AhR and ARNT have been identified (Andreasen et al., 
2002) and the signalling pathway is believed to be analogous to mammals, regulating 
cyp1a and cyp3a65 (Chang et al., 2013; Andreasen et al., 2002). Some studies described 
that exposure to benzo[a]pyrene (BaP) a known ligand of AhR induced the expression of 
phase I and II enzymes and ABC transporter mRNA in fish (Costa et al., 2011; Yuan et al., 
2014). 
1.4 Cell detoxification mechanism 
The combined actions of efflux proteins and biotransformation enzymes increase 
the cell’s capability to eliminate the xenobiotics and inhibit their accumulation inside the 
cell and the organism. The detoxification mechanism involve four phases of action, which 
involve biotransformation enzymes active in phase I and II, and efflux transporters that are 
active in phase 0 or III (Xu et al., 2005) (Fig. 1.3). A better description and function of the 
components detoxification mechanism are described in the next sections. 
Figure 1.3: Schematic representation of the mechanisms involved in detoxification of xenobiotic compounds 
in cells. Xenobiotics induced the activation of specific receptor-mediated gene expression of phase I 
enzymes, phase II enzymes, other stress enzymes and phase 0 and phase III transporters, which result in the 
enhancement of xenobiotic detoxification  
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1.4.1 ABC transport proteins – phase 0 and III 
Research on ATP – binding cassette (ABC) transporters has been mostly directed 
to chemotherapy resistance studies, due to a phenomenon called MDR (multidrug 
resistance) mediated by ABC proteins characterized by the low cellular accumulation of 
anticancer drugs (reviewed in Gottesman and Ling, 2006). MDR was initially related to the 
high levels of a membrane glycoprotein, denominated P-glycoprotein (Pgp) belonging to 
ABCB subfamily (Juliano & Ling, 1976; Sparreboom et al., 2003). In aquatic organisms, a 
mechanism analogous to the MDR, was proposed as a defence system allowing them to 
survive in contaminated environments with anthropogenic or natural toxic compounds, 
termed multixenobiotic resistance (MXR) (Kurelec, 1992). In aquatic species ABC proteins 
efflux toxicants and their metabolites out of the cells and are therefore denominated as a 
first line of defence (Bard, 2000; Epel et al., 2008). MXR was identified in different aquatic 
species including crabs (Kohler et al., 1998), molluscs (Luckenbach and Epel, 2008; Faria 
et al., 2011) and fish (Costa et al., 2012; Ferreira et al.,2014;  Zaja et al., 2008) including 
zebrafish (Long et al., 2011; Fischer et al., 2013).   
These proteins transport a large variety of endogenous and/or exogenous 
molecules (including phospholipids, ions, peptides, steroids, polysaccharides, amino 
acids, drugs and xenobiotics) across cellular membranes using ATP as driving energy 
(Higgins, 1992; Dean et al., 2001). 
ABC proteins are grouped into eight subfamilies in eukaryotes, ABCA to ABCH (H 
subfamily has been only found in Danio rerio, and also some invertebrates like Daphnia 
pulex, Tigriopus japonicus and Apis mellifera) (Table 3), (Dean and Annilo, 2005; Popovic 
et al., 2010; Jeong et al., 2014). Among all efflux proteins families the most relevant in a 
toxicological context are the ABCB, ABCC and ABCG families (Epel et al., 2008). Usually, 
a functional protein contains two nucleotide binding domains (NBDs) and two membrane 
spawning domains (MSDs) (Locher 2009) (Fig. 1.4). The NBDs are located in the 
cytoplasm and are responsible for ATP binding and hydrolysis, providing the required 
energy to transport substrate compounds across the cellular membrane. The NBDs are 
characterized by highly conserved Walker A, Walker B and C-motifs and the so-called 
ABC signature (Walker et al., 1982; Hyde et al., 1990). MSDs are composed by 6-10 
membrane spawning α-helices that confer the substrate specificity (Locher, 2009) and 
enable transport due to conformational changes within the MSD (Linton and Higgins, 
2007). Eukaryotic ABC proteins can be designated as full transporters (containing two 
NBDs and two or three MSDs), or as half transporters (containing one NBD and one 
MSD), that have to form homo- or heterodimers in order to constitute a functional protein 
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(Dean et al., 2001). The study of efflux proteins started due to the recognition of ABCB1 
implication in the multidrug resistance (MDR) phenomenon preventing the action of 
chemotherapy in cancer cells (Juliano and Ling, 1976; Gottesman and Ling, 2006). In the 
beginning of the 90’s also ABCC and ABCG proteins were associated with MDR (Cole et 
al., 1992; Kool et al., 1997; Doyle et al., 1998). The three ABC transporter subfamilies 
have been associated with different phases of the detoxification mechanism. ABCB1 is so 
called the “first line of defence” directly effluxing unmodified compounds when they cross 
the membrane, therefore named phase 0 of cellular detoxification. ABCC and ABCG 
transporters efflux mainly metabolites of phase I and II from the cell, such as oxidized 
molecules and glutathione-, glucuronic acid- or sulphate-conjugates, hence described as 
phase III of cellular detoxification (Bard, 2000; Epel et al., 2008).  
ABCB1, ABCC and ABCG-like-transporters have been identified in aquatic 
invertebrates (Chen et al., 2015; Faria et al., 2011) and vertebrates including several 
teleost fish species (Hamdoun et al., 2002, Luckenbach and Epel, 2008; Costa et al., 
2012). In mammals the presence of these proteins in the blood-tissue barriers, like blood-
brain barrier, protects specific tissues against toxicants (Schinkel, 1999). In aquatic 
organisms, efflux transporters can act as selective permeable “environment-tissue 
barriers” with the surrounding aqueous phase, allowing them to survive and reproduce in 
polluted environments (Luckenbach and Epel, 2008). 
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Table 3: Members of the human ABC transporter superfamily and function (based on Dean and Annilo, 2005, Szakacs et al., 2008, Slot et al., 2011) 
 
 
 
 
 
 
Subfamily 
 
Members Functions 
ABCA ABCA1-ABCA13 Cholesterol efflux, phosphatidil choline efflux, Nretinylidiene-PE efflux , Skin Barrier Function 
ABCB ABCB1 to ABCB11 Peptide transport; iron transport; Fe/S cluster transport; bile salt transport; xenobiotics 
transport 
ABCC ABCC1 to ABCC13 Organic anion efflux, nucleoside transport, chloride ion channel, sulfonylurea receptor, 
potassium channel regulation,  toxin transport 
ABCD ABCD1 to ABCD4 Very long chain fatty acids transport regulation 
ABCE ABCE1 Elongation factor complex 
ABCF ABCF1 to ABCF3 Translation Initiation 
ABCG ABCG1 to ABCG5 Cholesterol transport, sterol transport, toxin transport 
ABCH ABCH1 Unknown function 
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Superfamily ABCB  
This family contain the most studied and characterized protein of the ABC 
transporters, the ABCB1 (MDR1, Pgp) (Fig. 1.4a). Pgp is a protein ranging from 130 to 
170 kDa, depending on the degree of glycosylation (Dong et al., 1996). It is expressed in 
cancer cells, plasma membranes on the apical side of cells of intestine, kidney, liver, lung, 
placenta, testis, uterus tissues and the blood-brain barrier (Szakács et al., 2008). ABCB1 
is a promiscuous protein that transport exogenous and endogenous compounds and its 
substrates are mostly hydrophobic cations, amphiphilic drugs, antibiotics, insecticides, 
herbicides or fungicides (Leslie et al., 2005; Szakacs et al., 2008). The reason for the 
promiscuity of this protein is still unclear but some studies indicated that characteristics 
like moderate hydrophobicity and positively charged or neutral domains are cause for this 
fact (Schinkel and Jonker, 2003). In zebrafish, our research model, the abcb1 orthologue 
is absent, but a recent study demonstrated that abcb4 and abcb5 are structurally similar to 
abcb1 in mammals, and that Abcb4 protein has the same functional properties of ABCB1 
(Fischer et al., 2013). Hence Abcb4 can play a role in the bioavailability and toxicology of 
contaminants in this animal model. 
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a) ABCB1 
b) ABCC 
c) ABCG2 
Figure 1.4: Predicted structures of ABC transporters. a) predicted structure of ABCB1; b) predicted 
structure of “long-chain” ABCC proteins; c) predicted structure of ABCG2. Lipidic bilayer is shown in 
grey, membrane spawning domains (MSDs) in light brown and nucleotide binding domains (NBDs) in 
yellow (A - Walker A, B - Walker B, C - C-motif). Adapted from Ferreira et al., 2014. 
INTRODUCTION 
 
23 
Superfamily ABCC (MRPs – Multiresistance associated proteins) 
ABCC subfamily (Fig. 1.4b) comprises a total of 13 members, and includes 10 
“multi-drug resistance associated proteins” (ABCC1, ABCC2, ABCC3, ABCC4, ABCC5, 
ABCC6, ABCC10, ABCC11, ABCC12 and ABCC13) but also cystic fibrosis 
transmembrane conductance regulator (CFTR/ABCC7) and ATP-dependent potassium 
channel regulators, such as the sulfonylurea receptors SUR1/ABCC8 and SUR2/ABCC9 
(Cole et al., 1992; Deeley et al., 2006). The members of the ABCC subfamily can be 
divided in two different subclasses, “short” and “long” proteins (Deeley et al., 2006; 
Honorat et al., 2009). The “long” ABCC transporters (ABCC1, 2, 3, 6, 10 and 13) have an 
additional N-terminal MSD (MSD0) in comparison to the “short” transporters (ABCC4, 5, 
11 and 12). These transporters are ~190kDa proteins, and share a small percentage (14-
25%) amino acid identity with ABCB proteins (Cole et al., 1992; Keppler and Konig, 1997). 
There are evidences that suggest that ABCB and ABCC can operate either as 
homodimers or heterodimers (Graf et al., 2003; Xu et al., 2004). Several studies 
performed with different animal models indicate that ABCC1, ABCC2, ABCC3, ABCC4 
and ABCC5 are the most relevant MRPs in a toxicological level in mammalian tissues 
although ABCC1 and ABCC2 are the best characterized transporters in this family 
(Szakacs et al., 2008). ABCC1 (MRP1) shows ubiquitous tissue distribution with higher 
expression levels in the kidney, lung, testis, skeletal muscle and peripheral blood 
mononuclear cells in mammals (Cole et al., 1992; Flens et al., 1996) and is located on the 
basolateral membrane of epithelial cell layers (Cole et al., 1992) effluxing its substrates 
into the blood (Evers et al., 1996). ABCC2 (MRP2) is localized in the apical membrane of 
cells from liver, intestine and kidney, placenta, lungs, intestine and blood-brain barrier 
(Schinkel and Jonker, 2003). ABCC2 is essential for cellular detoxification effluxing 
diverse metabolites into bile, intestinal lumen and urine (Haimeur et al., 2004). ABCC1 
and ABCC2 substrates are very similar and include glutathione-, glucuronate- and sulfate-
conjugates, bile acids and different drugs and their metabolites (Cekic et al., 2003; Nies 
and Keppler, 2007) therefore their role associated with phase III of the detoxification 
process.  
Superfamily ABCG (ABCG2, BCRP - breast cancer resistance protein) 
ABCG2 protein, a member of the ABCG subfamily also known as breast resistance 
associated protein (BCRP) (Doyle et al., 1998), is a half-transporter consisting of one 
single NBD followed by one MSD (Wakabayashi et al., 2006). ABCG2 presents a different 
configuration of ABCB and ABCC whereas the MSD is followed by the NBD (Fig. 1.4c). 
This protein seems to operate as a homodimer (Doyle et al., 1998; Miyake et al., 1999; 
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Kage et al., 2002) or homotetramer (Xu et al., 2004). ABCG2 is mainly expressed in apical 
membranes of polarized epithelial cells of different organs, like intestine, placenta, blood 
brain barrier and liver (Rocchi et al., 2000; Scheffer et al., 2000). The physiological 
functions of ABCG2 involves the transport of a wide range of substrates like porphyrins, 
folic acids, bile salts, heme sulfated conjugates of steroids (Doyle and Ross, 2003, 
Haimeur et al., 2004). Studies with ABCG2 transfected mammalian cell lines have 
demonstrated high resistance of these cells against a wide variety of anticancer drugs, 
such as topotecan, mitoxantrone, doxorubicin, and daunorubicin (Sarkadi et al., 2006).  
1.4.1.1 Chemosensitisation 
Drugs that could interact with Pgp and other ABC proteins and reverse MDR by 
blocking or saturating binding sites (for example verapamil and cyclosporine A) (Barrand 
et al., 1993; Zaman et al., 1994) are called chemosensitisers. In aquatic organisms, MXR 
act as a defence system against contaminated environments (Kurelec, 1992), that can be 
compromised by chemosensitisers making the cells more sensitive to other xenobiotics 
(Kurelec, 1992) (Fig. 1.5). Efflux proteins interact with a wide range of compounds 
including environmental relevant pollutants that can be classified as substrates or 
inhibitors (chemosensitisers), however they are not mutually exclusive; some inhibitors 
are themselves transported by ABC proteins (Luckenbach et al., 2014). Due to ABC 
transporters un-specificity to chemicals, it is important to study the interaction of emerging 
compounds with these proteins to identify possible chemosensitisers that may 
compromise cell’s defence system. The chemosensitisers can block the ABC transporters 
by competitive or non-competitive inhibition binding to substrate binding sites or to other 
binding sites causing allosteric changes in the protein (Ford, 1996; Robert, 1999). 
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1.4.2 Phase I and II biotransformation enzymes   
Biotransformation of xenobiotics is a strategy adopted by organisms to cope with 
the presence of xenobiotics present in their habitats. It is defined by the transformation of 
both endogenous and xenobiotic compounds in the organism (Parkinson 1996). The 
biotransformation mechanism consist on a two-phase (phase I and II) process of 
enzymatic reactions that modify non-polar lipophilic chemicals into more polar water 
soluble metabolites, leading to the detoxification and elimination of the parent compound 
(Black and Coon, 1987; Buhler and Williams, 1989). Phase I is a non-synthetic alteration 
that include oxidation, reduction or hydrolysis transforming the parent compounds into 
metabolites which can then be conjugated in phase II to be effluxed by ABCC and ABCG 
proteins in phase III (Bard, 2000; Sturm & Segner, 2005). First discovered in mammalian 
liver, these enzymes were later found in several other animals, plants, bacteria and fungi 
(Nelson et al., 1996). These enzymes became important in ecotoxicology studies because 
they biotransform xenobiotics so that they could be excreted or transforming them in of 
more reactive metabolites, which leads to increased toxicity (reviewed in section 1.4.3) 
(van der Oost et al., 2003). Measurement of biotransformation enzymes have been also 
applied as biomarkers of biochemical effects, and as a complement to chemical analysis 
(Richardson et al., 2001; Ferreira et al., 2008). Recent studies have correlated ABC 
transporters expression and phase I and phase II enzymes in aquatic organisms exposed 
to pollutants and suggest that these systems work in a coordinated manner in xenobiotic 
detoxification (Paetzold et al., 2009, Zucchi et al., 2010; Costa et al., 2012a). 
Figure 1.5: Schematics of inhibition of efflux proteins by chemosensitizers. Chemicals (green circles) 
can enter cells by passive diffusion (dashed arrows). These chemicals then may undergo 
biotransformation metabolism (phase I and II) in metabolites (orange hexagons) that ultimately could be 
extruded by ABC transporters. In the presence of chemosensitizers (black rectangles) ABC proteins are 
inhibited, increasing the parent compound and it metabolite inside the cell, making the cells sensitive to 
their toxicity. 
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Phase I enzymes 
Phase I enzymes introduce a functional group (e.g., -OH, -COOH, -NO2) into the 
chemical through different chemical reactions (oxidation, reduction, hydration, hydrolysis), 
providing a non-synthetic alteration of the parent compound (Commandeur et al., 1995). 
Most of phase I reactions are catalysed by microsomal monooxygenase (MO) enzymes, 
also known as the mixed-function oxidase (MFO) system (cytochrome P450, cytochrome 
b5 and NADPH cytochrome reductase). The first isoenzyme of this CYP superfamily was 
described in 1962 as a new cytochrome, a membrane-bound haemoprotein (Omura & 
Sato, 1962). When this protein binds carbon monoxide, it absorbs light at 450 nm, hence 
the suffix P450 (Omura & Sato, 1962). The cytochromes P450 (CYPs) are predominantly 
located in the endoplasmic reticulum and catalyse biological oxidation and reduction 
reactions (Stegeman et al., 1992). A recent study of the zebrafish genome revealed 94 
CYP genes which can be divided into the 18 CYP gene families that are also present in 
human (Goldstone et al., 2010). These proteins are involved in the metabolism of 
endogenous substrates as well as exogenous compounds like drugs, chemicals 
carcinogens and pollutants (Nebert et al., 2004). CYP1, CYP2, CYP3 and CYP4 are the 
members of the CYP family responsible for xenobiotics metabolism and in this thesis will 
focus on the xenobiotic- and steroid-metabolizing CYP1A and CYP3A subfamilies.  
In fish, the most studied CYP isoform is CYP1A and has been used as a biomarker 
to monitor aquatic pollution (Fent, 2003; Uno et al., 2012). CYP1A-dependent 
ethoxyresorufin O-deethylase (EROD) activity and cyp1a mRNA expression have been 
used as biomarkers for the presence of and exposure to polycyclic aromatic hydrocarbons 
and dioxins in the environment (Stegeman and Hahn, 1994; Parente et al., 2008). 
Previous studies, in mammals and fish, showed that cyp1a transcription is regulated by 
AhR (Denison and Nagy 2003; Schlenk et al., 2008). CYP3A isoform is the predominant 
form in the liver in both fish and mammals (Celander et al., 1996; Thummel and Wilkinson, 
1998). In humans drugs are metabolized mostly by CYP enzymes and almost half of 
these reactions are catalysed by CYP3A4 (Guengerich, 2008). However, CYP3A4 
homolog is absence in zebrafish (Chng et al., 2012), so this activity was suggested to be 
carried out by other proteins, like CYP3A65 or CYP1A. In mammal’s the transcription of 
cyp3a is regulated by PXR that is very promiscuous and activated by a large number of 
lipophilic chemicals, including many pharmaceuticals (Wassmur et al., 2010; Kubota et al., 
2015). Also in zebrafish, exposure to the PXR ligand rifampicin and to the AhR ligand 
TCDD induced CYP3A65 transcription (Tseng et al., 2005), illustrating the intricacies in 
AhR and PXR receptor signalling pathways.  
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Phase II enzymes 
Phase II process involves the conjugation of an endogenous ligand (large and 
often polar chemical groups or compounds, such as sugars or amino acids) to the parent 
compound or the phase I metabolites facilitating their excretion (Lech and Vodicnik, 1985). 
These synthetic conjugations are catalysed by gluthathione S-transferases (GSTs), UDP-
glucuronyl transferases (UGTs) and sulfotransferases (SULT). In this study GST 
expression and/or activity will be used as indicative of phase II biotransformation therefore 
the description in more detail.  
GSTs belong to a multigene superfamily of dimeric, multifunctional enzymes 
(Hayes and Pulford, 1995b) that catalyse the conjugation of glutathione (GSH) with 
compounds that have an electrophilic centre, through the formation of a thioether bound 
between the sulphur atom of GSH and the substrate (Chasseaud, 1979; Mannervik, 
1985). In mammals GST can be divided in two superfamilies, cytosolic and membrane-
bound (Hayes and Strange, 2000), and based on their sequence homology, cytosolic 
enzymes can be divided into eight families or classes: α, μ, κ, π, ω, σ, θ and ζ (Meyer et 
al., 1991; Pemble et al., 1996; Board et al., 1997; Board et al., 2000). The membrane-
bound transferases were more recently discovered and are composed by at least six 
families (Jacobsson et al., 2000). The cytosolic GSTs are primarily involved in the 
metabolism of exogenous chemicals, such as environmental pollutants, cancer 
chemotherapeutic drugs but also potentially dangerous endogenously derived reactive 
compounds (Hayes and Pulford, 1995). Other GST substrates are endogenous 
substances formed as a consequence of reactive oxygen species making these 
transferases to act also as antioxidant enzymes (Hayes and McLellan, 1999). In aquatic 
organisms, GST activity and/or expression have been used as a biomarker in several 
studies to evaluate environmental contamination levels and effects (Ferreira et al., 2008; 
Della Torre et al., 2010). 
1.4.3 Oxidative stress enzymes 
Oxidative stress is the result of a disturbance in the balance between the 
prooxidants and antioxidants leading to negative biochemical and physiological effects. 
This imbalance increases free radical production or reactive oxygen species (ROS) (O2
•- - 
superoxide radical, H2O2 - hydrogen peroxide, OH• - hydroxyl radical), and/or decreases 
antioxidant defences that can be potentially damaging to the cells. When antioxidant 
defences decrease damages can happen to macromolecules such as DNA, proteins and 
lipids resulting in damaged DNA bases, protein oxidation products, and lipid peroxidation. 
Sources of ROS include aerobic respiration, irradiation, UV light, production of H2O2, NO 
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and O2
•- by activated macrophages and phagocytes, metal catalysed oxidation systems, 
autooxidation of electron transport carriers and xenobiotics (Stadtman and Levine 2000). 
Likewise xenobiotics may cause oxidative stress through the action of enzymes such as 
CYP1A, NAD(P)H oxidases, and flavoprotein oxidases, via metal-catalysed oxidation 
systems, or via redox cycling (Livingstone et al. 2000, Stadtman and Levine 2000). 
Biotransformation of xenobiotics by phase I enzymes activity can increase ROS 
production as unwanted products (van der Oost et al., 2003), causing enzyme 
inactivation, lipid peroxidation, DNA damage and eventually cell death (Winston and Di 
Giulio, 1991). Nevertheless, cells have defence mechanisms which include enzymatic 
inactivation of redox cycling compounds and peroxides, metabolism of ROS to water and 
oxygen by antioxidant enzymes (such as superoxide dismutase (SOD), Catalase (CAT)) 
or molecules that eliminate free radicals that can bind to transition metals ions and be 
converted in more detrimental ROS (Stegeman et al., 1992; Lopez-Torres et al., 1993) 
(Fig. 1.6).  
 
The increasing number of chemicals found in water systems, can consequently 
increase the risk of toxicity through oxidative stress. For this reason biomarkers of 
oxidative stress such as antioxidant enzyme activity or levels of damaged molecules, have 
been used as early warning of exposure effects to environmental pollution in aquatic 
environments (Livingstone, 2001; van der Oost et al., 2003) and can be useful for risk 
assessment of emering compounds. In fish the use of oxidative stress biomarkers, like 
measurement of SOD, CAT, GST activities and mRNA expression have become useful in 
risk assessment studies (van der Oost et al., 1998; Ferreira et al., 2008; Ellesat et al. 
2012).  
Figure 1.6: Schematics of antioxidant enzymatic removal of oxygen by-products 
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1.6 Model specie- zebrafish (Danio rerio) 
Danio rerio, zebrafish (Fig. 1.7), is a freshwater tropical fish of the Cyprinidae 
family, native to India and south Asia. This specie has been broadly used as a model for 
toxicological studies due to a large number of advantages. Zebrafish have easy and low 
maintenance costs, short life-cycle (10-12 weeks), high fecundity, fully described 
embryonic development and the genome fully sequenced, regulatory sequences and 
expression profiles (Kimmel et al., 1995; Chow et al., 2012) 
(http://www.ensembl.org/index.html). In laboratory zebrafish can breed all year round 
producing a large number of transparent embryos that allows a good and quick 
observation of embryonic development. It has been suggested that during critical stages 
in their development embryos might be more sensible to xenobiotics exposure 
(Versonnen and Janssen, 2004), making them a helpful model in toxicological research. 
Zebrafish embryo toxic assay (FET) has been proposed as an alternative to animal 
experiments and classical acute fish toxicity testing, required for regulatory activities 
(Lammer et al., 2009; Kaiser et al., 2012). Also, the availability of a full genome sequence 
is important in genomic studies in order to understand the toxics mode of action and which 
pathways are being affected.  
Source of adult zebrafish: http://info.noldus.com/bid/87981/5-must-read-articles-on-
zebrafish-behavioral-research 
Source of zebrafish embryo: photo was taken by the author 
 
 
 
 
 
 
 
Figure 1.7: Zebrafish (Danio rerio) adult (A) and embryo (B). 
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The process of cellular detoxification is of paramount importance to protect the organisms 
inhabiting polluted environments. Biotransformation enzymes in cooperation with MXR 
proteins are part of the cellular detoxification system and act to reduce cellular uptake and 
toxicity of a wide range of chemicals. Given the important role of this defence system it is 
important to understand the regulation by nuclear receptors (NRs). Moreover, recent 
evidences indicate that MXR mechanism may be compromised by the chemosentisation 
effect of numerous chemicals present in aquatic ecosystem. Furthermore, the knowledge 
on the interaction of emergent contaminants and the defence system is scarce therefore 
the main goals of this thesis were the following: 
1) to characterise the basal transcription profile of ABC transporters, 
biotransformation and antioxidant enzymes and NRs in zebrafish embryos, at 
different development stages and provide fundamental knowledge on components 
and functional characteristics of the pathways of detoxification system and their 
regulation by NRs after exposure to emerging contaminants  
2) to address chemosensitisation potential of different contaminants classes, focusing 
particularly in emerging pollutants, using zebrafish embryos as model organism. 
In order to achieve these goals, specific objectives have to be achieved: 
1. Characterisation of the transcriptional patterns of ABC efflux transporters and 
biotransformation enzymes of phase I and phase II and antioxidant enzymes and 
NRs during the developmental stages of zebrafish; 
2. Asses the toxicological effects of two pharmaceuticals (simvastatin (SIM) and 
fluoxetine(FLU)) in zebrafish embryo development; 
3. The characterisation of the expression and response patterns of ABC transporters 
(abcb4, abcc1, abcc2 and abcg2), biotransformation enzymes (cyp1a, cyp3a65 
and gstπ) and antioxidant enzymes (cat and Cu/Zn sod) after exposure to SIM 
and FLU at different development stages of zebrafish embryo;  
4.  Evaluate the effects of SIM and FLU at a biochemical level through the 
assessment of phase I and II catalytic activities (EROD and GST) and antioxidant 
activities (CAT and SOD);  
5. Assess the effects of SIM and FLU in the transcription level of NRs that may 
regulate genes belonging to the detoxification mechanism; 
6. Evaluate the interactions of SIM with lipid metabolism pathway and FLU with the 
neurotransmitter system in zebrafish embryos; 
7. Evaluate effects of different classes of contaminants (pharmaceuticals and 
personal care products), in zebrafish embryo and eleutheroembryos, and assess 
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chemosensitisation potential of emergent compounds using dye accumulation 
assay in combination with standardized parameters established for fish embryo 
test (FET).  
8. Assess chemosensitisation potential of emergent compounds in Abcb4 ATPase 
activity. 
 
The goals of this thesis were explored throughout the following chapters: 
 Chapter I - General Introduction 
 Chapter II - Objectives  
 Chapter III - Simvastatin effects on detoxification mechanisms in 
Danio rerio embryos. 
 Chapter IV - Simvastatin exposure can modulate gene expression of 
nuclear receptors linked to detoxification process in zebrafish 
embryos 
 Chapter V - Danio rerio embryos on Prozac – Effects on the 
detoxification mechanism and embryo development 
 Chapter VI - Fluoxetine modulate transcriptional level of genes 
involved in the neurotransmitter system in zebrafish embryos 
 Chapter VII - Effects of pharmaceuticals and personal care products 
(PPCPs) on multixenobiotic resistance (MXR) related efflux 
transporter activity in zebrafish (Danio rerio) embryos. 
 Chapter VIII – integrated discussion and main conclusions of the 
thesis, and also the presenting prospects for future work.
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Simvastatin effects on detoxification mechanisms in Danio rerio embryos. 
3.1 Abstract 
 
The transcription and protein activity of defence mechanisms such as ABC 
transporters, phase I and II of cellular detoxification and antioxidant enzymes can be 
altered in the presence of emerging contaminants such as pharmaceuticals impacting the 
overall detoxification mechanism. The present work aimed to characterise the effects of 
simvastatin on the detoxification mechanisms of embryonic stages of Danio rerio. In a first 
approach, constitutive transcription of key genes involved in detoxification was 
determined. Embryos were collected at different developmental stages, and transcription 
patterns of genes coding for ABC transporters, phase I and II and oxidative stress were 
analysed. With exception of abcc2, all genes seem to be from maternal transfer (0 - 2 
hpf). Embryos were then exposed to different concentrations of simvastatin (5 μg/L and 50 
μg/L), verapamil and MK571 (10 μM) (ABC protein inhibitors) and a combination of 
simvastatin and ABC inhibitors. mRNA expression levels of abcb4, abcc1, abcc2, abcg2, 
cyp1a, cyp3a65, gst, sod, cat was evaluated. Accumulation assays to measure ABC 
proteins activity and activity of EROD, GST, CAT and Cu/ZnSOD, were also undertaken. 
Simvastatin acted as a weak inhibitor of ABC proteins and increased EROD and GST 
activity, whereas Cu/ZnSOD and CAT activity were decreased. Simvastatin up-regulated 
abcb4 and cyp3a65 transcription (both concentrations), as well as abcc1 and abcc2 at 50 
μg/L, and down-regulated gst, sod, cat at 5 μg/L. In conclusion, our data revealed the 
interaction of simvastatin with detoxification mechanisms highlighting the importance of 
monitoring the presence of this emerging contaminant in aquatic environments. 
 
Keywords: Simvastatin; zebrafish embryos; ABC transporters; phase I and II; 
biotransformation; antioxidant enzymes 
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3.2 Introduction 
The aquatic environment is a known sink for a vast array of chemicals including 
emerging contaminants. Pharmaceuticals and their metabolites are often detected in 
surface waters in concentrations in the ng to the µg/L range (Kolpin et al. 2002; Wiegel et 
al. 2004). Pharmaceuticals are designed to be bioactive and act on selected signalling 
pathways in humans. Given the conservation of several signalling pathways across 
metazoans, some pharmaceuticals are expected to impact an array of taxa (Bound and 
Voulvoulis 2004; Castro and Santos 2014; Santos et al., 2016). In addition, other adverse 
effects can also arise, such as elevated mortality and anomalies in reproduction and 
behaviour (Ribeiro et al. 2015; Neuparth et al. 2014; Ortiz de García et al. 2014). Genes 
and proteins required for detoxifying environmental contaminants that include efflux 
transporters (ATP – binding cassette (ABC) transporters), phase I (cytochrome P450 
family, eg. CYP1A, CYP3A) and phase II (glutathione-S-transferase, GST, UDP-
glucuronlytransferases (UGTs), Sulfotransferases (SULTs)) biotransformation enzymes, 
and antioxidant enzymes are known to be present or genome predicted in several fish 
species (van der Oost et al. 2003; Bard 2000; Stegeman et al. 1992; Lopez-Torres et al. 
1993). ABC transporters are considered to be the first line of defence against toxicants 
and are grouped in seven different families (Bard 2000; Ferreira et al. 2014a; Luckenbach 
et al. 2014). The most relevant in the toxicological context are the ABCB, ABCC and 
ABCG families (Epel et al. 2008). ABCB1 effluxes mainly unmodified compounds from the 
cells (phase 0 of cellular detoxification) (Epel et al. 2008). Zebrafish, Danio rerio, as in 
other fish species, have a well-developed “detoxifying machinery”, however it has some 
specificities such as the absence of abcb1 orthologues. Nevertheless, it has recently been 
reported that Abcb4 has the same functional properties as ABCB1 (P-glycoprotein, P-gp) 
in mammals (Fischer et al. 2013). In a second line of defence, xenobiotics are 
biotransformed in phase I and II, increasing their hydrophobicity facilitating excretion 
(Lech and Vodicnik 1985). In phase III, the metabolites resulting from biotransformation 
are effluxed by transport proteins from ABCC and ABCG families (Bard 2000; Ferreira et 
al. 2014a). However, the biotransformation process mediated by CYPs enzymes can 
generate reactive oxygen species (ROS) as unwanted side products (Sapone et al. 2007). 
Therefore, antioxidant defences such as superoxide dismutase (SOD) and catalase (CAT) 
enzymes contribute to neutralize and detoxify ROS (Stegeman et al. 1992; Lopez-Torres 
et al. 1993). These biological responses have been widely used as biomarkers in 
environmental monitoring of aquatic ecosystems (van der Oost et al. 2003). Anti-
cholesterolemic drugs are among the most prescribed drugs in western countries and 
have been found in increasing concentrations in aquatic ecosystems ranging from 0.1 and 
7000 ng/L (Hernando et al. 2006; Corcoran et al. 2010; Santos et al. 2010; Pereira et al. 
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2015). Simvastatin (SIM) is one of the lipid regulator drugs commonly identified in water 
systems and previous studies have already reported that SIM can induce negative effects 
in non-target aquatic organisms at environmentally relevant concentrations (Ribeiro et al. 
2015; Neuparth et al. 2014; Ellesat et al. 2011). Some pharmaceuticals have the potential 
to act as inhibitors of ABC transporters, i.e., chemosensitisers (Caminada et al. 2008), 
decreasing transporter activity and thus causing the accumulation of toxic chemicals 
inside the cells (Epel et al. 2008). P-glycoprotein (P-gp, ABCB1) is a transmembrane 
protein and direct correlations were found between the cholesterol content of the 
membranes and ATPase activity of P-gp in mammals (Kimura et al. 2007; Eckford and 
Sharom 2008). Interestingly, some studies have reported the interaction between statins 
and P-gp (Kopecka et al. 2011; Wang et al. 2001), raising the hypothesis that statins may 
have a chemosensitising effect on the efflux activity by lowering cholesterol in the plasma 
membrane (Kopecka et al. 2011). Alternatively, statins can also act as substrates and/or 
as direct inhibitors of this protein (Wang et al. 2001). Therefore, the reported interaction of 
statins with human ABC transporters and its prevalence in the aquatic environment 
highlights the need for more detailed studies on the chemosensitiser potential using 
additional animal models. 
The zebrafish (Danio rerio) has emerged as a suitable model species in 
ecotoxicology and was selected for the present study given several favourable 
characteristics. For example, the transparency of the embryos allows for easy observation 
of the embryonic development and the assessment of toxicity, in addition to the extensive 
genomic data available. Moreover, previous studies demonstrate that zebrafish embryos 
are sensitive to SIM exposure (Ribeiro et al. 2015).   
Hence, this preliminary study aimed to i) characterize the basal transcription profile 
of key genes coding for proteins involved in the detoxification pathways in different 
development stages of zebrafish embryos, ii) assess the potential chemosensitiser effect 
of SIM and the toxicity of SIM in the presence of known chemosensitisers and iii) evaluate 
the effects and interaction of SIM with the components of the detoxification mechanism on 
zebrafish embryos 
3.3. Material and methods 
3.3.1 Chemicals 
β-naphthoflavone (β-NF), Rhodamine 123 (RH123), Simvastatin (SIM) (CAS # 
79902-63-9), Verapamil (VER), α-Dithiothreitol (99% purity), reduced glutathione (GSH, 
99% purity), 1-cloro-2,4-dinitrobenzene (CDNB, 97% purity), hydrogen peroxide (30% 
w/w), cytochrome c (95% purity), xanthine (99% purity), xanthine oxidase, bovine serum 
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albumin (BSA, 99% purity) were purchased from Sigma-Aldrich (Germany) and MK571 
from VWR International. All the other chemicals were of analytical grade, and were 
purchased from local companies. 
3.3.2 Parental animals 
Adult wild-type zebrafish, obtained from local suppliers, were used as breeding 
stocks. The stock was kept at a water temperature of 27±1 ºC and in a photoperiod of 
12:12 h (light:dark), in 60 L aquaria with dechlorinated and aerated water in a recirculation 
system with both mechanical and biological filters. The fish were fed ad libitum twice a day 
with a commercial fish diet Tetramin (Tetra, Melle, Germany), and supplemented once a 
day with live brine shrimp (Artemia spp.) (Machado et al. 2014; Soares et al. 2012). 
3.3.3 Rearing conditions and exposures 
For reproduction, females and males (ratio 1:2) were transferred to a spawning 
tank, and submitted to acclimatization for 12 h in a cage with a net bottom covered with 
glass marbles within a 30 L aquarium. After spawning, the following day, the breeders 
were removed after the beginning of the light period. To assess the transcription of genes 
belonging to the detoxification system in zebrafish early development phases, the eggs 
were collected, counted, cleaned and preserved in RNALater (30 embryos per time-
period) at 0, 2, 3, 6, 14, 24, 48 and 72 hours post fertilization (hpf), for transcription 
profiling. Different clutches were used to reduce variability in the development stages. 
Time-points for embryo and larvae collection were chosen based on the developmental 
embryonic and larval stages of D. rerio as described by Kimmel et al. (1995). Accordingly, 
embryos were grouped in 8 development stages - zygote (0 hpf), cleavage (2 hpf), 
blastula (3 hpf), gastrula (6 hpf), segmentation (14 hpf), pharyngula (24 hpf), hatching (48 
hpf), and larvae (72 hpf). For the toxicological assays (section 2.4), embryos (1 hpf) were 
transferred to a 24 well plate (10 embryos per well) and exposed to the different 
chemicals. For the accumulation assays (MXR activity)(section 2.6) the embryos were 
transferred to new aquaria (3.5 L) and were kept for 24 h, at 26 ± 1 ºC with aeration, until 
exposure. Prior to embryo exposures, the test solutions were placed into the plates for 24 
h so that the chemicals could adsorb to the plastic, and the solution renewed after 
preadsorption. For the determination of the biochemical parameters, 1 hpf embryos (100 
for antioxidant enzymes activities and 200 embryos for EROD activity) were placed in 
glass beakers at 26 ± 1 ºC with aeration, and exposed to the test solutions until 80 hpf 
with the test chemicals. In all assays the embryos were exposed to different 
concentrations of SIM (5 μg/L, 50 μg/L), chosen based on concentrations of previous 
studies that include the NOEC (5 μg/L) and the LOEC (50 μg/L) concentrations in 
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zebrafish embryos (Ribeiro et al. 2015; Torres 2013; Key et al. 2008). Exposures were 
also performed with two ABC transporter inhibitors (VER (10 µM) and MK571 (10 µM)) 
(previous accumulation tests using different concentrations of inhibitors were performed to 
choose the best inhibition concentration in zebrafish embryos, data not shown) and the 
combination of simvastatin with the two ABC transporters inhibitors.  
3.3.4 Toxicological assay 
Embryos were exposed from 1 hpf until 80 hpf to SIM, verapamil and MK571 (all 
diluted in DMSO), as previously described (section 3.3.3). The medium (water plus the 
tested compounds) was renewed daily during the experiment. Embryos were observed 
with an inverted stereoscope (Nikon Eclipse TS100) at 8 hpf, 32 hpf and 80 hpf and 
several parameters were recorded (mortality rate, 75% epiboly, delay/arrest of the 
division, abnormal cell masses, development delay, pericardia edema, head, eyes and tail 
abnormalities) at each time-point. The criteria such as heartbeat frequency, coagulation, 
pigmentation, involuntary movement and observed malformations were used to establish 
mortality and abnormality parameters. After the 80 h of exposure the embryos were 
collected and preserved in RNALater for gene expression analysis. Each assay was 
replicated at least six times. Data is presented as total percentage (%) of individuals that 
presented abnormalities or mortality. 
3.3.5 EROD, GST and antioxidant enzymes activity 
After 80 h of exposure, embryos were homogenized in ice-cold 100 mM potassium 
phosphate buffer pH 7.4, 150 mM KCl, 1 mM dithiothreitol (DTT), 0.1 mM 
phenylmethylsulfonyl fluoride (PMSF) and 1 mM disodic ethylenediaminetetra acetic acid 
(Na2EDTA) (Fernandes et al., 2008). Post-mitochondrial fractions were obtained after 
centrifugation at 15,000 g for 20 min at 4°C. Glutathione S-transferase (GST) activity was 
determined as described in Ferreira et al. (2008), using GSH 10 mM in potassium 
phosphate buffer 0.1 M, pH 6.5 and CDNB 60 mM in ethanol prepared just before the 
assay. Reaction mixture consisted of phosphate buffer, GSH solution and CDNB solution 
in the proportion 4.95:0.9:0.15, respectively. The reaction mixture (200 μL) was added to 
the sample (protein concentration 4 mg/mL) diluted in phosphate buffer, with a final 
concentration of 1mM GSH and 1 mM CDNB and a final of volume 300 μL. The 
absorbance was measured immediately every 20 s, at 340 nm, over the course of 5 min. 
GST activity was calculated through the slope of linear change in absorbance and 
expressed in nmol/min/mg protein. Since CDNB is a non-specific GST substrate total GST 
activity was measured. Superoxide dismutase (SOD) activity was determined by the 
degree of inhibition on the reduction of cytochrome c by superoxide anion generated by 
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the xanthine oxidase/xanthine system (Ferreira et al. 2005). Cytochrome c reduction was 
followed via the measurement of the absorbance at 550 nm. In the assay, concentration of 
the components were as follows ; sodium phosphate buffer 50 mM, pH 7.8, with Na2EDTA 
0.1 mM, xanthine 50 μM, xanthine oxidase 5.2 mU/mL and cytochrome c 18 μM. Two 
hundred and fifty μL of this mixture was reacted with the sample (protein concentration 4 
mg/mL) diluted in phosphate buffer to a final volume of 300 μL. To obtain linearity, the 
volume of sample and phosphate buffer per well were adjusted for each sample. SOD 
standards were used in each assay to calculate the activity given in SOD Units (1 SOD 
Unit=50% inhibition of the reduction of cytochrome c) per mg of protein. The samples 
were divided in two aliquots, one to measure the total SOD activity and in the other 
MnSOD activity by adding to the reaction KCN 2 mM. To obtain the Cu/ZnSOD activity we 
then deducted the MnSOD from the total SOD activity. Catalase (CAT) activity was 
determined by measuring the consumption of H2O2 at 240 nm (ε=40 M
−1cm−1) as 
described in Ferreira et al. (2008) with slight modifications. The reaction mixture contained 
65 mM potassium phosphate buffer, pH 7.8, 15.5 mM H2O2 and 0.01% TritonX-100. In the 
cuvette, 950 μL of reaction mixture was added to the sample (protein concentration 4 
mg/mL) and diluted in phosphate buffer to a final volume of 1000 μL. To obtain linearity, 
the volumes of sample and phosphate buffer were adjusted for each sample. CAT activity 
is expressed as μmol/min/mg protein. Ethoxyresorufin O-deethylase (EROD) activity was 
measured in the protein fraction as described by Otte et al. (2010), with some 
modifications. 50 µL of each sample was incubated with ethoxyresorufin 0.5 μM for 1 min, 
and the enzymatic reaction was initiated by the addition of 45 μM NADPH. β-NF (10 µg/L) 
was used as a positive control of EROD. EROD activity was measured for 5 min at 
λex=530 nm and λem=585 nm, and determined by comparison to a resorufin standard 
curve. EROD activity was expressed in pmol/min/mg protein. All measurements were 
performed in triplicate for each sample. Protein determinations were performed by the 
Lowry method using bovine serum albumin (BSA) as a standard (Lowry et al. 1951).  
3.3.6 Accumulation assay  
Fluorescent dye, RH123 acts as a proxy for efflux transporter activity in the fish 
embryos. When this activity is absent due to transporter inhibition, accumulation of dye in 
the embryo increases, resulting in a stronger fluorescence signal. Prior to conducting dye 
accumulation assays with the test substances the best concentration of RH123 and the 
time of exposure to be used in the assays were determined. Different concentrations of 
RH123 (1, 2, 5, 8, 16 µM) and different incubation time (30 min, 1, 2 and 3 h) were tested 
with standard MXR transporter inhibitors (MK571 and VER). Based on the results of these 
assays, 8 µM of RH123 and a 2 h incubation period was used in subsequent experiments 
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(data not shown). ABC transporter activity was determined by means of accumulation 
assays using the fluorescent substrate RH123 (8 µM) in the presence of the chemicals, as 
previously described (section 3.3.3). This assay was performed with 24 hpf embryos 
because the organism has most of the organs developed and all the genes targeted in this 
study are transcriptionally active. Embryos (24 hpf) were incubated in the dark, at 26 ± 1 
ºC, for 2 h. After the 2 h exposure period, embryos were washed three times with ice-cold 
water and mechanically disrupted. The fluorescence of RH123 accumulated inside the 
embryos was measured in the homogenate of 10 embryos using a fluorescent microplate 
reader (excitation/emission - 485/538 nm) reader (Fluoroskan Ascent, Labsystems). In 
each replicate (at least four times) RH123 accumulation in water and positive controls 
(MXR inhibitors) was also measured. Data is presented in percentage (%) of fluorescence 
in relation to the control (established as 100%). After the 2 h exposure, 30 embryos of 
each treatment were collected and preserved in RNALater for gene expression analysis. 
3.3.7 RNA isolation and cDNA synthesis 
Embryos preserved in RNALater from the toxicological and accumulation assays 
were used to extract total RNA according to Costa et al. (2012a). Briefly, total RNA was 
isolated using Illustra RNAspin Mini RNA Isolation kit (GE Healthcare), according to the 
manufacturer’s protocol. RNA quality was verified by electrophoresis in agarose gel and 
by the measurement of the ratio of optical density at λ260/ λ280 nm. RNA was quantified 
using Quant-IT RiboGreen RNA Reagent and Assay Kit (Invitrogen) using a Fluoroskan 
Ascent, Labsystems. One microgram of total RNA was subjected to digestion of genomic 
DNA using Deoxyribonuclease I, Amplification Grade (Invitrogen) and synthesis of cDNA 
was performed using Iscript cDNA Synthesis (Biorad). 
3.3.8 Quantitative real-time PCR (qRT-PCR) 
Gene expression levels of abcb4, abcc1, abcc2, abcg2a, cyp1a1, cyp3a65, gstπ, 
Cu/Zn sod, cat were assessed by means of quantitative real time PCR (qRT-PCR). Primer 
pairs for each target gene were designed with Primer 3 software available at 
http://www.ncbi.nlm.nih.gov/, based in available sequences in GenBank, or described by 
others such as abcb4 (Fischer et al. 2013), abcc2 (Long et al. 2011b), Cu/Zn sod (Banni 
et al. 2011) and gstπ (Timme-Laragy et al. 2009). Identities of the amplicons were 
confirmed by cloning and sequencing of the DNA fragments as described by Costa et al. 
(2012). Primer sequences, amplicon lengths, efficiencies and Genbank accession 
numbers of target sequences are given in Table 1S. To determine the efficiency of the 
PCR reactions, standard curves were made, with 6 serial dilutions of the template 
(concentrations range from 0.05 to 50 ng/μl), and the slopes and regression curves 
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calculated. Reactions for qRT-PCR were conducted in a iQ5 BioRad apparatus, with 10 μl 
of SYBR Green Supermix (BioRad), 2 μl of each primer (final concentrations ranging from 
10 nM to 300 nM, in Table 1S) and 2 μl of cDNA, in a total volume of 20 μl, in duplicate. 
Conditions were as follows: 95 °C for 3 min, followed by 40 cycles of 95 °C for 10 s, 54 °C 
for 30 s and 72 °C for 30 s. At the end of each run a melting curve analysis was done 
(from 55 to 95 °C) to determine the formation of the specific products. No template 
controls were run to exclude contamination and the formation of primer dimers. Reference 
gene data for fish species suggest transcription can be significantly dependent on tissue 
types, life stages, or treatment (Filby and Tyler, 2007; Zhang and Hu, 2007; McCurley and 
Callard, 2008, Mo et al., 2014). For these reasons, commonly used reference genes 
(elongation factor 1 (ef1), RNA polymerase II (pol II) and ribosomal protein l8 (rpl8) were 
tested (Fig. 1S, supplementary material for more detailed information) and gene 
expression was quantified by normalisation with multiple reference genes using 
Normfinder algorithm(s) (Urbatzka et al. 2013). For characterisation of the transcription 
profile, ef1 and pol II were used as reference genes and ef1 and rpl8 were used for the 
accumulation and toxicology assays. The relative expression ratio was calculated with 
efficiencies using the Pfaffl mathematical model (Pfaffl 2001). Despite this normalisation 
for gene transcription pattern, there were significant differences between zygote and 
cleavage stages (to be referred as group 1) and the other development stages (to be 
referred to as group 2). For this reason, no comparison was preformed of gene 
transcription data from cleavage to blastula. To calculate ΔΔct, the control group 
comprised the average of Cts from each group. Data is presented in mean of ΔΔct 
normalised to the reference genes.  
3.3.9 Statistical analysis 
Differences in mRNA transcriptional levels between treatments in the embryos 
from 2 h and 80 h exposure and the differences between treatments in accumulation 
assay and enzyme activities were evaluated by means of a one-way ANOVA, followed by 
a multiple comparison test (Tukey’s test) at a 5% significance level. Data were log (mRNA 
expression and enzyme activities) or sqrt (accumulation assay) transformed in order to fit 
ANOVA assumptions. Correlations between gene expression of embryos exposed for 2 h 
and 80 h were tested by Pearson analysis. All tests were performed using software 
Statistica 7 (Statsoft, Inc). Differences between frequencies of treatments in the 
toxicological assay were evaluated by means of cross table χ2 test at 5% significance 
level. Tests were performed using software SPSS 22 (IBM, Inc). Data is presented as 
mean ± standard error. 
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3.4 Results 
3.4.1 Characterization of the transcription profile 
 To establish the constitutive expression levels of genes involved in the 
detoxification mechanism during zebrafish embryo development, mRNA levels of abcb4, 
abcc1, abcc2, abcg2a, cyp1a1, cyp3a65, gstπ, Cu/Zn sod and cat, were assessed in the 
different development stages (Fig. 3.1). All target genes were expressed at the initial 
phases of development of D. rerio, with the exception of abcc2 that was detected only at 
gastrula phase (6 hpf). In group 1 mRNA transcription levels and patterns where similar 
for all genes measured (Fig. 3.1) whereas in group 2 different patterns of mRNA levels 
were recorded (Fig. 2S-10S, supplementary material for more detailed information). abcb4 
(Fig. 2S) exhibited the highest mRNA expression in comparison to the other ABC 
transporters and cyp3a65 exhibited the highest mRNA expression of all studied genes at 
larvae phase.  
 
3.4.2 Toxicological Assay  
Cumulative mortality and abnormalities after exposure to SIM (5 and 50 µg/L), 
MK571 (10 µM), VER (10 µM) alone and the combination of SIM plus MK571 or VER, at 
different embryo development stages (8, 32 and 80 hpf), are presented in Fig. 3.2a. 
Figure 3.1: Relative mRNA expression of abcb4, abcc1, abcc2, abcg2a, cyp1a1, cyp3a65, gstπ, Cu/Zn sod 
and cat during the different stages of embryonic development in D. rerio comprising the zygote and cleavage 
(group 1), blastula, gastrula, segmentation pharyngula, hatching and larvae periods (group 2). The grey bars 
represent the major significantly differences between the development phases (p<0.05). Results are given as 
mean±SE, n=6. 
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Increased mortality and developmental abnormalities were recorded in embryos treated 
with SIM (both concentrations) alone and in combination with ABC transporter inhibitors. 
The highest mortality rates were observed in embryos treated with SIM plus VER 
(p<0.05), at 8 hpf. The most severe effects were observed at the delay/arrest of division in 
embryos exposed to SIM alone and SIM in combination with VER, the latter condition also 
increased significantly the presence of abnormal cell masses in exposed embryos (Fig. 
11Sa, supplementary material for more detailed information). 
At 32 hpf, exposure to SIM alone (5 µg/L) and the combination of SIM (50 μg/L) 
plus VER (p<0.05) significantly increased embryo mortality rate. A high percentage of 
abnormalities, mainly delay in development and tail abnormalities (Fig. 3.2 b2) was 
detected in embryos exposed to SIM (5 µg/L) plus both efflux protein inhibitors. One 
hundred percent of severe development delay and abnormalities (p<0.05) (Fig. 3.2 b3) 
were observed in embryos treated with SIM (50 µg/L) alone and in combination with ABC 
transporter inhibitors (MK571 or VER) (Fig. 11Sb, supplementary material for more 
detailed information). 
After 80 h of exposure to SIM at 50 μg/L, alone and in combination with MK571 or 
VER, led to a 100 % mortality rate. Also, SIM (5 µg/L) alone or in combination with MK571 
or VER has significantly increased (p<0.05) embryo mortality rate and abnormalities (such 
as tail deformities and pericardium edema) (Fig. 3.2 b6) (p<0.05), (Fig.11Sb, 
supplementary material for more detailed information).  
3.4.3 EROD activity, GST and antioxidant enzymes  
EROD, GST, SOD and CAT activities were measured in zebrafish embryos after 
80 h exposure to SIM and the ABC transporter inhibitors at the same conditions as for the 
toxicology assay (Fig. 3.3). EROD activity (Fig. 3.3 a) was significantly induced by SIM 
and both ABC protein inhibitors (MK571 and VER) (p<0.05) showing a level of activity 
higher than the positive control (β-NF). GST activity (Fig. 3.3 b) was also significantly 
stimulated (p<0.05) in the presence of SIM and the inhibitors. Cu/ZnSOD (Fig. 3.3 c) and 
CAT (Fig. 3.3 d) activities were significantly inhibited in all treatments in comparison with 
control. No significant correlations were observed between the activity of the GST, 
antioxidant enzymes and EROD and the mRNA levels of the genes encoding for these 
enzymes. 
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3.4.4 Accumulation Assay 
ABC transporter activity was determined by means of accumulation assays using 
the fluorescent substrate RH123, and results are presented in Fig. 3.4. As expected, an 
increase on RH123 accumulation inside the embryos was observed after the exposure to 
ABC transporter’s inhibitors being significantly different in embryos exposed to MK571 
(p<0.05). Embryos exposed to SIM showed a pattern of increased accumulation of 
RH123, similar to VER, but lower than MK571. Embryos exposed to the combination of 
SIM plus MK571, and SIM plus VER exhibited a significant increase in RH123 
accumulation similar to the one observed in embryos under SIM exposure alone.  
 
 
 
Figure 3.2: Cumulative mortality and abnormality rates at 8, 32 and 80 hpf (a), examples of 
abnormalities observed in the different treatments; (b) control at 32 hpf (b1), development delay with 
head and tail abnormalities at 32 hpf (b2), severe development delay with head abnormalities at 32 
hpf (b3), control at 80 hpf (b4), blood in the pericardium (b5), multiple abnormalities (pericardia 
edema and tail abnormalities) at 80 hpf (b6) of D. rerio embryos exposed to different concentrations 
of SIM (SIM 5 - 5 µg/L and SIM 50 - 50 µg/L), verapamil (10 µM) and MK571 (10 µM) and the 
combination with SIM and ABC transporters inhibitors, for 80 h (%). Results are expressed as mean 
± SE, n=6. Bars with asterisk are significantly different from the control (p<0.05). 
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Figure 3.3: EROD (a), GST (b) and Antioxidant enzymes (c, d) activity in D. rerio embryos exposed to 
SIM (SIM 5 - 5 µg/L), verapamil (10 µM), MK571 (10 µM) and β-FN (10 µg/L) for 80 h. Results are given 
as mean±SE, n=4. Bars with different letters are significantly different from each other (p<0.05). 
Figure 3 4: Accumulation of rhodamine 123 in D. rerio embryos (24 hpf) exposed to ABC transporters 
inhibitors (MK571 (10 µM) and VER (10 µM)), SIM (SIM 5 - 5 µg/L and SIM 50 - 50 µg/L), and the 
combination with SIM and ABC transporters inhibitors, for 2 h (% - percentage of accumulation 
compared to the controls). Results are given as mean±SE, n=4. Bars with different letters are 
significantly different from each other (p<0.05). 
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3.4.5 Transcription of target genes in exposed embryos  
In order to increase our understanding on the impact of SIM in the detoxification 
mechanisms, we evaluated mRNA transcripts of a set of genes encoding proteins that 
play a key role in the detoxification mechanisms. mRNA levels of the selected genes in 
embryos (24 hpf) exposed for 2 h (accumulation assay) to SIM and ABC transporter 
inhibitors are presented in Fig. 3.5. MK571 and VER have significantly increased mRNA 
transcripts of abcb4 and abcc2 (p<0.05), while no changes were observed for abcc1 and 
abcg2a. The higher concentration of SIM (50 µ/L) led to an increased mRNA expression 
of abcb4, abcc1, abcc2, abcg2a, cyp1a1, cyp3a65 and cat. In embryos exposed to the 
combination of SIM (both concentrations) plus MK571, the mRNA transcription of abcb4, 
abcc1, abcc2, abcg2a and cyp3a65 was up-regulated, while cyp1a1, gstπ, Cu/Zn sod and 
cat were down-regulated. abcb4, abcc2 and abcg2a mRNA expression was down-
regulated in embryos treated with SIM (5 ug/L) plus VER, while the opposite occurred with 
SIM at 50 ug/L. cyp1a1, gstπ and Cu/Zn sod mRNA transcription were down-regulated by 
the combination of SIM (5 and 50 µg/L) plus VER, whereas cyp3a65 and cat were 
downregulated only in the combination of the lower concentration (5 µg/L) of SIM plus 
VER. 
Gene expression at 80 hpf was assessed only in embryos exposed to the lower 
SIM concentration (Fig. 3.6), due to 100 % mortality in embryos exposed to SIM at 50 
µg/L. In embryos exposed to MK571, mRNA expression of abcb4, abcc1 and abcc2 
(p<0.05) was significantly up-regulated, whereas no differences were detected for abcg2a. 
In the presence of VER only abcc2 mRNA transcription was increased, whereas for 
abcb4, abcc1 and abcg2a no differences were observed. In embryos exposed to SIM, 
mRNA transcripts of abcb4, abcc1, gstπ and Cu/Zn sod were increased, and cyp3a65 and 
cat were down-regulated, while no differences were observed for abcc2, abcg2a, cyp1a1 
transcript levels. In embryos exposed to the combination of SIM plus MK571, mRNA 
expression of abcb4, cyp3a65 and cat was down-regulated, while gstπ was up-regulated. 
Cu/Zn sod and gstπ mRNA expression was significantly up-regulated (p<0.05) in embryos 
exposed to SIM plus VER, and cyp3a65 and cat were down-regulated, while no 
differences were observed for the other analysed genes. 
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Figure 3.5: Relative mRNA expression of abcb4, abcc1, abcc2, abcg2a, cyp1a1, cyp3a65, gstπ, Cu/Zn sod 
and cat in D. rerio embryos exposed to SIM (SIM 5 - 5 µg/L and SIM 50 - 50 µg/L), verapamil (10 µM) and 
MK571 (10 µM) at 24 hpf for 2 h. Bars with different letters are significantly different from each other (p<0.05). 
Results are given as mean±SE, n=6 
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Figure 3.6: Relative mRNA expression of abcb4, abcc1, abcc2, abcg2a, cyp1a1, cyp3a65, gstπ, Cu/Zn sod 
and cat in D. rerio embryos exposed to SIM (SIM 5 - 5 µg/L), verapamil (10 µM) and MK571 (10 µM) for 80 h. 
Bars with different letters are significantly different from each other (p<0.05). Results are given as mean±SE, 
n=6 
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3.5. Discussion 
3.5.1 Characterization of the transcription profile in early stages of development 
The determination of constitutive transcription patterns for the detoxification 
components will increase background knowledge for future toxicity studies, enabling a 
better understanding of the interaction of chemicals with detoxification mechanisms in 
early embryo development stages of zebrafish.  
In the two first stages of development, zygote (0 hpf) and cleavage (2 hpf), mRNA 
of all the selected genes (with the exception of abcc2) was detected indicating maternal 
transfer. Accordingly, Long et al. (2011b) have also shown that abcc2 mRNA transcripts 
are not from maternal origin. Embryo gene transcription begins only after cleavage, in 
midblastula transition (Abrams and Mullins 2009), thus the presence of transcripts of 
these genes in such early stages of development, confirm their maternal origin. A 
decreased pattern of mRNA transcription was observed after blastula (3 hpf) until gastrula 
(6 hpf), increasing afterwards due to new transcripts of embryo origin. After blastula, 
primary germ layer and embryonic axis are produced and coincide with the major wave of 
embryo genome activation in fish (Tadros and Lipshitz 2009). Thus, the fluctuations in 
gene expression are related with embryo development that lead to a low mRNA 
expression before 6 hpf, due to the degradation of maternal mRNA, followed by an 
increase due to new transcripts being produced by the embryos. After hatching, mRNA 
expression of all the evaluated genes was increased suggesting that at this stage the 
larvae require additional protection against the environmental stressors. These results are 
in line with other studies with aquatic organisms that also reported increased transcription 
of genes involved in detoxification processes after hatching (Costa et al. 2012b; Faria et 
al. 2011; Minier et al. 2002).  
3.5.2. Potential chemosensitizer effect of SIM 
To evaluate the chemosensitisation potential of simvastatin, two known ABC 
transporter inhibitors (MK571 and VER) were used to assess the degree of inhibition of 
SIM in comparison to model inhibitors. MK571 has been described as an ABCC inhibitor 
(Navarro et al. 2012) but recent studies showed that it may also inhibit other ABC proteins 
(Mease et al. 2012), including Abcb4 in zebrafish (Fischer et al. 2013); while verapamil is 
a P-gp competitive inhibitor and substrate (Fischer et al. 2013; Ferreira et al. 2014b). SIM 
and/or their metabolites may have a weak inhibitory effect on the ABC proteins that is 
comparable to VER as shown by the increase in accumulation of RH123 inside the 
embryos when exposed to SIM. Indeed, an inhibitory effect of SIM on ABCB1 protein was 
already reported in mammals and fish cell lines (Caminada et al. 2008; Bogman et al. 
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2001; Wang et al. 2001; Sieczkowski et al. 2010). In contrast, other studies have 
demonstrated that statins can be transported by ABCC2 in humans and rats and also by 
ABCG2 in humans (Ellis et al. 2013; Hirano et al. 2005).To our knowledge this is the first 
study to evaluate the chemosensitising potential of SIM in in vivo fish embryos and the 
results also point to a potential inhibitory effect on ABC transporters by SIM. Moreover, in 
humans it has been shown that certain statins metabolites inhibit P-gp, increasing the 
systemic exposure to statins (Lemahieu et al. 2005). However, the accumulation assay 
does not show which efflux proteins are being inhibited and further studies should be 
performed in order to understand which ABC transporters can possibly be inhibited by this 
pharmaceutical. In mammals, statins inhibit the CYP3A and P-gp activity which was 
related to an increase in the bioavailability of other pharmaceuticals (Yang et al. 2011; Lee 
et al. 2015). This demonstrates that statins, including SIM, can diminish the cells 
capability to efflux other drugs. Nevertheless, to some extent statins can have a weak 
chemosensitiser potential on ABC transporters, and SIM and/or its metabolites might, to 
some extent, impact the toxicity of other pollutants and consequently have an effect in the 
detoxification potential in aquatic organisms. However, further studies must be performed 
to fully understand the potential of SIM to inhibit ABC transporters. 
3.5.3. Simvastatin effects on zebrafish embryos and on transcription of genes 
involved in detoxification processes   
The toxicity of simvastatin to D. rerio embryos has been previously reported 
(Ribeiro et al. 2015; Neuparth et al. 2014; Dahl et al. 2006). Here, MK571 and VER were 
used as a proxy of a chemosensitiser to test if SIM, in the presence of other 
chemosensitisers, could be more toxic. However, despite the use of NOEC (5 µg/L) and 
LOEC (50 µg/L) concentrations found in a previous study (Ribeiro et al. 2015; Torres 
2013), our results revealed that embryos treated with SIM (50 µg/L) presented severe 
developmental delays and abnormalities that resulted in increased mortality. Nevertheless 
our results identify SIM as a weak inhibitor, hence SIM can act as a competitive inhibitor 
and/or SIM can selectively inhibit only some efflux proteins entering the cells and exerting 
its toxic effects. SIM plus MK571, led to a higher inhibitory effect when compared with SIM 
plus VER, probably related to the higher inhibitory effect of MK571. Also, in humans, the 
co-administration of SIM and VER increased the risk of adverse drug reactions like statin-
induced toxicity (Holtzman et al. 2006; Knauer et al. 2010) which is in line with our results. 
mRNA of ABC transporters, mainly abcb4, were up-regulated after 2 h exposure to SIM, 
which correlated with the MXR assay where a weak chemosensitiser potential was 
observed. A cross-talk mechanism where the inhibition of efflux proteins triggers the 
transcription of ABC transporters can be the cause of this increase. In agreement, in vitro 
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studies in mammals and fish described an up-regulation and inhibition of ABCB1 
(Yamasaki et al. 2009; Ellesat et al. 2012; Caminada et al. 2008; Wang et al. 2001). 
Additionally, an up-regulation of genes coding for biotransformation and antioxidant 
enzymes was also observed, mainly in embryos treated with the higher concentration of 
SIM (50 µg/L), demonstrating that SIM can also interact with the transcription of other 
genes of the detoxification mechanism. Supporting the present findings, the up-regulation 
of cyp3a, cyp2b6 and sod, under exposure to SIM and other statins such as atorvastatin, 
was also reported in in vitro studies in mammal and fish cell lines (Kocarek et al. 2002; 
Ellesat et al. 2012). After 80 h exposure to SIM embryos maintained the abcb4 up-
regulated pattern observed. An induction of EROD activity was observed after 80 h of 
exposure to SIM but no effect on the transcription of cyp1a1 was detected. Phase II gene 
and enzyme activity levels were both increased in the presence of SIM. In vitro studies, 
with different fish species, also showed induction of phase I and II transcription and 
catalysis by different pharmaceuticals (such as rifampicin or diclofenac) (Gröner et al. 
2015; Ku et al. 2014; Wassmur et al. 2013). Although to our knowledge there are no 
studies addressing the effects of statins, our results show that SIM, like other 
pharmaceuticals, can influence the biotransformation mechanism at a transcriptional and 
catalytic level.  
In the presence of SIM, antioxidant enzyme activity decreased while a pattern of 
up-regulation was observed for Cu/Zn sod mRNA expression that can result from a 
transcription level response to compensate the diminished catalytic activity. In a study 
performed with rainbow trout gills, atorvastatin has also up-regulated sod expression 
(Ellesat et al. 2012). SIM also appears to interact with antioxidant protein synthesis and 
mRNA levels showing different dynamics over time. Our results showed that SIM effects 
on antioxidant enzymes are different than those reported in in vivo and in vitro mammalian 
studies where these proteins were induced in the presence of statins (Hsieh et al. 2008; 
Landmesser et al. 2005; Sanchez et al. 2008). These contrasting results may be due to 
different times of exposure and/or the use of different model organisms. Even though 
concentrations above the ones observed in the environment were used in the present 
study, the results described herein showed that statins can possibly interfere with the 
detoxification mechanism which can result in negative effects to the organism. Overall, our 
results demonstrated that transcripts of detoxification genes are present in early 
development stages and their transcription can be altered in the presence of xenobiotics 
(e.g. pharmaceuticals).Therefore the results presented in this study showed that SIM can 
impact gene expression and enzyme activities (such as MXR, phase I and antioxidant 
enzyme activities) important features for cellular defence against harmful compounds.  
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3.6. Conclusions 
In conclusion, the majority of the target genes evaluated in these studies appear to 
be from maternal origin supporting their importance in the protection of the organism in 
early life stages of development. This preliminary study focused on the effects of SIM on 
the detoxification mechanisms demonstrating that, in the presence of common ABC 
inhibitors, SIM can be more toxic to D. rerio embryos. Also, SIM appears to act as a weak 
inhibitor of MXR, and to influence the mRNA transcription of key genes and enzymes 
belonging to the detoxification process which can increase the potential toxicity of other 
chemicals present in the water, supporting the importance of monitoring the presence of 
this class of substance in the aquatic environment. 
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SUPPLEMENTARY DATA 
Table 1S: Gene list  Genbank accession numbers Primer sequences and concentrations, amplicon lengths, efficiency of reaction for, ABC transporters (abcb4, abcc2, abcc1, 
abcg2a), biotransformation (cyp1a1, cyp3a65, gstπ) and antioxidant (Cu/Zn sod, cat) enzymes,  ef1, pol II and rpl8 gene expression quantification by qRT-PCR in zebrafish. 
 
Gene Accession number Primers Sequence 
(5’3’) 
Final 
Conc. 
(nM) 
Amplicon 
length (bp) 
Efficiency 
(%) 
abcb4 JQ014001 F: TACTGATGATGCTTGGCTTAATC 300 159 110.6 
R: TCTCTGGAAAGGTGAAGTTAGG    
abcc1 
 
XM_002661199 F: GCTCGAGCTCTCCTCAGAAA 
R:TCGGATGGTGGACTGTATCA 
300 99 125.1 
abcc2 NM_200589 F: GCACAGCATCAAGGGAAACA 300 87 116.5 
  R: CCTCATCCACTGAAGAACCGA    
abcg2a NM_001042775.1 F: AAGGGTATCGAGGACCGTCT 300 97 113.1 
R: AATCCTGACCCTGAACGATG   
cyp1a1 NM_131879.1 F: AACTCTTCGCAGGTGCTCAT 300 97 102.0 
R: ACAAACTGCCATTGGAGACC   
cyp3a65 NM_001037438.1 F: TGACCTGCTGAACCCTCTCT 
R: AAGGGCGAAATCCATCTTCT 
300 82 91.0 
gstπ NM_131734 F: TCTGGACTCTTTCCCGTCTCTCAA 
R: ATTCACTGTTGCCGTTGCCGT 
300 105 119.0 
Cu/Zn sod Y12236 F: GTCGTCTGGCTTGTGGAGTG 
R: TGTCAGCGGGCTAGTGCTT 
300 113 110.0 
cat NM_130912.1 F: CAGGAGCGTTTGGCTACTTC 
R: ATCGGTGTCGTCTTTCCAAC 
  300 91 113.0 
ef1 NM_131263.1 F: GGACACAGAGACTTCATCAAGAAC 
R: ACCAACACCAGCAGCAACGT 
300 84 116.8 
pol II NM_001024461.2 F: CAATGACGACCCGACCG 
R: CGCCAGCAACTCAGTCACT 
10 292 96 
rpl8 NM_200713.1 F: CAATGACGACCCGACCG 
R: CGCCAGCAACTCAGTCACT 
10 136 96 
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Fig 1S : Ct values of ef1, rpl8 and polII during the different stages of embryonic development in D. rerio 
comprising the zygote (0 hpf) and cleavage (2 hpf), blastula (3 hpf), gastrula (6 hpf), segmentation (14 hpf), 
pharyngula (24 hpf), hatching (48 hpf) and larvae (72 hpf) periods. Results are given as mean±SE, n=6. 
 
 
 
Figure 2S 
 
 
 
Fig 2S: Relative mRNA expression of abcb4 during the different stages of embryonic development in D. rerio 
comprising the zygote (0 hpf) and cleavage (2 hpf) (group 1), blastula (3 hpf), gastrula (6 hpf), segmentation 
(14 hpf), pharyngula (24 hpf), hatching (48 hpf) and larvae (72 hpf) (group 2) periods. Different upper-case 
letters represent significantly differences between the development phases in group 1 (p<0.05). Different 
lower-case letters represent significantly differences between the development phases in group 2 (p<0.05). 
Results are given as mean±SE, n=6. 
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Figure 3S 
 
Fig 3S: Relative mRNA expression of abcc1 during the different stages of embryonic development in D. rerio 
comprising the zygote (0 hpf) and cleavage (2 hpf) (group 1), blastula (3 hpf), gastrula (6 hpf), segmentation 
(14 hpf), pharyngula (24 hpf), hatching (48 hpf) and larvae (72 hpf) (group 2) periods. Different upper-case 
letters represent significantly differences between the development phases in group 1 (p<0.05). Different 
lower-case letters represent significantly differences between the development phases in group 2 (p<0.05). 
Results are given as mean±SE, n=6. 
 
 
Figure 4S 
 
Fig 4S: Relative mRNA expression of abcc2 during the different stages of embryonic development in D. rerio 
comprising the zygote (0 hpf) and cleavage (2 hpf) (group 1), blastula (3 hpf), gastrula (6 hpf), segmentation 
(14 hpf), pharyngula (24 hpf), hatching (48 hpf) and larvae (72 hpf) (group 2) periods. Different upper-case 
letters represent significantly differences between the development phases in group 1 (p<0.05). Different 
lower-case letters represent significantly differences between the development phases in group 2 (p<0.05). 
Results are given as mean±SE, n=6. 
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Figure 5S 
 
Fig 5S: Relative mRNA expression of abcg2a during the different stages of embryonic development in D. rerio 
comprising the zygote (0 hpf) and cleavage (2 hpf) (group 1), blastula (3 hpf), gastrula (6 hpf), segmentation 
(14 hpf), pharyngula (24 hpf), hatching (48 hpf) and larvae (72 hpf) (group 2) periods.  Different upper-case 
letters represent significantly differences between the development phases in group 1 (p<0.05). Different 
lower-case letters represent significantly differences between the development phases in group 2 (p<0.05). 
Results are given as mean±SE, n=6. 
 
 
 
Figure 6S 
 
 
 
 
Fig 6S: Relative mRNA expression of cyp1a1 during the different stages of embryonic development in D. rerio 
comprising the zygote (0 hpf) and cleavage (2 hpf) (group 1), blastula (3 hpf), gastrula (6 hpf), segmentation 
(14 hpf), pharyngula (24 hpf), hatching (48 hpf) and larvae (72 hpf) (group 2) periods. Different upper-case 
letters represent significantly differences between the development phases in group 1 (p<0.05). Different 
lower-case letters represent significantly differences between the development phases in group 2 (p<0.05). 
Results are given as mean±SE, n=6. 
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Figure 7S 
 
 
 
Fig 7S: Relative mRNA expression of cyp3a65 during the different stages of embryonic development in D. 
rerio comprising the zygote (0 hpf) and cleavage (2 hpf) (group 1), blastula (3 hpf), gastrula (6 hpf), 
segmentation (14 hpf), pharyngula (24 hpf), hatching (48 hpf) and larvae (72 hpf) (group 2) periods. Different 
upper-case letters represent significantly differences between the development phases in group 1 (p<0.05). 
Different lower-case letters represent significantly differences between the development phases in group 2 
(p<0.05). Results are given as mean±SE, n=6. 
 
 
 
Figure 8S 
 
 
 
 
Fig 8S: Relative mRNA expression of gstπ during the different stages of embryonic development in D. rerio 
comprising the zygote (0 hpf) and cleavage (2 hpf) (group 1), blastula (3 hpf), gastrula (6 hpf), segmentation 
(14 hpf), pharyngula (24 hpf), hatching (48 hpf) and larvae (72 hpf) (group 2) periods. Different upper-case 
letters represent significantly differences between the development phases of group 1 (p<0.05). Different 
lower-case letters represent significantly differences between the development phases in group 2 (p<0.05). 
Results are given as mean±SE, n=6. 
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Figure 9S 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 9S: Relative mRNA expression of Cu/Zn sod during the different stages of embryonic development in D. 
rerio comprising the zygote (0 hpf) and cleavage (2 hpf) (group 1), blastula (3 hpf), gastrula (6 hpf), 
segmentation (14 hpf), pharyngula (24 hpf), hatching (48 hpf) and larvae (72 hpf) (group 2) periods. Different 
upper-case letters represent significantly differences between the development phases in group 1 (p<0.05). 
Different lower-case letters represent significantly differences between the development phases in group 2 
(p<0.05). Results are given as mean±SE, n=6. 
 
 
Figure 10S 
 
 
 
 
Fig 10S: Relative mRNA expression of cat during the different stages of embryonic development in D. rerio 
comprising the zygote (0 hpf) and cleavage (2 hpf) (group 1), blastula (3 hpf), gastrula (6 hpf), segmentation 
(14 hpf), pharyngula (24 hpf), hatching (48 hpf) and larvae (72 hpf) (group 2) periods. Different upper-case 
letters represent significantly differences between the development phases of group 1 (p<0.05). Different 
lower-case letters represent significantly differences between the development phases in group 2 (p<0.05). 
Results are given as mean±SE, n=6. 
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Figure 11S 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 11S : Percentage of 75% epiboly, delay/arrest of the division, abnormal cell masses (ab) in D. rerio 
embryos at 8 hpf (a),  and percentage of different anomalies presented by the embryos at 32 hpf and 80 hpf 
(b) exposed to different concentrations of SIM (SIM 5 - 5 µg/L and SIM 50 - 50 µg/L), verapamil (10µM) and 
MK571 (10µM) and the combination with SIM and ABC transporters inhibitors. Results are expressed as 
mean ± SE. Bars with asterisk are significantly different from the control. 
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Simvastatin exposure can modulate gene expression of nuclear receptors linked to 
detoxification process in zebrafish embryos 
4.1 Abstract  
Nuclear receptors (NRs) are involved in the regulation of several metabolic 
processes, and can be modulated by different chemicals, including emerging 
contaminants. This work aimed at characterizing the effect of an emerging contaminant 
the simvastatin (SIM), a regulator of cholesterol (Chol) levels, on selected NRs and aryl 
hydrocarbon receptor (AhR) transcription during embryonic and larvae stages of 
zebrafish. Embryos were collected at different development stages (0, 2, 6, 14, 24, 48 and 
72 hpf) and transcription patterns of genes coding for NRs evaluated. Embryos were 
exposed to different concentrations of simvastatin (5 μg/L and 50 μg/L) at different 
development stages (0 hpf and 24 hpf) and exposure times (2 h and 80 h). In mammals, 
pharmaceuticals have been found to modulate the transcription of Pxr, Ppars and Ahr 
affecting the mRNA expression of genes belonging to different regulatory pathways, such 
as lipid metabolism and detoxification mechanism. The transcription levels of ahr2, raraa, 
rarab, rarga, pparαa, pparβ1, pparγ, pxr, rxraa, rxrab, rxrbb, rxrga, rxrgb, as well as the 
levels of Chol were evaluated. All target genes seem to be from maternal transfer as 
revealed by their mRNA presence at 0 hpf. SIM did not change the levels of Chol, in 
embryos or larvae, but altered the mRNA expression of NRs and AhR in a time and NR-
specific manner. After 2 h exposure to SIM in 24 hpf embryos, the transcription of ppars, 
pxr and ahr was up regulated, while after an 80 h exposure mRNA levels of pxr and ahr 
were decreased. Our results demonstrate a possible impact of SIM in the transcription 
regulation of NRs that play a key role in several downstream pathways involved in 
different physiologic functions. 
 
Keywords: statins, cholesterol, mRNA levels, emerging contaminants, nuclear receptors, 
detoxification 
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4.2 Introduction 
Nuclear receptors (NRs) comprise a large group of transcription factors, involved in 
the regulation of several biological processes such as reproduction, cell differentiation, 
metabolism, and development (Gronemeyer et al., 2004). The disruption of these NRs 
and their controlled signalling cascades can alter the regulation of genes involved in a 
variety of metabolic mechanisms, ultimately impacting the physiology of the organisms. 
NRs are activated by the binding of endogenous or exogenous small lipophilic compounds 
(Mangelsdorf et al., 1995; Pardee et al., 2011). Different chemicals, of which 
pharmaceuticals are a prime example, are present in the aquatic environment and can 
mimic bona fide ligands (Delfosse et al., 2015). Numerous studies have shown that some 
of these compounds have the ability to activate NR-mediated signals leading to toxic 
responses (Janosek et al., 2006; Grun and Blumberg, 2006; Castro and Santos, 2014). 
Pharmaceutical compounds are among the emerging contaminants detected in 
aquatic environments in increasing concentrations. Simvastatin (SIM), an 
anticholesterolemic drug from the statins group, is one of the top prescribed 
pharmaceutical and has been detected in aquatic environments (Hernando et al., 2006; 
Santos et al., 2010). In humans, SIM reduces cholesterol (Chol) inhibiting 3-hydroxy-3-
methylglutaryl-coenzymeA (HMG-CoA) reductase limiting HMG-CoA conversion into 
mevalonate and increasing low density lipoproteins cholesterol (LDL-C) receptors and 
LDL-C uptake (Rodwell et al., 1976; Fent et al., 2006). SIM also exerts significant 
immunomodulatory and anti-inflammatory effects autonomous of lipid lowering (Alvarez de 
Sotomayor et al., 2008; Fraunberger et al., 2009). Previous studies reported negative 
effects of SIM in non-target aquatic organism (Ribeiro et al., 2015; Neuparth et al., 2014; 
Ellesat et al., 2011). However the knowledge is still scarce on its ability to regulate and 
affect NRs in particular in fish early stages of development. 
This study focused in NRs which can be involved in the lipid metabolism, 
inflammatory and immune homeostasis and in xenobiotic metabolism. The peroxisome 
proliferator activated receptor subfamily (PPAR) includes three subtypes (PPARα, PPARβ 
and PPARγ), which were identified in the genome of various vertebrate species including 
fish (Ruyter et al., 1997; Cajaraville et al., 2003; Ibabe et al., 2002; Zhao et al., 2015). In 
mammals, PPARs were shown to be involved in the regulation of inflammatory and 
immune homeostasis and lipid, glucose and xenobiotic metabolism (Janani and Ranjitha 
Kumari, 2015; Ipseiz et al., 2014; Xu et al., 2005). The Pregnane X receptor (PXR) and 
constitutive androstane receptor (CAR) are known to regulate different gene cascades 
involved in the transport, metabolism and elimination of xenobiotics in mammals (Xu et al., 
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2005; Wang et al., 2012). The Retinoid X receptor (RXR) can form homodimers and 
heterodimers with other NRs, including PXR, PPAR and retinoid acid receptors (RAR) (Yu 
et al., 1991; Mangelsdorf and Evans, 1995; Wang and LeCluyse, 2003). Other receptor 
relevant in cell detoxification processes is the aryl hydrocarbon receptor (AhR) that is 
transactivated by aromatic and halogenated compounds (Elferink, 2003; Hahn, 2002).  
In fish, the regulation of several of these mechanisms by NRs is not fully 
understood. Nevertheless, given the phylogenetic proximity between fish and mammals, 
several NR-dependent signalling pathways are phylogenetically conserved (Corcoran et 
al., 2012; Cocci et al., 2015; Bou et al., 2014; Carmona-Antoñanzas et al., 2014; Lima et 
al., 2015). In mammals gene expression of NRs such as Pxr, Ppar and the transcription of 
Ahr were found to be modulated by different anthropogenic chemicals, including 
pharmaceuticals that subsequently affected gene expression of drug-metabolizing genes 
(Aleksunes and Klaassen, 2012). Similar findings were reported for teleosts, including 
changes in the transcription levels of genes involved in drug metabolism such as  cyp1a 
or cyp3a  (Wassmur et al., 2010; Mortensen and Arukwe, 2007). Given the paucity of 
toxicological data for several classes of pharmaceuticals, it is essential to evaluate their 
effects in non-target organisms, such as teleost fish. 
Zebrafish, Danio rerio, is widely used as a model species in several research 
areas, showing interesting features such as the fully sequenced genome, available 
molecular tools, and a short life-cycle and amenable laboratory maintenance (Baker and 
Hardiman, 2014). Furthermore it is an interesting species for comparative studies with 
mammals showing a high degree of conservation of several signalling pathways. 
Therefore, this study aims at i) characterize the basal transcription profile of NRs in 
zebrafish embryos, at different development stages and ii) evaluate the effects of SIM in 
mRNA transcription of NRs involved in different regulatory pathways including lipid 
regulation and ahr gene transcription at different stages of development and different 
exposure times. 
4.3 Material and methods 
4.3.1 Maintenance of zebrafish, rearing conditions and exposure assays 
Adult wild-type zebrafish, obtained from local suppliers, were used as breeding 
stocks. Fish were kept at a water temperature of 27±1 ºC and in a photoperiod of 12:12 h 
(light:dark) in 60 L aquaria with dechlorinated and aerated water in a recirculation system 
with both mechanical and biological filters. The fish were fed ad libitum twice a day with a 
commercial fish diet Tetramin (Tetra, Melle, Germany), supplemented once a day with live 
brine shrimp (Artemia spp.). For reproduction, females and males (ratio 1:2) were 
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transferred to a maternity, and submitted to acclimatization for 12 h in a cage with a net 
bottom covered with glass marbles within a 30 L aquarium. After spawning on the 
following day, the breeders were removed after the beginning of the light period. The 
spawned eggs were collected, counted, cleaned and stored in RNALater (30 embryos per 
time-point) at 0, 2, 3, 6, 14, 24, 48 and 72 hours post fertilization (hpf), for further 
transcription profiling. Different clutches were used to reduce variability in the 
development stages. Time-points for embryo and larvae collection were chosen based on 
the developmental embryonic and larval stages of D. rerio as described by Kimmel et al. 
(1995). Accordingly, embryos were grouped in 8 development stages - zygote (0 hpf), 
cleavage (2 hpf), blastula (3 hpf), gastrula (6 hpf), segmentation (14 hpf), pharyngula (24 
hpf), hatching (48 hpf), and larvae (72 hpf). 
Two assays were performed with zebrafish embryos exposed to SIM (5, 50 µg/L) 
chosen according to previous studies (Ribeiro et al., 2015; Torres, 2013; Key et al., 2008). 
Briefly, for assay 1, after reproduction, 1 hpf embryos were transferred to new aquaria (3.5 
L) and were kept for 24 h, at 26 ± 1 ºC with aeration, and then exposed to SIM in a 24 well 
plate (10 embryos per well), for 2 hours and then collected for lipid extraction and the 
remaining stored in RNALater. In assay 2, after spwanning, embryos (10 per well) were 
transferred to a 24 well plate and exposed to SIM for 80h. Throughout the experiment, the 
medium was renewed every day and at 80 hpf, 60 embryos per treatment were collected 
for lipid extraction and 30 embryos stored in RNALater. The two assays were performed 
according to a previous study (Cunha et al., 2016), in order to evaluate the effects of 
short-term exposure to SIM (2 h) and exposure throughout the embryonic development 
(80 h). 
4.3.2 RNA isolation and cDNA synthesis 
Embryos stored in RNALater from both assays were used to isolate total RNA. 
RNA isolation was performed according to Costa et al., 2012.  Briefly, total RNA was 
isolated using Illustra RNAspin Mini RNA Isolation kit (GE Healthcare), according to the 
manufacturer’s protocol. RNA quality was verified by electrophoresis in agarose gel and 
by measurement of the ratio of optical density at λ260/280 nm. RNA was quantified using 
Quant-IT RiboGreen RNA Reagent and Assay Kit (Invitrogen) using a Fluoroskan Ascent, 
Labsystems. One microgram of total RNA was subjected to digestion of genomic DNA 
using Deoxyribonuclease I, Amplification Grade (Invitrogen) and synthesis of cDNA was 
performed using Iscript cDNA Synthesis (Biorad). 
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4.3.3 Quantitative real-time PCR (qRT-PCR) 
Gene expression of ahr2, raraa, rarab, rarga, pparαa, pparβ1, pparγ, pxr, rxraa, 
rxrab, rxrbb, rxrga, rxrgb, was assessed in embryo and larvae at the different stages of 
development by means of quantitative real time PCR (qRT-PCR). Primer pairs for each 
target gene were designed with Primer 3 software 
(http://www.ncbi.nlm.nih.gov/tools/primer-blast/), based on available sequences in 
GenBank. Identities of the amplicons were confirmed by cloning and sequencing of the 
DNA fragments as described by Costa et al. (2012). Primer sequences, amplicon lengths, 
efficiencies and Genbank accession numbers of target sequences are given in Table 1S. 
To determine the efficiency of the PCR reactions, standard curves were made, with 6 
serial dilutions of the template (concentrations range from 0.05 to 50 ng/μl), and the 
slopes and regression curves were calculated (Table 1S). Reactions for qRT-PCR were 
conducted in an iQ5 BioRad, with 10 μl of SYBR Green Supermix (BioRad), 2 μl of each 
primer (final concentrations ranging from 0.001µM to 0.6µM) and 2 μl of cDNA, in a total 
volume of 20 μl, in duplicate. Conditions were as follows: 95 °C for 3 min, followed by 40 
cycles of 95 °C for 10 s, 54 °C with exception of rxr and rar (60°C) (for 30 s and 72 °C for 
30 s. At the end of each run a melting curve analysis was done (from 55 to 95 °C) to 
determine the formation of the specific products. No template controls were run to exclude 
contamination and the formation of primer dimers.  
Gene expression was quantified according to Cunha et al., 2016, by normalizing 
with multiple reference genes using Normfinder algorithm (Andersen et al., 2004; 
Urbatzka et al., 2013). For characterization of the transcription profile the elongation factor 
1 (ef1) and RNA polymerase II (pol II) were used while ef1 and ribosomal protein l8 (rpl8) 
collected from the two assays. The relative expression ratio was calculated with PCR 
efficiencies using the Pfaffl mathematical model (Pfaffl, 2001). Despite this normalization 
for gene transcription pattern, there were significantly differences between zygote and 
cleavage stages (to be considered as group 1) and the following development stages (to 
be considered as group 2). For this reason, no comparison was performed for gene 
transcription data from cleavage to blastula. To calculate ΔΔCt for gene transcription 
pattern, the reference or control Ct was assigned as the average of Cts from each group. 
Data is presented in mean of mRNA expression in relation to the reference genes. 
4.3.4 Lipid extraction 
Lipids were extracted from zebrafish embryos (60 embryos) exposed to SIM, in 
both assays, using the Folch method, with some modifications (Folch et al., 1957). Briefly, 
embryos were homogenized in chloroform:methanol solution (2:1). The homogenate was 
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transferred to a glass vial and incubated at room temperature, in the dark, in an orbital 
shaker (100 rpm) for 30 min. To avoid lipid oxidation, a nitrogen atmosphere was always 
insured inside the glass vials before closing. The solution containing the lipids was then 
washed with 0.9 % NaCl and vortexed for 1 min and centrifuged for 10 min at 2000 rpm 
(15 ºC). The two phases were then separated and the upper phase removed. The solution 
was again washed with methanol:water (1:1), centrifuged at 2000 rpm and the upper 
phase removed. The lower phase containing the lipids was evaporated under nitrogen 
stream, and the dried extracts stored at -20ºC until quantification. Recovery rate of the 
extraction method was performed by spike procedure with Chol (1 mg/ml) and calculated 
to be 70%.  
4.3.5 Cholesterol quantification 
Dry extracts containing the lipids were re-suspended in 500 µL methanol and 
dissolved with ultrasound for at least 2 hours at 35ºC until complete dissolution. 
Determination of cholesterol (Chol) was performed by using a colourmetric assay, 
InfinityTM Cholesterol Liquid Stable Reagent (Thermo Scientific, Biognóstica, Portugal) 
following the manufacture’s protocol. The absorbance was measured at 490 nm and 630 
nm at 37 ºC. Standard curves using cholesterol dissolved in metanol were performed in 
every run and each assay was replicated at least three times. Data is expressed in µg/µl. 
4.3.6 Statistical analysis 
Differences in mRNA gene transcription and Chol quantification among treatments 
in the two assays were evaluated by means of a one-way ANOVA, followed by a multiple 
comparison test (Tukey’s test) at a 5% significant level. Data were log transformed in 
order to fit ANOVA assumptions. All tests were performed using software Statistica 7 
(Statsoft, Inc). Data is presented as mean ± standard error. 
4.4. Results 
4.4.1 Characterization of the transcription profile 
The mRNA transcription of ahr2, raraa, rarab, rarga, pparαa, pparβ1, pparγ, pxr, 
rxraa, rxrab, rxrbb, rxrga, rxrgb in the eight development stages of D. rerio were assessed 
and are presented in Fig. 4.1. All target genes were expressed at the initial phases 
(zygote and cleavage phases) of development showing similar transcription levels (Fig. 
1S-13S, supplementary material for more detailed information). In group 2, different 
patterns of mRNA transcripts of the target genes were observed (Fig. 4.1). The mRNA 
expression pattern of pxr, rxraa (Fig. 1S and 2S) was similar, increasing from blastula until 
pharyngula phase (24 hpf), decreasing at hatching (48 hpf) (p<0.05), increasing again in 
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the larvae phase (72 hpf) (p<0.05). rxrab, pparα (Fig. 3S and 10S, respectively) mRNA 
decreased from blastula until gastrula (6 hpf) (p<0.05), gradually increasing after gastrula 
up to larvae phase. rxrbb, pparβ, pparγ, ahr2 (Fig. 4S, 8S, 11S, 12S and 13S) mRNA 
levels decreased from blastula until segmentation phase (14 hpf), increasing after 
segmentation until larvae phase. Regarding rxrga (Fig. 5S) the mRNA expression 
increased gradually from blastula (3 hpf) until larvae phase. Transcription of rxrgb (Fig. 
6S) was up regulated from blastula until gastrula phase (6 hpf), decreasing at 
segmentation phase, increasing again after segmentation until larvae stage. mRNA levels 
of raraa, rarga (Fig. 9S) increased from blastula until the segmentation phase (14 hpf), 
decreasing at 24 hpf, increasing again the transcription in the later phases (48 and 72 
hpf). rarga displayed the highest transcripts levels of all NRs at larvae phase. mRNA 
expression of rarab decreased from blastula until segmentation phase maintaining the 
expression levels in the following phases. 
4.4.2 Gene expression in embryos exposed to simvastatin  
The mRNA levels on embryos in the assay 1 are presented in Fig. 4.2. The mRNA 
level of ppar’s, pxr and ahr was significantly up regulated in embryos exposed to the 
highest concentration of SIM (50 µg/L) (p<0.05), whereas no differences were observed at 
the lowest SIM concentration (5 µg/L). An mRNA downward pattern was observed for rar’s 
when the embryos were treated with SIM (at both concentrations). This down regulation 
was more evident in the embryos exposed to the highest concentration of SIM, being 
significant different for raraa, rarab and rarga (p<0.05). The transcription of rxr’s was also 
down regulated in the presence of SIM (at both concentrations) (p<0.05), being significant 
at the lowest concentration.  
In assay 2 (Fig. 4.3) the mRNA expression of the target genes was evaluated only 
in the lowest concentration of SIM due to a 100% mortality registered in embryos treated 
with 50 µg/L at 32 hpf. No significant changes were observed for ppars in embryos treated 
with SIM. Transcription of pxr and ahr was significantly down regulated in the presence of 
SIM (p<0.05). The mRNA of rarab, was up regulated (p<0.05), and like pxr and ahr 
exhibited an opposite pattern from the embryos in assay 1. No differences in mRNA levels 
were observed for rxrab, rxrbb and rxrga, only rxrgb was significantly up regulated with 
SIM exposure. 
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4.4.3 Cholesterol quantification 
Chol levels in zebrafish embryos after SIM exposure in both assays are presented 
in Fig. 4.4. No significant differences among groups were observed for both assays.  
 
 
 
 
 
 
Figure 4.1: Relative mRNA expression of ahr2, raraa, rarab, rarga, pparα, ppar β, pparγ, pxr, rxraa, rxrab, 
rxrbb, rxrga and rxrgb, during the different stages of embryonic development in D. rerio comprising the zygote 
and cleavage (group 1), blastula, gastrula, segmentation pharyngula, hatching and larvae periods (group 2). 
The grey bars represent the major significantly differences between the development phases (p<0.05). 
Results are given as mean±SE, n=6. 
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Figure 4.2: Relative mRNA expression of ahr2, raraa, rarab, rarga, pparα, ppar β, pparγ, pxr, rxraa, 
rxrab, rxrbb, rxrga and rxrgb, in D. rerio embryos exposed to simvastatin 5 µg/L and 50 µg/L), at 24 hpf for 
2 h. Results are given as mean±SE, n=6.   
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Figure 4.3: Relative mRNA expression ahr2, raraa, rarab, rarga, pparα, ppar β, pparγ, pxr, rxraa, rxrab, 
rxrbb, rxrga and rxrgb, in D. rerio embryos exposed to simvastatin (5  µg/L) for 80 h. Results are given as 
mean±SE, n=6. 
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4.5 Discussion 
i) Characterization of the basal profile of nuclear receptors expression 
Several classes of contaminants can affect aquatic organisms, particularly during 
sensitive early-life stages (Mohammed, 2013). Hence, it is important to establish a 
transcriptional baseline profile for key transcription factors involved in lipid metabolism and 
xenobiotic response. Furthermore, given their mode of action NRs are also key players in 
endocrine processes (Lima et al., 2015; Frey et al., 2012; Colliar et al., 2011). 
Comprehending their diversity, ligand specificity and controlled pathways in different taxa 
is thus fundamental to address the impact of xenobiotics namely in aquatic environments 
(Castro and Santos, 2014). In the two first stages of development, zygote (0 hpf) and 
cleavage (2 hpf), mRNA from all target genes was detected in the embryos. Hence, these 
transcripts are believed to be from maternal origin since evidences indicate that 
transcripts from embryo origin only appear after cleavage, in midblastula transition 
(Abrams and Mullins, 2009). Therefore, the presence of these transcripts points to the 
importance of these genetic regulators in early life stages of development. Further, 
supporting our findings, several studies showed the presence of mRNA transcripts of the 
NRs studied here, such as rxrs, ahr, ppars and pxr in early embryo development in fish 
species (Bertrand et al., 2007; Tallafuss et al., 2006; Fernandez et al., 2013; Powell et al., 
Figure 4.4: Effects of SIM in Chol content in D. rerio embryos at 2 h exposure (A) and 80 h exposure (B). 
Results are given as mean±SE, n=3. 
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2000; Prasch et al., 2003). Genes with detected expression at the zygote period 
maintained transcription in the following development stages (group 2: from blastula to 
larvae phase). mRNA expression of most genes, with exception of rxrgb and raraa, has 
decreased after blastula (3 hpf) until gastrula (6 hpf), associated with the degradation of 
maternal transcripts, increasing afterwards due to new transcripts produced by the 
embryo. After hatching (48 hpf), mRNA expression of all the studied genes was increased 
supporting the hypothesis that these NRs are important regulators of key signalling 
pathways after the loss of chorion and the direct contact of the embryo with the aquatic 
environment. The results described herein are important to establish a transcription 
baseline to be used in future toxicological studies. 
ii) Simvastatin effects on transcription of NRs and AhR 
Toxic effects of SIM such as mortality, reproduction, behavioural and 
developmental abnormalities have recently been demonstrated for some invertebrate and 
vertebrate aquatic organisms (Ribeiro et al., 2015; Neuparth et al., 2014; Ortiz de García 
et al., 2014). In mammals, SIM impacts different physiological mechanisms, interacting in 
lipid, inflammatory and immune homeostasis pathways (Alvarez de Sotomayor et al., 
2008; Fraunberger et al., 2009). Evidences showed that their mode of action (MOA) might 
be conserved across metazoans, particularly vertebrates (Fent t al., 2006, Santos et al., 
2016). Therefore it is important to identify, in aquatic organisms, which pathways can be 
disrupted by SIM. In mammals, the expression of lipid regulating proteins is modulated by 
PPARs, and SIM is recognised to be a transcriptional activator of these NRs (Martin et al., 
2001; Lee et al., 2010; Wang et al., 2011; Zou et al., 2013). In fish, lipid regulation and 
signalling pathways are similar to mammals (Carmona-Antoñanzas et al., 2014; 
Lyssimachou et al., 2015; Den Broeder et al., 2015). More recently, zebrafish embryos 
have been used as a model to study lipid metabolism and the interaction of 
pharmaceuticals (including statins) with lipid metabolism (Miyares et al., 2014; Campos et 
al., 2015; Hachicho et al., 2015; Ho et al., 2016). Additionally, the mevalonate pathway 
and HMGCR, the gene encoding for HMG-CoA reductase, a target of SIM, shows a high 
degree of conservation between mammals and fish (Santos et al., 2016; Thorpe et al., 
2004). Therefore it can be hypothesized that fish may experience similar effects to those 
recorded in mammals in the presence of SIM. In assay 1, the transcription of ppars gene 
was up regulated mainly at the highest concentration (50 µg/L). There is a lack of studies 
addressing in the effects of pharmaceuticals, including statins, in the modulation of NRs 
transcription. Nevertheless, our data are in line with previous in vitro studies with 
mammalian cells where Ppars, mainly Pparα and Pparγ were up regulated in the 
presence of statins, including simvastatin (Martin et al., 2001; Lee et al., 2010; Wang et 
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al., 2011; Zou et al., 2013). In a previous study performed in our lab, zebrafish embryos 
exposed for 80 h at the same SIM concentrations tested here, showed no changes in the 
transcription of hmgcr (unpublished data). In accordance to this result, no changes in 
hmgcr mRNA was also observed in rainbow trout exposed to atorvastatin (Ellesat et al., 
2012). Additionally, in the present work, we determined the concentration of Chol in 
embryos exposed for 80 h to SIM, as a proxy to evaluate changes on the main target of 
SIM in mammals. However, no changes in Chol concentration were observed in the 
presence of SIM. In humans, administration of SIM lowers Chol (Rodwell et al., 1976; Fent 
et al., 2006) and increases Hmgcr mRNA levels after 3 weeks of treatment (Rudling et al., 
2002). However, in vitro studies with mammalian cells, a down regulation of Hmgcr after 
long term exposures to statins was observed, including SIM (Liu et al., 2010; Cho et al., 
2008). Hence, although no changes have been recorded here in Chol levels, we cannot 
exclude the possibility that longer exposures could also impact Hmgcr transcription in a 
similar manner to that observed in mammalian models. Chronic exposure in future studies 
should clarify this hypothesis. In fact, zebrafish larvae at 80 hpf lack white adipose tissue, 
and therefore changes in lipid metabolism may not be clear at such early developmental 
stages, which may explain the observed results of Chol levels (Flynn III et al., 2009; Imrie 
and Sadler, 2010; Tingaud-Sequeira et al., 2011).PPARα is involved in the regulation of 
lipid metabolism, and also promote anti-inflammatory effects by negatively interfering with 
pro-inflammatory signalling pathways including NF-kB (Marx et al., 2004; Okamoto et al., 
2005; Paukkeri et al., 2007; Becker et al., 2008). In a recent study in mice, it was reported 
that SIM protected against molecular and cellular damage caused by systemic 
inflammation via PPARα receptor, also increasing its mRNA expression (Rinaldi et al., 
2011). In zebrafish the outcome of altered pparα mRNA levels by SIM is still unknown, but 
taking into account the effects on mammals we can hypothesize that inflammatory and 
immune homeostasis can be impaired. In mammals, gene expression of Pxr, Ppars and 
Ahr has been found to be modulated by some pharmaceuticals, subsequently affecting 
the mRNA expression of genes belonging to the detoxification mechanism (Aleksunes and 
Klaassen, 2012). Hence, the effects of SIM in transcription of other NRs and AhR involved 
in the xenobiotic metabolism were also evaluated in this study. The transcription of pxr 
and ahr was up regulated in the presence of the highest concentration of SIM (50 µg/L) in 
assay 1, contrasting with assay 2, where a down regulation was observed, which may 
suggest some type of compensatory mechanisms. Furthermore, rars and rxrs also 
displayed different gene expression profile at 2 h and 80 h. A time and tissue specific 
mRNA expression of ahr has been reported before, in aquatic invertebrates and mammals 
(Hamadeh et al., 2002; Tian et al., 2013, Kim et al., 2015). AhR and PXR in mammals are 
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known to regulate CYPs mRNA and proteins (Xu et al., 2005, Aleksunes and Klaassen, 
2012). Several studies showed that certain pharmaceuticals such as dexamethasone, 
17alpha-ethynylestradiol affect the transcription of ahr and pxr and their downstream 
pathways such as cyp1a and cyp3a expression (Wassmur et al., 2010; Mortensen and 
Arukwe, 2007). Our previous study, where the same methodology was used, revealed an 
up regulation of cyp1a1, cyp3a65 after 2 h exposure and a down regulation of cyp3a65 
after 80 h. Additionally, an induction of EROD activity was observed while no effect on the 
transcription of cyp1a1 was detected after 80 h of exposure (Cunha et al., 2016). 
Altogether these results suggest that SIM can impact the transcription of cyps, pxr and 
ahr, which points to a possible regulation of cyps through modulation of pxr and ahr. 
Furthermore, in humans, statins are mostly metabolized by CYP3A4 enzyme (Jacobson 
2004) and enhance CYP3A, CYP2B6 and MDR1 (multidrug resistance protein 1, efflux 
transporter) mRNA expression (Kocarek et al., 2002; Yamasaki et al., 2009) through 
pathways downstream to PXR and CAR (absent in teleosts) (Kobayashi et al., 2005; 
Yamasaki et al., 2009). Although teleost fish and mammals show a well conserved 
mevalonate pathway, the metabolization of SIM in teleosts has yet to be study in detail. 
However, it has been established that zebrafish has a CYP3A4/5 like-activity that has 
been hypothesized to be carried out through the presence of a CYP3A65 (Chng et al., 
2012). If we assume a similar metabolization pathway between both groups one can 
hypothesize that SIM may be metabolized by CYP3A65, a downstream pathway of PXR. 
Given the results observed here that points to an effect of SIM in the transcription of pxr 
and ahr, we theorize that it may ultimately affect the transcription of genes involved in 
biotransformation of xenobiotics. 
4.6. Conclusions 
In conclusion, the transcripts of NRs and AhR evaluated in this study seem to be 
from maternal origin in the first developmental stages, i.e., zygote to blastula, supporting 
their importance in the early life stages. Exposure to SIM impacts the transcription levels 
of different NRs and AhR in a time- specific manner. Although the mRNA of ppars was 
affected by SIM, the modulation of this transcription factor does not seem to impact the 
total Chol levels, at least up to 80 hpf. Given the key role of these transcription factors in 
many signalling pathways, these findings should prompt more detail studies involving 
chronic exposures. Similarly, the modulation of the transcription of ahr and pxr by SIM 
indicate that phase I biotransformation may be affected.  
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SUPPLEMENTARY DATA 
 
Table 1S: Gene list, Genbank accession numbers, Primer sequences and concentrations, amplicon lengths, efficiency of reaction for ef1, pol II, rpl8, raraa, 
rarab, rarga, pparα, pparβ, pparγ, pxr, rxraa, rxrab, rxrbb, rxrga, rxrgb and ahr gene expression quantification by qRT-PCR in zebrafish  
 
 
Gene Accession 
number 
Primers Final 
Conc. 
(nM) 
Amplicon 
length 
(bp) 
Efficiency 
(%) 
ef1 NM_131263.1 F: 5’-GGACACAGAGACTTCATCAAGAAC-3’ 
R: 5’-ACCAACACCAGCAGCAACGT-3’ 
300 84 116.8 
pol II NM_001024461.2 F: 5’-CAATGACGACCCGACCG-3’ 
R: 5’-CGCCAGCAACTCAGTCACT-3’ 
10 292 96 
rpl8 NM_200713.1 F: 5’-CAATGACGACCCGACCG-3’ 
R: 5’-CGCCAGCAACTCAGTCACT-3’ 
10 136 96 
pxr DQ069792.1 F: 5’-CTTTTTCAGACGTGCGATGA-3’ 
R: 5’-TTGGCACTGTCTTCTGTTGC-3’ 
300 94 112.7 
rxraa NM_001161551.1 F: 5’-ATTCAATGGCATCTCCTG-3’ 
R: 5’-GCGGCTTAATATCCTCTG-3’ 
600 99 101.8 
rxrab NM_131153.1 F: 5’-CGCCGCATCAAATCACATAAAC-3’ 
R: 5’-TGAATGGGTTGGACAGTATTTAGC-3’ 
300 87 109.4 
rxrbb NM_131238.1 F: 5’-TCACAACTTGGGCGTGGAGGC-3’ 
R: 5’-CGCATCTTGCAGACCAGCTCAG-3’ 
300 105 100.7 
rxrga NM_131217.2 F: 5’-ATCTCAGTTCTTCGTTGCAGGTAG-3’ 
R: 5’-CGTTGATGATGGATGGGTGATGG-3’ 
300 105 99.6 
rxrgb NM_001002345.1 F: 5’-CGCGGAATGGATACTCACG-3’ 
R: 5’-GCTGATGACGGACGGATGAC-3’ 
300 114 97.7 
raraa NM_131406.2 F:5’-GTAGTGGAGTGTGGATGTGAA-3’ 
R: 5’-GTGCTGATGTCTGATGGATGA-3’ 
300 118 108.7 
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rarab NM_131399.1 F:5’-ATGGATTACTACCACCAGAAC-3’ 
R: 5’-TCTCCACAGAGTGATTCGAGC-3’ 
300 115 109.4 
rarga NM_131339.1 F: 5’-CCCGCCAACTGTACGATGTCA-3’ 
R: 5’-GGGTCCAGTCCAGCATAGAAA-3’ 
300 79 117.6 
pparα NM_001161333.1 F: 5’-CATCTTGCCTTGCAGACATT-3’ 
R: 5’-CACGCTCACTTTTCATTTCAC-3’ 
600 81 88.3 
pparβ AF342937.1 F: 5’-GCGTAAGCTAGTCGCAGGTC-3’ 
R: 5’-TGCACCAGAGAGTCCATGTC-3’ 
600 204 81.6 
pparγ DQ839547.1 F: 5’-GGTTTCATTACGGCGTTCAC-3’ 
F: 5’-TGGTTCACGTCACTGGAGAA-3’ 
600 250 87.0 
ahr2 NM_001007789.2 F: 5’-TTCTGTTGCCGATTCAGATG-3’ 
R: 5’-CTTGTTTTGCCCATGGAGAT-3’ 
300 96 113,8 
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Figure 1S  
 
 
 
 
 
 
 
 
 
Fig 1S: Relative mRNA expression of pxr during the different stages of embryonic development in 
D. rerio comprising the zygote (0 hpf) and cleavage (2 hpf) (group 1), blastula (3 hpf), gastrula (6 
hpf), segmentation (14 hpf), pharyngula (24 hpf), hatching (48 hpf) and larvae (72 hpf) (group 2) 
periods. Different upper-case letters represent significantly differences between the development 
phases of group 1 (p<0.05). Different lower-case letters represent significantly differences between 
the development phases of group 2 (p<0.05). Results are given as mean±SE, n=6.  
 
 
Figure 2S 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 2S: Relative mRNA expression of rxraa during the different stages of embryonic development 
in D. rerio comprising the zygote (0 hpf) and cleavage (2 hpf) (group 1), blastula (3 hpf), gastrula (6 
hpf), segmentation (14 hpf), pharyngula (24 hpf), hatching (48 hpf) and larvae (72 hpf) (group 2) 
periods. Different upper-case letters represent significantly differences between the development 
phases of group 1 (p<0.05). Different lower-case letters represent significantly differences between 
the development phases of group 2 (p<0.05). Results are given as mean±SE, n=6. 
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Figure 3S 
  
 
 
 
 
 
 
 
 
 
 
Fig 3S: Relative mRNA expression of rxrab during the different stages of embryonic development 
in D. rerio comprising the zygote (0 hpf) and cleavage (2 hpf) (group 1), blastula (3 hpf), gastrula (6 
hpf), segmentation (14 hpf), pharyngula (24 hpf), hatching (48 hpf) and larvae (72 hpf) (group 2) 
periods. Different upper-case letters represent significantly differences between the development 
phases of group 1 (p<0.05). Different lower-case letters represent significantly differences between 
the development phases of group 2 (p<0.05). Results are given as mean±SE, n=6. 
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Fig 4S: Relative mRNA expression of rxrbb during the different stages of embryonic development 
in D. rerio comprising the zygote (0 hpf) and cleavage (2 hpf) (group 1), blastula (3 hpf), gastrula (6 
hpf), segmentation (14 hpf), pharyngula (24 hpf), hatching (48 hpf) and larvae (72 hpf) (group 2) 
periods. Different upper-case letters represent significantly differences between the development 
phases of group 1 (p<0.05). Different lower-case letters represent significantly differences between 
the development phases of group 2 (p<0.05). Results are given as mean±SE, n=6. 
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Figure 5S 
 
 
 
Fig 5S: Relative mRNA expression of rxrga during the different stages of embryonic development 
in D. rerio comprising the zygote (0 hpf) and cleavage (2 hpf) (group 1), blastula (3 hpf), gastrula (6 
hpf), segmentation (14 hpf), pharyngula (24 hpf), hatching (48 hpf) and larvae (72 hpf) (group 2) 
periods. Different upper-case letters represent significantly differences between the development 
phases of group 1 (p<0.05). Different lower-case letters represent significantly differences between 
the development phases of group 2 (p<0.05). Results are given as mean±SE, n=6. 
 
 
Figure 6S 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 6S: Relative mRNA expression of rxrgb during the different stages of embryonic development 
in D. rerio comprising the zygote (0 hpf) and cleavage (2 hpf) (group 1), blastula (3 hpf), gastrula (6 
hpf), segmentation (14 hpf), pharyngula (24 hpf), hatching (48 hpf) and larvae (72 hpf) (group 2) 
periods. Different upper-case letters represent significantly differences between the development 
phases of group 1 (p<0.05). Different lower-case letters represent significantly differences between 
the development phases of group 2 (p<0.05). Results are given as mean±SE, n=6. 
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Figure 7S 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 7S: Relative mRNA expression of raraa during the different stages of embryonic development 
in D. rerio comprising the zygote (0 hpf) and cleavage (2 hpf) (group 1), blastula (3 hpf), gastrula (6 
hpf), segmentation (14 hpf), pharyngula (24 hpf), hatching (48 hpf) and larvae (72 hpf) (group 2) 
periods. Different upper-case letters represent significantly differences between the development 
phases of group 1 (p<0.05). Different lower-case letters represent significantly differences between 
the development phases of group 2 (p<0.05). Results are given as mean±SE, n=6. 
 
 
 
Figure 8S 
 
 
 
 
 
 
 
 
 
 
Fig 8S: Relative mRNA expression of rarab during the different stages of embryonic development 
in D. rerio comprising the zygote (0 hpf) and cleavage (2 hpf) (group 1), blastula (3 hpf), gastrula (6 
hpf), segmentation (14 hpf), pharyngula (24 hpf), hatching (48 hpf) and larvae (72 hpf) (group 2) 
periods. Different upper-case letters represent significantly differences between the development 
phases of group 1 (p<0.05). Different lower-case letters represent significantly differences between 
the development phases of group 2 (p<0.05). Results are given as mean±SE, n=6. 
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Figure 9S 
 
 
 
 
 
 
 
 
 
 
Fig 9S: Relative mRNA expression of rarga during the different stages of embryonic development 
in D. rerio comprising the zygote (0 hpf) and cleavage (2 hpf) (group 1), blastula (3 hpf), gastrula (6 
hpf), segmentation (14 hpf), pharyngula (24 hpf), hatching (48 hpf) and larvae (72 hpf) (group 2) 
periods. Different upper-case letters represent significantly differences between the development 
phases of group 1 (p<0.05). Different lower-case letters represent significantly differences between 
the development phases of group 2 (p<0.05). Results are given as mean±SE, n=6. 
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Fig 10S: Relative mRNA expression of pparα during the different stages of embryonic development 
in D. rerio comprising the zygote (0 hpf) and cleavage (2 hpf) (group 1), blastula (3 hpf), gastrula (6 
hpf), segmentation (14 hpf), pharyngula (24 hpf), hatching (48 hpf) and larvae (72 hpf) (group 2) 
periods. Different upper-case letters represent significantly differences between the development 
phases of group 1 (p<0.05). Different lower-case letters represent significantly differences between 
the development phases of group 2 (p<0.05). Results are given as mean±SE, n=6. 
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Figure 11S 
 
 
 
 
 
 
 
 
 
 
 
Fig 11S: Relative mRNA expression of pparβ during the different stages of embryonic development 
in D. rerio comprising the zygote (0 hpf) and cleavage (2 hpf) (group 1), blastula (3 hpf), gastrula (6 
hpf), segmentation (14 hpf), pharyngula (24 hpf), hatching (48 hpf) and larvae (72 hpf) (group 2) 
periods. Different upper-case letters represent significantly differences between the development 
phases of group 1 (p<0.05). Different lower-case letters represent significantly differences between 
the development phases of group 2 (p<0.05). Results are given as mean±SE, n=6. 
 
 
Figure 12S 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 12S: Relative mRNA expression of pparγ during the different stages of embryonic development 
in D. rerio comprising the zygote (0 hpf) and cleavage (2 hpf) (group 1), blastula (3 hpf), gastrula (6 
hpf), segmentation (14 hpf), pharyngula (24 hpf), hatching (48 hpf) and larvae (72 hpf) (group 2) 
periods. Different upper-case letters represent significantly differences between the development 
phases of group 1 (p<0.05). Different lower-case letters represent significantly differences between 
the development phases of group 2 (p<0.05). Results are given as mean±SE, n=6. 
 
 
Simvastatin exposure can modulate gene expression of nuclear receptors linked to detoxification 
process in zebrafish embryos 
123 
 
 
 
Figure 13S 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 13S: Relative mRNA expression of ahr during the different stages of embryonic development in 
D. rerio comprising the zygote (0 hpf) and cleavage (2 hpf) (group 1), blastula (3 hpf), gastrula (6 
hpf), segmentation (14 hpf), pharyngula (24 hpf), hatching (48 hpf) and larvae (72 hpf) (group 2) 
periods. Different upper-case letters represent significantly differences between the development 
phases of group 1 (p<0.05). Different lower-case letters represent significantly differences between 
the development phases of group 2 (p<0.05). Results are given as mean±SE, n=6. 
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Danio rerio embryos on Prozac – Effects in the detoxification mechanism and embryo 
development 
5.1 Abstract  
In the past decade the presence of psychopharmaceuticals in the aquatic 
environment, including fluoxetine (FLU), has been raising due to the increasing trend in 
human consumption. Aquatic organisms are usually exposed to chronic low doses and 
therefore risk assessment should evaluate the effects of these compounds in non-target 
organisms. Teleost fish possess an array of active defence mechanism to cope with the 
deleterious effects of xenobiotics that include ABC transporters, phase I and II of cellular 
detoxification and oxidative stress enzymes. Hence, the present study aimed at 
characterising the effect of FLU on embryo development of the model teleost zebrafish 
(Danio rerio) concomitantly with changes in the detoxification mechanisms during early 
developmental phases. Embryos were exposed to different concentrations of FLU 
(0.0015, 0.05, 0.1, 0.5 and 0.8 µM) for 80 hours post fertilization. Development was 
screened and the impact in the transcription of key genes, i.e., abcb4, abcc1, abcc2, 
abcg2, cyp1a, cyp3a65, gst, sod, cat, ahr, pxr, pparα, pparβ, pparγ, rxraa, rxrab, rxrbb, 
rxrga, rxrgb, raraa, rarab, rarga evaluated. In addition, accumulation assays were 
performed to measure ABC proteins activity and antioxidant enzymes (CAT and 
Cu/ZnSOD) activities determined after exposure to FLU. Embryo development was 
disrupted at an environmental relevant concentration of FLU (0.0015 µM). Embryos 
exposed to FLU exhibited a decreased pattern for Cu/Zn SOD and increased CAT (FLU at 
0.0015 and 0.5 µM) enzymatic activity. A down regulation pattern was observed for most 
genes belonging to the detoxification system with exception of cat that was upregulated at 
0.0015 µM of FLU. For most of the tested concentrations, a down regulation pattern was 
observed for pparα, pparβ, pparγ, raraa, rxraa, rxrab, rxrbb rxrgb and ahr, while pxr was 
significantly up regulated in all tested concentrations. In conclusion, our work shows that 
FLU impacts zebrafish embryo development at environmentally relevant concentrations 
concomitantly with changes in antioxidant enzymes, and the transcription of key genes 
involved in detoxification and development. These finding raises additional concerns 
supporting the need to monitor the presence of this compound in aquatic reservoirs. 
 
Keywords: Fluoxetine, zebrafish embryos, ABC transporters, phase I and II, antioxidant 
enzymes, nuclear receptors 
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5.2 Introduction 
 
In the past decade the consumption of psychopharmaceuticals has increased due 
to the socio-economic context and a higher prevalence of psychiatric disorders (Silva et 
al., 2012). This therapeutic class of pharmaceuticals is one of the most commonly 
detected in the aquatic environment (Santos et al., 2010). Fluoxetine (FLU), commercial 
name Prozac®, is one of the top prescribed psychopharmaceutical (Mennigen et al., 2011; 
Winder et al., 2012) to treat depression, compulsive behaviour and eating disorders 
(Dulawa et al., 2004). The presence of FLU in the environment was first reported by 
Kolpin et al. (2002) in USA surface waters and since then numerous reports have shown 
the presence of this drug in different water matrices, in concentrations ranging from 12 to 
929 ng/L (Fent et al., 2006; Lajeunesse et al., 2011; Barry et al., 2013; Silva et al., 2014). 
Previous studies have reported negative impacts of psychopharmaceuticals (including 
FLU) on invertebrates and fish species, such as impaired reproduction, mortality and 
behavioural changes like decreased aggressiveness and feeding responses (Monpelat et 
al., 2009; Lister et al., 2009; Santos et al., 2010; Schultz et al., 2011). Nonetheless, the 
physiological consequences of the exposure to FLU are still not fully understood in non-
target aquatic organisms. Fish have well-developed mechanisms that contribute to cell 
detoxification and to counteract the effects of environmental pollutants. Among these are 
ATP – binding cassette (ABC) transporter proteins (ABCB, ABCC and ABCG families), 
phase I (cytochrome P450 family, CYPs) and phase II (eg. glutathione-S-transferase, 
GST)  biotransformation enzymes, and antioxidant enzymes (eg. superoxide dismutase, 
SOD, catalase, CAT) (Van der Oost et al., 2003; Bard, 2000; Stegeman et al., 1992; 
Lopez-Torres et al., 1993). In aquatic organisms the multixenobiotic resistance (MXR) 
mechanism incorporates members of the ABC transporter family (Kurelec, 1992) that are 
considered to be the first line of defence against toxicants (Bard, 2000; Ferreira et al., 
2014; Luckenbach et al., 2014). Nonetheless, the MXR system can be inhibited by certain 
chemicals (chemosensitisers) known to be present in the aquatic ecosystems, potentially 
increasing the toxicity of other chemicals that would normally be effluxed from the cells 
(Epel et al., 2008). Some psychopharmaceuticals, including FLU, have been described to 
be P-gp inhibitors in mammals (Peer and Margalit, 2006; O’Brien et al., 2013; Schrickx 
and Fink-Gremmels et al., 2014). Also, has been reported that FLU can inhibit P-gp (P-
glycoprotein, ABCB1) and biotransformation enzymes in both mammals and fish (Peer 
and Margalite, 2006; Smith et al., 2012; Thibaut and Porte, 2008; Sager et al., 2015). 
Hence, given the central role of detoxification in the toxicity of both endogenous and man-
made chemicals, it is important to understand the regulation of detoxification signalling 
pathways. In mammals, this defence system is mostly regulated by nuclear receptors 
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(NRs), which include pregnane X receptors (PXR), peroxisome proliferated activated 
receptors (PPAR), retinoid X receptors (RXR), constitutive androstane receptors (CAR) 
and glucocorticoid receptor (GR), and by aryl hydrocarbon receptor (AhR) (Xu et al., 2005; 
Ferreira et al., 2014). Among other pathways, NRs are involved in xenobiotics 
metabolism, regulating the transcription of genes belonging to the detoxification process 
(Wang and LeCluyse, 2003; Robinson-Rechavi et al., 2003; Xu et al., 2005; Castro and 
Santos, 2014). Danio rerio is a well-known model fish species that has been used in 
different fields of research, including ecotoxicology. Therefore, it was selected for the 
present study due to characteristics such as embryo transparency that allows the 
observation of development and the assessment of embryo toxicity, and the availability of 
a full genome sequence. 
This study aimed at i) evaluate the effects of FLU in embryo development; ii) 
characterise the expression and response patterns of genes belonging to the 
detoxification mechanism as well as MXR and antioxidant activities on D. rerio embryos 
exposed to FLU; iii) evaluate the modulation of key transcription factors (ppars, pxr, rxrs, 
rars and ahr) after FLU exposure; and iv) assess the potential chemosensitiser effect of 
FLU using D. rerio embryos as model. 
5.3 Material and methods 
5.3.1 Chemicals 
Fluoxetine (FLU) (CAS #56296-78-7), rhodamine 123 (RH123), verapamil (VER) 
and vinblastine were purchased from Sigma-Aldrich (Germany) and MK571 from VWR 
International. All the other chemicals were of analytical grade, and were purchased from 
local companies. 
5.3.2 Parental animals 
Adult wild-type zebrafish, obtained from local suppliers, were used as breeding 
stocks. The stock was kept at a water temperature of 27±1 ºC and in a photoperiod of 
12:12 h (light:dark), in 60 L aquaria with dechlorinated and aerated water in a recirculation 
system with both mechanical and biological filters. The fish were fed ad libitum twice a day 
with a commercial fish diet Tetramin (Tetra, Melle, Germany), and supplemented once a 
day with live brine shrimp (Artemia spp.). 
5.3.3 Rearing conditions and exposures 
For reproduction, females and males (ratio 1:2) were transferred to a spawning 
tank, and submitted to acclimatization for 12 h in a cage with a net bottom covered with 
glass marbles within a 30 L aquarium. After egg-laying, in the following day, the breeders 
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were removed after the beginning of the light period. For the toxicological assays (section 
2.4), embryos (1 hpf) were transferred to a 24 well plate (10 embryos per well) and 
exposed to FLU at different concentrations (0.0015, 0.05, 0.1, 0.5 and 0.8 µM; diluted in 
DMSO, 0.004 % (ranging from 519 to 2.8 x 105 ng/L). The tested concentrations are 
environmentally relevant, particularly the lowest (0.0015 µM = 519 ng/L). Prior to embryo 
exposures, the test solutions were placed into the plates for 24 h so that the chemicals 
could adsorb to the plastic, and the solutions renewed after preadsorption. For the 
determination of the biochemical parameters (section 2.5), 100 embryos (1 hpf) were 
placed in glass beakers at 26 ± 1 ºC with aeration, and exposed to the test solutions until 
80 hpf. For the accumulation assays (MXR activity) (section 2.6) the embryos (1 hpf) were 
transferred to new aquaria (3.5 L) and were kept for 24 h, at 26 ± 1 ºC with aeration, until 
the assays execution. 
5.3.4 Toxicological assay 
Embryos were exposed from 1 hpf until 80 hpf to different concentrations of FLU 
as previously described (section 5.3.3). The medium (water plus FLU) was renewed daily 
for the duration of the experiment. Embryos were observed with an inverted microscope 
(Nikon Eclipse TS100) and the selected endpoints (mortality rate, 75% epiboly, 
delay/arrest of the division, abnormal cell masses, development delay, pericardia edema, 
head, eyes and tail abnormalities) recorded at 8 hpf, 32 hpf and 80 hpf (Soares et al., 
2009; Ribeiro et al., 2015). After 80 h of exposure, 30 embryos were collected and 
preserved in RNALater for gene expression analysis. Mortality and abnormalities data are 
presented in total percentage (%). 
5.3.5 Antioxidant enzymes activity  
After exposure to FLU, 100 embryos (80 hpf) were homogenized in ice-cold 100 
mM potassium phosphate buffer pH 7.4, 150 mM KCl, 1 mM dithiothreitol (DTT), 0.1 mM 
phenylmethylsulfonyl fluoride (PMSF) and 1 mM disodic ethylenediaminetetra acetic acid 
(Na2EDTA) (Fernandes et al., 2008). Post-mitochondrial fractions were obtained after 
centrifugation at 15,000 g for 20 min at 4°C. Superoxide dismutase (SOD) activity was 
determined by the degree of inhibition on the reduction of cytochrome c by superoxide 
anion generated by the xanthine oxidase/xanthine system (Ferreira et al., 2005). 
Cytochrome c reduction was followed through the measurement of the absorbance at 550 
nm. In the assay concentration of the components was sodium phosphate buffer 50 mM, 
pH 7.8, with Na2EDTA 0.1 mM, xanthine 50 μM, xanthine oxidase 5.2 mU/mL and 
cytochrome c 18 μM. 250 μL of these components was reacted with the sample (protein 
concentration 4 mg/mL) diluted in phosphate buffer to a final volume of 300 μL. To obtain 
Danio rerio embryos on Prozac – Effects in the detoxification mechanism and embryo development 
131 
linearity, the volume of sample and phosphate buffer, per well, were adjusted for each 
sample. SOD standards were used in each assay to calculate the activity given in SOD 
Units (1 SOD Unit=50% inhibition of the reduction of cytochrome c) per mg of protein. The 
samples were divided in two aliquots, one to measure the total SOD activity and the other 
to measure MnSOD activity by adding to the reaction KCN 2 mM. To obtain the 
Cu/ZnSOD activity we then deduct the MnSOD from the total SOD activity. Catalase 
(CAT) activity was determined by measuring the consumption of H2O2 at 240 nm (ε=40 
M−1cm−1) as described in Ferreira et al., (2008) with slight modifications. The reaction 
mixture contained 65 mM potassium phosphate buffer, pH 7.8, 15.5 mM H2O2 and 0.01% 
TritonX-100. In the cuvette, 950 μL of reaction mixture was added to the sample (protein 
concentration 4 mg/mL), diluted in phosphate buffer, to a final volume of 1000 μL. To 
obtain linearity, the volumes of sample and phosphate buffer were adjusted for each 
sample. CAT activity is expressed as μmol/min/mg protein. All measurements were 
performed in triplicate for each sample. Protein determinations were performed by the 
Lowry method using bovine serum albumin (BSA) as a standard (Lowry et al., 1951). 
5.3.6 Accumulation assay 
The accumulation of the fluorescent substrate (RH123) in zebrafish embryo tissue 
served as measure for MXR transporter activity. This assay was performed according to 
Cunha et al., 2016. Briefly, ABC transporter activity was determined by means of 
accumulation assays using RH123 (8 µM) in presence of FLU (0.0015, 0.05, 0.1, 0.5 and 
0.8 µM), and ABC protein inhibitors (VER (10 µM), MK571 (10 µM), and Vinblastine (10 
µM)). The assay was performed with 24 hpf embryos when the organism has most of the 
organs formed and all the genes targeted in this study are transcriptionally active. 
Embryos (24 hpf) were incubated in the dark, at 26 ± 1 ºC, for 2 h. After the 2 h exposure 
period, embryos were washed three times with ice-cold water and mechanically disrupted. 
The fluorescence of RH123 accumulated inside the embryos was measured in the 
homogenate of 10 embryos using a fluorescent microplate reader (excitation/emission - 
485/538 nm) (Fluoroskan Ascent, Labsystems). Each assay was replicated at least four 
times. Data is presented in percentage (%) in relation to the control established as 100%. 
5.3.7 RNA isolation and cDNA synthesis 
Embryos preserved in RNALater from the toxicological assays and from the 
accumulation assays were used to isolate total RNA according to Costa et al. (2012). 
Briefly, total RNA was isolated using Illustra RNAspin Mini RNA Isolation kit (GE 
Healthcare), according to the manufacturer’s protocol. RNA quality was verified by 
electrophoresis in agarose gel and by the measurement of the ratio of optical density at 
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λ260/ λ280 nm. RNA was quantified using Quant-IT RiboGreen RNA Reagent and Assay 
Kit (Invitrogen) using a Fluoroskan Ascent, Labsystems. One microgram of total RNA was 
subjected to digestion of genomic DNA using Deoxyribonuclease I, Amplification Grade 
(Invitrogen) and synthesis of cDNA was performed using Iscript cDNA Synthesis (Biorad). 
5.3.8 Quantitative real-time PCR (qRT-PCR) 
Gene expression of abcb4, abcc1, abcc2, abcg2a, cyp1a1, cyp3a65, Cu/Zn sod, 
cat, gstπ, ahr, pxr, pparα, pparβ, pparγ, rxraa, rxrab, rxrbb, rxrga, rxrgb, raraa, rarab, 
rarga was assessed by means of quantitative real time PCR (qRT-PCR). Primer pairs for 
each target gene were designed using Primer 3 software available in 
http://www.ncbi.nlm.nih.gov/, based on available sequences in GeneBank. Primer 
sequences, amplicon lengths, efficiencies and Genebank accession numbers of target 
sequences are given in Table 1S. Identities of the amplicons were confirmed by cloning 
and sequencing of the DNA fragments as described by Costa et al. (2012). To determine 
the efficiency of the PCR reactions, standard curves were made, with 6 serial dilutions of 
the template (concentrations range from 0.05 to 50 ng/μl), and the slopes and regression 
curves were calculated. Reactions for qRT-PCR were conducted in an iQ5 BioRad, with 
10 μl of SYBR Green Supermix (BioRad), 2 μl of each primer (final concentrations ranging 
from 0.001µM to 0.6µM) and 2 μl of cDNA, in a total volume of 20 μl, in duplicate. 
Conditions were as follows: 95 °C for 3 min, followed by 40 cycles of 95 °C for 10 s, 54 °C 
with exception of rxr and rar (60°C) for 30 s and 72 °C for 30 s. At the end of each run a 
melting curve analysis was done (from 55 to 95 °C) to determine the formation of the 
specific products. No template controls were run to exclude contamination and the 
formation of primer dimers. Gene expression was quantified by normalization with multiple 
reference genes (elongation factor 1 (ef1) and actin β1 (actb1) using Normfinder algorithm 
(Urbatzka et al., 2013), and the relative expression ratio was calculated with efficiencies 
using the Pfaffl mathematical model ΔΔCt (Pfaffl, 2001). Data is presented as mean of 
mRNA transcription in relation to the reference genes.  
5.3.9 Statistical analysis 
Differences in mRNA expression and the differences between treatments in 
accumulation assay were evaluated by means of a one-way ANOVA, followed by a 
multiple comparison test (Tukey’s test) at a 5% significant level. Data were log (mRNA 
expression and enzymatic activities) or square root (accumulation assay) transformed in 
order to fit ANOVA assumptions. All tests were performed using software Statistica 7 
(Statsoft, Inc). Differences between treatments in the toxicological assay were evaluated 
by means of cross table χ2 test at 5 % significance level. Correlations between mRNA 
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expressions of the evaluated genes were tested by Pearson analysis. Tests were 
performed using software SPSS 22 (IBM, Inc). Data is presented as mean ± standard 
error. 
5.4 Results 
5.4.1 Toxicological assay 
To test the toxicity of FLU in the embryos the cumulative mortality and total 
abnormalities after exposure to FLU (0.0015, 0.05, 0.1, 0.5 and 0.8 µM), at different 
embryo development periods (8, 32 and 80 hpf) was tested and are presented in Fig. 
5.1A. No significant differences in mortality were observed in embryos exposed to FLU, in 
comparison to the solvent control group, and there was no increased mortality between 32 
and 80 hpf. Regarding the development of abnormalities no differences were observed at 
8 hpf in the presence of FLU. However, at 32 and 80 hpf a significant increase in 
abnormalities was detected in embryos treated at all tested concentrations (p<0.05). At 32 
hpf, the highest percentage (48 %) of abnormalities was registered at 0.8 µM of FLU 
(p<0.05) where 35% of the embryos exhibited pigmentation anomalies. In addition, a high 
percentage (26 – 30 %) of embryos exposed to the lower concentrations (0.0015 and 0.05 
µM) displayed other abnormalities such as pericardium edema and tail abnormalities (Fig. 
1S, supplementary material for more detailed information). Similar to 32hpf, at the end of 
the assay (80 hpf), pigmentation, pericardium edema and tail abnormalities were the most 
prevalent anomalies in embryos exposed to FLU. (Fig. 2S, supplementary material for 
more detailed information). 
5.4.2 Antioxidant enzymes activity 
To address the question of correlation of the morphological effects of FLU with 
toxicity parameters, we assayed two anti-oxidant defences, SOD and CAT in zebrafish 
embryos after 80 h of exposure to FLU (Fig. 5.2). Cu/ZnSOD activity (Fig. 5.2A) was 
significantly decreased in the presence of FLU, even at the intermediate concentrations 
(0.1 µM) (p<0.05) while the CAT activity (Fig. 5.2B) seemed to be stimulated in all 
treatments, with significant differences (p<0.05), in comparison to controls 
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Figure 5.1: Cumulative mortality and abnormality rates at 8, 32 and 80 hpf of D. rerio embryos exposed to 
different concentrations of fluoxetine (0.0015, 0.05, 0.1, 0.5 and 0.8 µM) for 80 h (%). Results are expressed as 
mean ± SE, n=6. Bars with asterisk are significantly different from the solvent control group (p<0.05). 
Figure 5.2: SOD (A) and CAT (B) activity in 
(100) D. rerio embryos exposed to FLU 
(0.0015, 0.05, 0.1, 0.5 and 0.8 µM) for 80 h. 
Results are given as mean±SE, n=3. Bars 
with different letters indicate significant 
differences among treatments (p<0.05). 
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5.4.3 Accumulation Assay 
As the toxicity can be due to the accumulation of the drug ABC transporter activity 
was determined by means of accumulation assays using the fluorescent substrate RH123 
in the presence of the test chemicals (Fig. 5.3). A significant increase in RH123 
accumulation inside the embryos was observed in the presence of ABC transporters 
inhibitors (MK571, VER and Vinblastine (10 µM)) (p<0.05) whereas no differences were 
observed in RH123 accumulation in embryos exposed to FLU. 
 
5.4.4 Gene expression in embryos exposed to FLU  
To evaluate if the levels of the detoxification components were dependent on 
transcription, mRNA transcription levels of abcb4, abcc1, abcc2, abcg2a, cyp1a1, 
cyp3a65, Cu/Zn sod, cat, gstπ and NRs (pxr, pparα, pparβ, pparγ, rxraa, rxrab, rxrbb, 
rxrga, rxrgb, raraa, rarab, rarga) and ahr, in embryos exposed to FLU for 80 h was 
assayed (Fig. 5.4 and Fig. 5.5). A pattern of down regulation was observed for most of the 
genes coding for detoxification components in embryos exposed to the different 
concentrations of FLU, with exception of cat that was up-regulated in the presence of the 
lowest concentration of FLU (0.0015 µM) (p<0.05). Moreover, abcb4, abcc1, cyp1a1, 
Cu/Zn sod showed a concentration dependent down regulation pattern. Interestingly, 
abcc2 mRNA was significantly down regulated at all tested concentrations (Fig. 5.4). The 
transcription of most nuclear receptors (pparα, pparβ, raraa, rxraa, rxrab, rxrbb rxrgb) was 
also down-regulated in embryos exposed to all FLU concentrations while pxr transcription 
Figure 5.3: Accumulation of rhodamine 123 in D. rerio embryos exposed to ABC transporters inhibitors 
(MK571 (10 µM), VER (10 µM) and Vinblastine (10 µM)), FLU (0.0015, 0.05, 0.1, 0.5 and 0.8 µM) for 2 h (%). 
Results are given as mean±SE, n=4. Bars with different letters indicate significant differences among 
treatments (p<0.05). 
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was up-regulated (p<0.05) (Fig. 5.5). ahr and pparγ displayed a down regulation pattern 
with the exception of embryos exposed to 0.05 µM of FLU. mRNA levels of rarab, rarga 
were significantly decreased in embryos exposed to 0.05 and 0.8 µM (p<0.05), whereas 
rxrga demonstrated an up-regulation pattern at 0.0015, 0.5 and 0.8 µM of FLU. 
Significant correlations in gene transcription were found between cyp1a and both 
pxr and ahr (r=0.75 and r=0.66, respectively; p<0.05). Also, between cyp3a65 and both 
pxr and ahr (r=0.91 and r=0.41, respectively; p<0.05). Moreover, significant correlations 
were found between transcription levels of Cu/Zn sod and SOD activity (r=0.72) and cat 
and CAT activity (r=0.64), (p<0.05), showing a coordinated response in gene expression 
and protein activity at the level of antioxidant defences. 
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Figure 5.4: Relative mRNA expression of abcb4, abcc1, abcc2, abcg2a, cyp1a1, cyp3a65, gstπ, Cu/Zn sod 
and cat in (30) D. rerio embryos exposed to FLU (0.0015, 0.05, 0.1, 0.5 and 0.8 µM) for 80h. Bars with different 
letters indicate significant differences among treatments (p<0.05). Results are given as mean±SE, n=6.   
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Figure 5.5: Relative mRNA expression of pparα, pparβ, pparγ, pxr, ahr, raraa, rarab, rarga, rxraa, rxrab, 
rxrbb, rxrga and rxrgb in (30) D. rerio embryos exposed to FLU (0.0015, 0.05, 0.1, 0.5 and 0.8 µM) for 80h. 
Bars with different letters indicate significant differences among treatments (p<0.05). Results are given as 
mean±SE, 
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5.5 Discussion 
5.5.1. Effects of FLU on detoxification 
Previous studies on the effects of FLU in zebrafish focused their research mainly in 
the neuroendocrine disruption and the behaviour changes induced by this 
psychopharmaceutical in adults (Airhart et al., 2007; Pan et al., 2012; Wong et al., 2013; 
Connors et al., 2014). However, it is important to understand the effects of this ubiquitous 
drug on fish embryonic development and the interaction with components of the cellular 
detoxification system, since FLU can affect not only the neurologic pathway but also other 
regulatory systems in non-target organisms. Hence, in this study we evaluated the effects 
of FLU in zebrafish embryo development and in the detoxification mechanism. Clearly, 
FLU leads to developmental abnormalities, within the range of concentrations found in the 
aquatic environment. A high percentage of pigmentation anomalies were observed in 
exposed embryos. One hypothesis is that FLU might be interfering with pigmentation by 
modulating embryo adrenoceptors present in the melanophores, as shown with other 
pharmaceuticals (such as propranolol and phentolamine) in fish including zebrafish (Fujii, 
2000; Xu and Xie, 2011). In agreement, a previous study performed in our lab, zebrafish 
embryos exposed for 80 h at the same FLU concentrations tested here, showed changes 
in the transcription of adrenoceptors (unpublished data). A general pattern of down 
regulation of genes involved in detoxification mechanisms was observed in the embryos 
after exposure to FLU including ABC transporters and biotransformation enzymes of 
phase I and II. A similar pattern of down regulation of ABC transporter expression was 
also reported in aquatic invertebrates (Franzelliti et al., 2014; Chen et al., 2015) and 
mammalian cell lines (Zhang et al., 2013). In adult zebrafish FLU inhibited CYP1 
expression and EROD activity (Smith et al., 2012; Laville et al., 2004), and our results 
show a down regulation of cyp1a1 and cyp3a65 in zebrafish embryo. Altogether, these 
results suggest that FLU can disrupt the detoxification mechanism in fish during different 
developmental phases. FLU has also been found to induce ROS production in fish cell 
lines (Laville et al., 2004) and the increase in ROS production, like H2O2, can inhibit CYP 
enzymes and their transcription regulation (Barker et al., 1994; Risso-de Faverney et al., 
2000). In fact, an inhibition of Cu/Zn SOD and induction of CAT was observed, at 
transcription and activity level after exposure to FLU. It is known that the SOD enzyme 
that would respond to an increase of ROS level should be MnSOD, and thus the increase 
of CAT activity can be to cope with more hydrogen peroxide resulting from the MnSOD 
activity. This is consistent with the decrease of CuZnSOD. A similar response to FLU was 
also reported in invertebrates (Gonzalez-Rey and Bebiano, 2013; Franzelliti et al., 2014; 
Chen et al., 2015). This was justified by the increase in superoxide anions that stimulated 
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the consumption of SOD, and H2O2 formation inducing CAT activity (Chen et al., 2015; 
Gonzalez-Rey and Bebiano, 2013).  
5.5.2. Effects of FLU on NR and AhR 
Aiming to understand the regulation of expression of the genes that code for 
detoxification proteins it is important to dissect the associated signalling cascades. NRs 
are one of the largest classes of transcriptional regulators, providing a direct link between 
signalling molecules and the transcriptional responses (Wang and LeCluyse, 2003; 
Robinson-Rechavi et al., 2003; Castro and Santos, 2014). In mammals, the NRs PXR, 
CAR, and AhR are the most well-known xenosensors (Moreau et al., 2008) and regulate 
CYPs mRNA and protein expression (Xu et al., 2005, Aleksunes and Klaassen, 2012). 
CAR is absent in most teleost fish, including zebrafish (Zhao et al., 2014), nonetheless 
other NR, such as PXR and AhR were shown to mediate cyp3a65 transcription (Tseng et 
al, 2004; Li et al, 2013; Bainy et al, 2013; Chang et al., 2013). The present results showed 
that FLU leads to a down regulation pattern of ahr in zebrafish embryos that could explain 
the observed down regulation pattern of cyp1a and cyp3a65. Previous studies with 
Oncorhynchus mykiss and Salmo salar reported that ahr and pxr transcription can be 
decreased or increased by certain pharmaceuticals thus changing transcription regulation 
of cyp1a and cyp3a (Mortensen and Arukwe, 2007; Wassmur et al., 2010). The positive 
correlation observed in this study between the transcription levels of ahr, cyp1a and 
cyp3a65, in response to FLU exposure, further corroborates the suggested role of ahr and 
pxr in the regulation of cyp1a and cyp3a65 transcription. Notwithstanding, more studies 
have to be performed to verify this hypothesis. pxr mRNA exhibited the highest 
transcription levels of all NRs evaluated after FLU exposure. This may indicate that pxr 
modulation by this pharmaceutical can affect also other regulatory systems since, in 
mammals, PXR also mediates biological functions such as immune and inflammatory 
responses or lipid metabolism (di Masi et al., 2009; Smutny et al., 2013; Ma et al., 2015). 
ppars, rars and rxrs in mammals are involved in the regulation of inflammatory and 
immune homeostasis and lipid, glucose and xenobiotics metabolism (Janani and Ranjitha 
Kumari, 2015; Ipseiz et al., 2014; Xu et al., 2005) and were all down regulated by 
exposure to FLU in zebrafish embryos. In fact, other studies with fish have demonstrated 
that PPAR regulate pro-inflammatory genes and cytokines (Luo et al., 2015), lipid 
metabolism (Maradonna et al., 2015, Coimbra et al., 2015), xenobiotic metabolism (Wang 
et al., 2008; Cajaraville et al., 2003) and PPAR/RXR are involved in the regulation of 
glucose transporter 4 (GLUT4) (Marín-Juez et al., 2013). In mammalian cell lines, FLU 
decreases pparγ transcription levels, concomitantly with changes in lipid accumulation 
(Sun et al., 2015). Other lipid regulators pharmaceuticals have been reported to modulate 
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ppars gene transcription (Mimeault et al., 2006; Velasco-Santamaria et al., 2011, Coimbra 
et al., 2015). Therefore, the present results suggest that FLU can influence the regulation 
pathways of other metabolic functions, important to development through the modulation 
of NRs, such as ppars, rars and rxrs. Studies in vertebrates have demonstrated that 
nuclear receptors play an important role in embryonic development, specially retinoic acid 
(RA) receptors (RAR and RXR), since both excess or deficiency of vitamin A can lead to a 
wide range of abnormalities in the developing embryos (Klymkowsky,et al., 2010; Clagett-
Dame and Knutson, 2011; André et al., 2014; Xavier-Neto et al., 2015; Samarut et al., 
2015). AHR also plays an important role in the development of blood vessels and bone in 
fish embryos; as shown in medaka treated with AHR antagonist and cytochrome P450 
inhibitor (Kawamura and Yamashita, 2002). Our results show developmental 
abnormalities in zebrafish embryo after FLU exposure as well as a decreased 
transcription trend in cyp1a, cyp3a65, ahr, rxr and rar. These combined effects of FLU 
appear to be related to the embryo abnormalities observed. 
5.5.3 Potential chemosensitizer effect of FLU 
The presence of chemosensitising xenobiotics in aquatic environments can 
influence the toxicity of other chemicals that normally are efflux out (Epel et al., 2008). As 
previously mentioned, FLU is found in water system in concentrations up to 929 ng/L 
(0.0027 µM). Hence, in this study we evaluated if FLU can be considered an MXR inhibitor 
at environmentally relevant concentrations. Yet, no inhibitory effect on MXR activity was 
observed in embryos exposed to FLU. In mammalian models, the effects of FLU in 
multidrug resistance (MDR) are not consensual, since some studies describe FLU as an 
inhibitor of MDR activity (Peer et al., 2004; Peer and Margalit, 2006, Zhang et al., 2013), 
while others found no effects (Kappor et al., 2013, O’Brien et al., 2013) like the results 
found in this study. The MXR assay is not limited to one efflux protein and therefore the 
inhibitory effect can involve other proteins beside Abcb4, a zebrafish protein with the 
same functional properties as ABCB1 in mammals (Fischer et al., 2013). Nevertheless, a 
down-regulation of abc transporters mRNA was observed, namely the decrease of abcc2 
mRNA levels at environmental relevant concentration, showing that even in the absence 
of transporter activity inhibition, FLU influences the transcription of genes belonging to the 
MXR system. Hence it cannot be excluded the possibility that longer exposure could 
impact ABC transporter’s activity.  
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5.6 Conclusions 
In conclusion, the results presented here show a clear effect of FLU on zebrafish 
embryo development at environmentally relevant levels (0.0015 µM = 519 ng/L). These 
effects are observed concomitantly with changes in the transcription of NRs and genes 
involved in the detoxification mechanisms. Evidence suggests that FLU can disrupt the 
MXR system via downregulation of ABC transporters transcription. These effects at both 
developmental (embryo) and transcriptional level have been observed in parallel with 
changes on the enzymatic activity of Cu Zn SOD and CAT. Herewith the results indicate 
that FLU can disrupt the detoxification mechanisms impairing at the same time embryo 
development, and the overall cell defence system. This can potentially affect important 
population related endpoints, which highlights the relevance of monitoring the presence of 
FLU in the aquatic environment. 
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SUPPLEMENTARY DATA 
 
Table 1S: Gene list  Genbank accession numbers Primer sequences and concentrations, amplicon lengths, efficiency of reaction for, ABC transporters 
(abcb4, abcc2, abcc1, abcg2a), biotransformation (cyp1a1, cyp3a65, gstπ), antioxidant (Cu/Zn sod, cat) and nuclear receptors (raraa, rarab, rarga, pparα, 
pparβ, pparγ, pxr, rxraa, rxrab, rxrbb, rxrga, rxrgb and ahr) enzymes, ef1, and Actb1gene expression quantification by qRT-PCR in zebrafish. 
 
 
Gene Accession number Primers Sequence 
(5’3’) 
Final 
Conc. 
(nM) 
Amplicon 
length (bp) 
Efficiency 
(%) 
abcb4 JQ014001 F: TACTGATGATGCTTGGCTTAATC 300 159 110.6 
R: TCTCTGGAAAGGTGAAGTTAGG    
abcc1 
 
XM_002661199 F: GCTCGAGCTCTCCTCAGAAA 
R:TCGGATGGTGGACTGTATCA 
300 99 125.1 
abcc2 NM_200589 F: GCACAGCATCAAGGGAAACA 300 87 116.5 
  R: CCTCATCCACTGAAGAACCGA    
abcg2a NM_001042775.1 F: AAGGGTATCGAGGACCGTCT 300 97 113.1 
R: AATCCTGACCCTGAACGATG   
cyp1a1 NM_131879.1 F: AACTCTTCGCAGGTGCTCAT 300 97 102.0 
R: ACAAACTGCCATTGGAGACC   
cyp3a65 NM_001037438.1 F: TGACCTGCTGAACCCTCTCT 
R: AAGGGCGAAATCCATCTTCT 
300 82 91.0 
gstπ NM_131734 F: TCTGGACTCTTTCCCGTCTCTCAA 
R: ATTCACTGTTGCCGTTGCCGT 
300 105 119.0 
Cu/Zn 
sod 
Y12236 F: GTCGTCTGGCTTGTGGAGTG 
R: TGTCAGCGGGCTAGTGCTT 
300 113 110.0 
cat NM_130912.1 F: CAGGAGCGTTTGGCTACTTC 
R: ATCGGTGTCGTCTTTCCAAC 
  300 91 113.0 
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pxr DQ069792.1 F: CTTTTTCAGACGTGCGATGA 
R:TTGGCACTGTCTTCTGTTGC 
300 94 112.7 
rxraa NM_001161551.1 F:ATTCAATGGCATCTCCTG 
R:GCGGCTTAATATCCTCTG 
600 99 101.8 
rxrab NM_131153.1 F:CGCCGCATCAAATCACATAAAC 
R:TGAATGGGTTGGACAGTATTTAGC 
300 87 109.4 
rxrbb NM_131238.1 F:TCACAACTTGGGCGTGGAGGC 
R:CGCATCTTGCAGACCAGCTCAG 
300 105 100.7 
rxrga NM_131217.2 F:ATCTCAGTTCTTCGTTGCAGGTAG 
R:CGTTGATGATGGATGGGTGATGG 
300 105 99.6 
rxrgb NM_001002345.1 F:CGCGGAATGGATACTCACG 
R:GCTGATGACGGACGGATGAC 
300 114 97.7 
raraa NM_131406.2 F:GTAGTGGAGTGTGGATGTGAA 
R:GTGCTGATGTCTGATGGATGA 
300 118 108.7 
rarab NM_131399.1 F:ATGGATTACTACCACCAGAAC 
R:TCTCCACAGAGTGATTCGAGC 
300 115 109.4 
rarga NM_131339.1 F:CCCGCCAACTGTACGATGTCA 
R:GGGTCCAGTCCAGCATAGAAA 
300 79 117.6 
pparα NM_001161333.1 F:CATCTTGCCTTGCAGACATT 
R:CACGCTCACTTTTCATTTCAC 
600 81 88.3 
pparβ AF342937.1 F:GCGTAAGCTAGTCGCAGGTC 
R:TGCACCAGAGAGTCCATGTC 
600 204 81.6 
pparγ DQ839547.1 F:GGTTTCATTACGGCGTTCAC 
F:TGGTTCACGTCACTGGAGAA 
600 250 87.0 
ahr2 NM_001007789.2 F:TTCTGTTGCCGATTCAGATG 
R:CTTGTTTTGCCCATGGAGAT 
300 96 113,8 
ef1 NM_131263.1 F: GGACACAGAGACTTCATCAAGAAC 
R: ACCAACACCAGCAGCAACGT 
300 84 116.8 
actb1 NM_131031.1 F: TCCCAAAGCCAACAGAGAGAAG 
R: GTCACACCATCACCAGAGTCC 
10 147 100.5 
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Figure 1S 
 
 
 
 
 
 
 
 
 
 
Fig 1S: Percentage of different anomalies presented by D. rerio embryos at 32 hpf and exposed to 
different concentrations of FLU (0.0015, 0.05, 0.1, 0.5 and 0.8 µM). Results are expressed as 
mean ± SE. Bars with asterisk are significantly different from the solvent control. 
 
Figure2S 
 
Fig 2S: Percentage of different anomalies presented by D. rerio embryos at 80 hpf and exposed to 
different concentrations of FLU (0.0015, 0.05, 0.1, 0.5 and 0.8 µM). Results are expressed as 
mean ± SE. Bars with asterisk are significantly different from the solvent contro
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Fluoxetine modulate transcriptional level of genes involved in the neurotransmitter 
system in zebrafish embryos 
6.1 Abstract  
Neurotransmitters pathways in fish and mammals are phylogenetically conserved, 
therefore, the presence of psychopharmaceuticals, such as fluoxetine (FLU), in the 
aquatic environment can interact with serotonergic, dopaminergic and adrenergic 
systems, affecting their behaviour and biological functions. Hence, the present work 
aimed at evaluating the effects of FLU on transcription of serotonin, dopamine and 
adrenergic transporters and receptors in early stages of Danio rerio. Embryos were 
exposed to different concentrations of FLU (0.0015, 0.05, 0.1, 0.5 and 0.8 µM) and mRNA 
expression of sert, 5-ht1a, 5-ht2c, dat, drd1b, drd2b, net, adra2a, adra2b, adra2c, vmat 
and mao were evaluated. The transcription level of serotonergic and dopaminergic 
transporters (sert and dat) and vmat were down-regulated at environmentally relevant 
concentration (0.0015 µM). mRNA of receptors 5-ht2c, drd2b adra2b and adra2c also 
displayed a down regulation pattern after FLU exposure. In conclusion, this study 
demonstrated the interaction of FLU with the neurotransmission system even at an 
environmental concentration which can disturb the behavior and biological functions of 
fish impacting the aquatic ecosystem and supporting importance of monitoring the 
presence of this psychopharmaceutical in the aquatic environment. 
 
  
Keywords: psychopharmaceuticals, Danio rerio embryos, mRNA levels, monoamine 
receptors and transporters 
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6.2 Introduction 
Fluoxetine (FLU) is one of the most prescribed selective serotonin reuptake 
inhibitors (SSRIs) (Mennigen et al., 2011; Winder et al., 2012) indicated in the treatment of 
depression, anxiety, compulsive behaviour and eating disorders (Dulawa et al., 2004). 
SSRIs act on the serotonergic system of the Centre Nervous System (CNS) inhibiting the 
reuptake of serotonin (monoamine serotonin, 5-hydroxytryptamine, 5-HT) by serotonin 
transporter (SERT, 5-HTT) in the presynaptic membrane. This inhibition leads to the 
accumulation of serotonin in the synaptic clefts, increasing the serotonergic 
neurotransmission through postsynaptic serotonin receptors (Raap and Van der Kar 1999; 
Bisesi, 2011). Other psychopharmaceuticals are as serotonin norepinephrine reuptake 
inhibitors (SNRIs) inhibiting not only the reuptake of serotonin but also norepinephrine and 
to some degree dopamine, affecting the adrenergic and dopaminergic systems (Fenli et 
al., 2013; Yamamoto and Vernier, 2011). In the absence of inhibitors, serotonin and other 
catecholamine’s are recycled and stored in a vesicular monoamine transporter (VMAT), a 
non-specific monoamine transporter, or degraded by monoamine oxidase (MAO) 
enzymes located in the outer mitochondrial membrane (Hoffman et al., 1998; Maximino, 
2012). The neurotransmitters pathways in fish are phylogenetically conserved with 
mammals, and hence are expected to be affected by exposure to SSRIs (Kreke and 
Dietrich, 2008; Valenti et al., 2012). FLU is detected in the environment in concentrations 
ranging from 12 to 929 ng/L (Metcalfe et al., 2003; Brook et al., 2003; Santos et al., 
2010;Metcalfe et al., 2010; Styrishave et al., 2011; Silva et al., 2012). Hence, to address 
conserved molecular targets and their interaction with environmental pharmaceuticals is 
key to develop of more efficient strategies for risk assessment, providing the rationale for 
the mode of action (MOA) approach (Franzellitti et al., 2013). Previous studies on aquatic 
organisms indicated alterations of biological functions such as inhibition of egg production 
or delayed development of sexual characteristics and behavioural changes, like 
decreased feeding rates, reduced locomotor activity or aggressiveness of predatory 
species with exposure to FLU and other psychopharmaceuticals (Monpelat et al., 2009; 
Lister et al., 2009; Santos et al., 2010; Schultz et al., 2011; Eisenreich and Szalda-Petree, 
2015; Ansai et al., 2016). These alterations in behaviour seem to be directly linked to the 
effect of FLU in neurotransmission pathway, where studies showed FLU influence 5-HT 
levels after exposure (Gaworecki and Klaine, 2008; Franzellitti et al., 2013). Serotonin is 
known to play an important role in vertebrate embryo development (Buznikovet al., 2001; 
Levin, 2006) so is important to understand the effects of SSRI influence fish embryos and 
the neurotransmitter system at a biochemical and transcriptional level. Recent studies 
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demonstrated that zebrafish embryo development was affected in the presence of the 
SSRIs sertraline and fluoxetine (Ribeiro et al., 2015; Cunha et al., 2016). Hence, it is 
important to understand how FLU interacts with serotonergic system on non-target 
organisms, as well as with other neurotransmitters systems, such dopaminergic or 
adrenergic systems, where an interaction between dopaminergic and adrenergic systems 
and SSRI was already demonstrated in fish (Kreke and Dietrich, 2008; Mennigen et al., 
2008). The zebrafish (Danio rerio) has emerged as a suitable model species in 
ecotoxicology due to several characteristics that include extensive genomic data but also 
zebrafish have been suggested as a sensitive in-vivo neurotoxicological and 
ecotoxicological screen for various serotonergic drugs, including SSRIs (Stewart et al., 
2014). 
The aim of this study was to assess the effects of FLU on mRNA transcription of 
serotonin, dopamine and adrenergic transporters and receptors in early stages of 
zebrafish embryos. 
6.3 Material and methods 
6.3.1 Parental animals 
Adult wild-type zebrafish, obtained from local suppliers, were used as breeding 
stocks. The stock was kept at a water temperature of 27±1 ºC and in a photoperiod of 
12:12 h (light:dark), in 60 L aquaria with dechlorinated and aerated water in a recirculation 
system with both mechanical and biological filters. The fish were fed ad libitum twice a day 
with a commercial fish diet Tetramin (Tetra, Melle, Germany), and supplemented once a 
day with live brine shrimp (Artemia spp.). 
6.3.2 Rearing conditions and exposures 
Reproduction and embryos exposure was performed according to Cunha et al., 2016. 
Briefly, females and males (ratio 1:2) were transferred to a maternity, and submitted to 
acclimatization for 12 h in a cage with a net bottom covered with glass marbles within a 30 
L aquarium. After egg-laying, in the following day, the breeders were removed after the 
beginning of the light period. After spawning, the embryos (1 hpf) were cleaned, counted 
and transferred to a 24 well plate (10 embryos per well) and exposed until 80 hpf to 
different concentrations of FLU (0.0015, 0.05, 0.1, 0.5 and 0.8 µM; ranging from 519 to 2.8 
x 105 ng/L) (diluted in DMSO, 0.004%). The lowest concentration (0.0015 µM) is in the 
environmentally relevant range. The medium (water plus FLU) was renewed daily, for the 
duration of the experiment. Each plate had three replicates for exposure and each assay 
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was at least replicated four times. After the 80 h of exposure the embryos were collected 
and preserved in RNALater for gene expression analysis. 
6.3.3 RNA isolation and cDNA synthesis 
Total RNA was isolated from embryos preserved in RNALater according to Costa et al. 
(2012).  Briefly, total RNA was isolated using Illustra RNAspin Mini RNA Isolation kit (GE 
Healthcare), according to the manufacturer’s protocol. RNA quality was verified by 
electrophoresis in agarose gel and by the measurement of the ratio of optical density at 
λ260/ λ280 nm. RNA was quantified using Quant-IT RiboGreen RNA Reagent and Assay 
Kit (Invitrogen) using a Fluoroskan Ascent, Labsystems. One microgram of total RNA was 
subjected to digestion of genomic DNA using Deoxyribonuclease I, Amplification Grade 
(Invitrogen) and 1 µg of cDNA was synthesised using Iscript cDNA Synthesis (Biorad). 
6.3.4 Quantitative real-time PCR (qRT-PCR) 
Gene expression of serotinergic (sert, 5-ht1a, 5-ht2c), dopaminergic (dat, drd1b, drd2b) 
and adrenergic (net, adra2a, adra2b, adra2c) systems, vmat and mao was assessed by 
means of quantitative real time PCR (qRT-PCR) and performed according to Cunha et al., 
2016. Primer pairs for each target gene were designed with Primer 3 software available in 
http://www.ncbi.nlm.nih.gov/, based in available sequences in GeneBank. Primer 
sequences, amplicon lengths, efficiencies and Genbank accession numbers of target 
sequences are given in Table 6.1. To determine the efficiency of the PCR reactions, 
standard curves were made, with 6 serial dilutions of the template (concentration range 
from 0.05 to 50 ng/μl), and the slopes and regression curves were calculated. Gene 
expression was quantified by normalization with multiple reference gene (elongation factor 
1 (ef1) and actin β1 (Actb1) using Normfinder algorithm (Urbatzka et al., 2013), and the 
relative expression ratio was calculated with efficiencies using the Pfaffl mathematical 
model (Pfaffl, 2001). Data is presented in mean of mRNA expression in relation to the 
reference genes.  
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Table 6.1:Gene list Genbank accession numbers Primer sequences and concentrations, amplicon lengths, efficiency of reaction for serotonin transporters (sert), serotonin 
receptors (5-ht1aa, 5-ht2c), dopamine transporter (dat) dopamine receptors (drd1b, drb2b), norepinephrine transporter (net), adrenergic receptors (adra2a , adra2c, adra2b), 
vmat, mao gene expression quantification by qRT-PCR in zebrafish. 
Gene Accession number Primers Sequence 
(5’3’) 
Final 
Conc
. 
(nM) 
Amplicon 
length (bp) 
Efficiency 
(%) 
serta 
 
NM_001039972.1 F: CATCTATGCTGAGGCTATTG 
R: AAGAATATGATGGCGAAGA 
0.3 73 100 
5-ht1aa NM_001123321.1 F: ATGAGGATGAGCGGGATGTAG 
R: CAATCAGCCAGGACCACG 
0.3 80 125 
5-ht2c  NM_001129893.1  F: GCGCTCTCTGTCCTATTTGG  
R: GTAGCGGTCGAGAGAAATGG  
0.001  89  126.4  
dat  NM_131755.1 F:ACGTCAATTCTCTTTGGAGT 
R:TCCTCGATATCATCACTGAA 
0.15 86 97 
drd1b  NM_001135976.2  F: CTGCGACTCCAGCCTTAATC  
R: AGATGCGGGTGTAAGTGACC  
0.6  98  117.2  
drd2b  NM_197936.1  F: ACGCCGAATATCAGTCCAAC  
R: GCAGTGCCTGAGTTTCAACA  
0.3  96  110.7  
Net XM_689046.5 F: AGTCCAGCGTTCTTGCTGTT 
R: TCTGCCCAGTATGGGAAAAC 
0.3 92 117.0 
adra2a NM_207637.2 F: AGCGTTTTGTGACTGCTGTG 
R: TAATGGGATTGAGGGAGCTG 
0.3 86 114.0 
adra2b  NM_207638.1  F: GTCTGCCTGGCCACACTAAT  
R: GTACGGGGCGAGTTTTATCA  
0.001  80  119.7  
adra2c NM_207639.1  F: CTATTCTCCGGCCACCATTA  
R: CCAGCACATTCCCCACTATT  
0.001  80  133.8  
vmat2 NM_001256225.2 F: CTAAAAAGCTCCGCATCCAG 
R: TGTCCAAGAGCAAAGCAATG 
0.15 231 133 
mao NM_212827.2 F: ACCAACTCAAAACCGCATTC 
R: GTAGGCAAAAGGGTTCCACA 
0.3 151 105.0 
      
Fluoxetine modulate transcriptional levels of genes involved in the neurotransmitter system in 
zebrafish embryos 
 
158 
6.3.5 Statistical analysis 
Differences in mRNA expression were evaluated by means of a one-way ANOVA, 
followed by a multiple comparison test (Tukey’s test) at a 5% significant level. Data were 
log transformed in order to fit ANOVA assumptions. All tests were performed using 
software Statistica 7 (Statsoft, Inc). Data is presented as mean ± standard error. 
6.4 Results 
mRNA levels of neurotransmission transporters and receptors (sert, 5-ht1a, 5-ht2c, dat, 
drd1b, drd2b, net, adra2a, adra2b, adra2c), vmat and mao in embryos exposed to FLU 
are presented in Fig. 6.1. The transcription level of the transporters sert and dat was down 
regulated at 0.5 and 0.1 µM concentrations, respectively, as well as at the lowest 
concentration (0.0015 µM) (p<0.05), while no changes were observed for net. mRNA 
levels of 5-ht1a and adra2a were significantly increased in embryos exposed to 0.8 µM of 
FLU (p<0.05), whereas 5-ht2c and drd2b exhibited a down regulation pattern for all 
concentration with exception of 0.1 µM. adra2b and adra2c also displayed a down 
regulation pattern mainly at higher concentrations (p<0.05). The transcription levels of 
drd1b were also decreased at 0.05, 0.5 and 0.8 µM (p<0.05). vmat was down regulated in 
embryos exposed to 0.0015 and 0.1 µM concentrations (p<0.05), while no changes were 
observed for mao.  
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Figure 6.1: Relative mRNA expression of in D. rerio embryos exposed to FLU (0.0015, 0.05, 0.1, 0.5 
and 0.8 µM) for 80h. Bars with different letters are significantly different from each other (p<0.05). 
Results are given as mean±SE, n=6.   
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6.5 Discussion 
Neurotransmitters pathways within vertebrates, including fish, are well conserved 
(Kreke and Dietrich, 2008; Valenti et al., 2012). Therefore it is important to study how the 
presence of psychopharmaceuticals, design to act on these pathways, will interact and 
possible affect the neurotransmission systems of non-target aquatic organism. Our 
previous study demonstrated that FLU, at the concentrations tested in the present study, 
impacts the development of zebrafish embryos (Chapter V). Hence, given the reported 
mode of action of FLU in vertebrates, this study aimed at evaluate the impact of FLU in 
monoamine receptors and transporters at the transcription level, particularly of serotonin 
(sert, 5-ht1a, 5-ht2c), as well as dopamine (dat, drd1b, drd2b) and adrenergic (net, 
adra2a, adra2b, adra2c) transporters and receptors. In mammalian model species, FLU 
leads to a down regulation of Sert, 5-Ht1a and 5-Ht2c and this decrease has been 
attributed to the increase of serotonin accumulation in the synaptic clefts by repeated 
SERT inhibition by FLU (Oliva et al., 2005; Gomez et al., 2015; Lesemann et al., 2012; 
Barbon et al., 2011; Messripour and Clark, 1985). This seems to be in agreement with the 
down regulation observed for sert and 5-ht2c in this study, even at the lowest and 
environmental relevant concentration. In mammals, FLU promotes behavioural and 
emotional changes by serotonergic system modulation. Hence, FLU seems to affect the 
serotonergic neurotransmission system in zebrafish embryos in a similar manner to 
mammals, which can possible provoke behavioural changes described by previous 
studies (Santos et al., 2010; Pelli and Connaughton, 2015). Serotonin and serotonergic 
system play a role in vertebrate embryo development (Buznikovet al., 2001; Levin, 2006), 
so a down regulation of genes involved in this system can affect fish embryo 
development. A previous study performed by our laboratory demonstrated that FLU 
affected zebrafish embryos development at the tested concentrations (Chapter V), which 
seem to agree with FLU effects in serotonin transporters and receptors transcription found 
in this study. This is important since these transcription alterations were observed at 
environmentally relevant concentration, making it essential to perform more studies that 
address FLU interaction with the serotonergic system and pathway. This work also 
evaluated the effects of FLU in the transcription of receptors and transporters of 
dopaminergic and adrenergic systems, since there is evidence of interactions between 
these systems and the serotonergic (Kreke and Dietrich, 2008; Boulay et al., 2011; 
Lesemann et al., 2012). A tendency for mRNA down regulation was observed for 
dopamine transporter (dat) and receptors (drd1b, drd2b) and adrenergic receptors 
(adra2b, adra2c) in embryos exposed to most of the tested concentrations. Similar to our 
results, FLU decreased dopaminergic D2 receptor transcription in mammals (Dziedzicka-
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Wasylewska et al., 2002; Lesemann et al., 2012). The decrease of mRNA levels of 
dopamine receptors and transporter may have a negative impact in key functions, known 
to be controlled by this system, such as cognition, locomotor activity, motivation and 
reward, mood, attention and learning (Beaulieu and Gainetdinov, 2011). In fish, dopamine 
inhibits basal and GnRH-stimulated gonadotropin release by binding to the Dopamine 2 
receptors (DR2) on gonadotropes, and by decreasing pituitary GnRH receptor expression 
which can impair gonadal growth and spawning (Chang et al., 2000; Dufour et al., 2005; 
Crago and Schlenk, 2015). In another study, Sebastiscus marmoratus was exposed to 
Tributyltin (TBT) and observed a decrease in the transcription levels of dopamine 
receptors affecting the predatory activities of the fish (Yu et al., 2013). Therefore, the 
down regulation of dopamine transporter and receptors by FLU may negatively influence 
the reproduction and the behaviour of fish. Adrenoceptors are present in fish 
melanophores, modulating the pigmentation, as reported in previous studies with other 
pharmaceutical classes (Fujii, 2000; Xu and Xie, 2011). In a previous work performed in 
our laboratory, zebrafish embryos were exposed to the same FLU concentrations and a 
high percentage of pigmentation anomalies was observed, mainly at the highest 
concentration (0.8 µM) (Chapter V). This seems to be in agreement with the results found 
in this study where FLU can impact the transcription of adrenoceptors mainly at higher 
concentrations. The storage process of monoamines is performed by VMAT that is 
release at the synapse following neuronal membrane depolarization. When monoamines 
are not stored in presynaptic vesicles by VMAT, they are degraded by MAO enzyme 
(Maximino, 2012). Transcription levels of vmat were diminished in the presence of FLU, 
while no changes were observed for mao. In contrast to our results, a previous study with 
rats, FLU increased the transcription levels of Vmat (Rehavi et al., 2002). However, since 
FLU can inhibit monoamine transporters, they accumulate in the synaptic clefts and are 
not stored by VMAT, therefore in response to this a decrease of vmat is expected. In 
several of our target genes, it was not observed a dose-response relation with FLU 
exposure, like it was detected for 5-ht2c, adra2c, adra2b or drd2c. For other genes maybe 
more concentrations have to be tested in order a dose-response curve to be observed. 
Overall, FLU seems to impact neurotransmitter systems of zebrafish embryos, 
even at environmentally relevant concentrations, which can impair functions, like 
reproduction, behaviour and embryo development. 
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6.6 Conclusions 
In conclusion, FLU decreases the transcription of important neurotransmitters 
transporters and receptors, even at concentrations found in the environment. Our results 
show that FLU may regulate different monoamine pathways involved in important 
physiologic functions. Hence, future studies should address the ecological relevance of 
the findings reported here. The fact that environmentally relevant concentrations can 
disturb the neurotransmitters systems supports the importance of monitoring the presence 
of this psychopharmaceutical in the aquatic environment.  
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Effects of pharmaceuticals and personal care products (PPCPs) on multixenobiotic 
resistance (MXR) related efflux transporter activity in zebrafish (Danio rerio) embryos 
7.1 Abstract 
Multidrug resistance (MXR) system act as defence against a wide range of compounds 
and are mediated by ATP binding cassette (ABC) transporters. However, certain 
compounds, so called chemosensitisers, have the potential to inhibit these proteins 
increasing the toxicity of chemicals that would normally be effluxed out of the cells. In this 
study different pharmaceuticals and personal care products (PPCPs), highly prescribed 
and present in common household products and that are increasingly detected in aquatic 
systems, were chosen to assess their chemosensitisation potential.  To addresses this 
question, zebrafish embryos were used since they are a suitable model specie in 
ecotoxicology and the chemosensitisation assays can be performed rapidly and efficiently. 
Two types of assays were used: Abcb4 ATPase activity, a highly specific and artificial 
assay that examine chemical interaction with Abcb4; and therefore the effect 
concentrations in ATPase assay cannot be directly related to concentrations effects 
determined in vivo. And an in vivo dye accumulation assay, a less specific with regard to 
the type of the transporter activity (dyes can be substrates of different transporter types), 
but can be more information about whether the effects are environmentally relevant. MXR 
activity was determined with dye accumulation assays using rhodamine 123 (8 µM) in 24 
hours post fertilization embryos exposed for 2 h to known ABC protein inhibitors (MK571 
and VER) and celestolide, musk xylene, musk ketone, nerol, citronellol, isoeugenol, 
camphene, α-amylcinnamaldehyde, α-hexylcinnamaldehyde, propylparaben, sertraline, 
fluoxetine, diclofenac and simvastatin. The interaction of the test compounds with 
zebrafish Abcb4 was determined by recording their effects on Abcb4 ATPase activity. 
Results demonstrated a concentration dependent interaction to some of the tested 
chemicals. Some PPCPs inhibited ABC proteins, such as isoeugenol at environmentally 
relevant concentration. Abcb4 ATPase activity was inhibited by sertraline, fluoxetine, 
diclofenac, simvastatin and isoeugenol. On the other hand, musk xylene, nerol, 
isoeugenol, α-amylcinnamaldehyde and α-hexylcinnamaldehyde and simvastatin 
demonstrated Abcb4 substrates properties. Taken together, the results show that both 
assays should be used in combination to better determine the interaction of PPCPs with 
ABC proteins. One specifically evaluate if the chemicals are inhibitors or substrates of a 
particular efflux transporter and the other give more information about relevant 
concentration in vivo. Diclofenac, sertraline and fluoxetine can be recognised as potential 
chemosensitisers inhibiting both ATPase activity assay and MXR system. These results 
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highlight the importance of screening emerging pollutants for chemosensitiser potential 
and their role in the toxicity of other xenobiotics. 
Keywords: Pharmaceuticals; PCPs; Abcb4; Inhibitors; Substrates; Chemosensitisation  
7.2 Introduction 
The integrity of marine and freshwater aquatic ecosystems across the world is 
threatened by the adverse impacts of a variety of anthropogenic chemicals. In the last 
decades, advances in new technologies enable the detection of low concentrations of 
many emerging compounds (Lapworth et al., 2012; Stuart et al., 2012; Jiang et al., 2013) 
including pharmaceuticals and personal care products (PPCPs) that have been quantified 
in the ng/L to μg/L concentration range in water (Table 7.1) (Kim et al., 2009; Chen et al., 
2012, Santos et al., 2016). Commonly used pharmaceuticals such as diclofenac, 
simvastatin, fluoxetine and sertraline and synthetic musk fragrances (celestolide, musk 
xylene, musk ketone), essential oils (nerol, citronellol, isoeugenol, camphene, α-
amylcinnamaldehyde, α-hexylcinnamaldehyde) and propylparaben found in a variety of 
cosmetics, perfumes, and soaps are the PPCPs most frequently occurring in the aqueous 
environment. Even if industry and household waste waters undergo purification in waste 
water treatment plants (WWTP), complete removal of many contaminants is not ensured, 
so significant concentrations of some PPCPs occur in effluents, groundwater, surface 
waters and also in drinking water (Soares et al., 2008; Santos et al., 2010; Lapworth et al., 
2012; Jiang et al., 2013) (Table 7.1). Aquatic organisms have cellular mechanisms serving 
as protection against the adverse effects of xenobiotics such as the multixenobiotic 
resistance (MXR) mechanism. MXR is mediated by ATP-binding cassette (ABC) 
transporters and this mechanism is considered to be the first line of cellular defence 
against toxicants (Kurelec, 1992; Epel, 1998; Bard, 2000; Ferreira et al., 2014; 
Luckenbach et al, 2014). The ABC transporter super family is subdivided into subfamilies 
ABCA to ABCH (Dean and Annilo, 2005; Popovic et al., 2010), although only members of 
the ABCB, ABCC and ABCG subfamilies are considered important in a toxicological 
context (Epel et al., 2008). ABCB1 (P-glycoprotein, P-gp) homologs efflux a variety of 
mainly unmodified compounds from the cells (Epel et al., 2008) and are an important 
component of the “environment-tissue barrier” (Luckenbach and Epel, 2008). Notably, 
high expression levels and increased efflux activity of ABCB1 orthologues have been 
found in aquatic species from polluted environments (Smital et al., 2000). In zebrafish, 
Danio rerio, the abcb1 orthologue is absent, but zebrafish Abcb4 was recently reported to 
have the same functional properties as ABCB1 in mammals (Fischer et al., 2013). 
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A range of environmentally relevant chemicals were found to interfere with efflux 
transporter function, thus increasing the susceptibility of cells/organisms to the toxic 
effects of other compounds that are usually kept out of cells/tissues by the efflux 
transporters, an effect called “chemosensitisation” (Kurelec, 1997). So far examined 
compounds included some PPCPs such as tonalide, galaxolide and other musk 
compounds that were shown to act as chemosensitisers (Epel et al., 2008; Caminada et 
al., 2008, Fischer et al., 2013; Kurth et al., 2015). To measure the levels of MXR activity 
and/or chemosensitisation several techniques have been used. Fluorescent cell-based 
transport assays or radiolabeled substrates and ATPase assays with overexpressing cell 
lines have been used for screening for substrates and inhibitors of ABC transporters 
(Luckenbach et al., 2014). In this study, two assays were used to characterise the 
chemosensitisation potential; Abcb4 ATPase activity and dye accumulation assay. 
Transport activity of ABC proteins (ATPase activity assay) is strongly combined with ATP 
cleavage and can be determined by ATPase activity. Studies with P-glycoproteins (P-gp, 
ABCB1) demonstrated that modulation of ATPase activity is highly correlated with the 
interaction of P-gp with any given compound. Furthermore, the ATPase assay is very 
specific and can distinguish between substrates and inhibitors (Sarkadi et al., 1992; Zaja 
et al., 2011). Dye accumulation assay is a less specific assay since dyes can be 
substrates of different ABC proteins. However, as an in vivo assay gives more information 
about relevant effect concentrations. 
The aim of this study was to determine the chemosensitisation potential of 
representatives of four classes of commonly used PPCPs, i.e, pharmaceuticals, synthetic 
musk fragrances, parabens and essential oils applying two different transporter protein 
activity assays. Zebrafish embryos were used to determine the effects of these 
compounds on the ABC efflux transporters activity and the recombinant zebrafish Abcb4 
protein to assess the specific interaction of different PPCPs compounds with the Abcb4 
transporter.   
7.3 Material and methods 
7.3.1 Chemicals 
Rhodamine 123 (RH123), verapamil (VER), simvastatin, diclofenac sodium salt, propyl-4-
hydroxybenzoate (propylparabene), sodium acid, Dithiothreitol (DTT), sodium 
orthovanadate, adenosine triphosphate (ATP), zinc acetate, ammonium molybdate, 
protease inhibitor P8340 were purchased from Sigma-Aldrich (Germany), MK571 from 
VWR International and vinblastine sulfate (VIN) from Tocris Bioscience (USA). Musk 
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ketone, musk xylene, celestolide were kind gifts from International Flavors & Fragances 
Inc. (IFF: Union Beach, NJ). Sertraline hydrochloride and fluoxetine hydrochloride were 
purchased from abcr (Germany). Isoeugenol, camphene, α-amylcinnamaldehyde, α-
hexylcinnamaldehyde, citronellol and nerol were purchased from SAFC supply solutions 
(Germany). Maximum test concentrations were at or below water solubility (information 
taken from www.chemspider.com) (Table 7.1). All other chemicals were of analytical 
grade, and were purchased from local companies. 
7.3.2 Production of recombinant zebrafish Abcb4 protein and ATPase activity 
Specific interactions of test compounds with zebrafish Abcb4 were determined with 
an in vitro assay using recombinant zebrafish Abcb4 protein generated with the 
baculovirus expression system (Fischer et al., 2013). Similar to ABCB1 zebrafish Abcb4 is 
an ATPase that uses the energy liberated by the cleavage of ATP to ADP and Pi for 
transporting its substrates against a concentration gradient across cell membranes (Chen 
et al., 1986). In the assays applied here, the ATPase activity of recombinant zebrafish 
Abcb4 was used as indication for interaction of the test compounds with the transporter 
protein using the amount of generated Pi in the experiment as measure for the Abcb4 
ATPase activity as first described by Sarkadi et al. (1992) for ABCB1. Interaction of the 
test compounds with zebrafish Abcb4 was examined in experimental series with Abcb4 
protein with non-stimulated (“basal”) and with verapamil-stimulated ATPase activities, 
which can provide indication for the interaction of the compound with the transporter 
protein as substrate (i.e., a compound that is transported by the protein) and/or as 
inhibitor (i.e., a compound that disrupts transporter function). For achieving a stimulated 
state of the Abcb4 ATPase, showing activity close to its maximum, verapamil was applied 
at 40 µM in the experiments according to Fischer et al. (2013). Stimulation of the basal 
transporter ATPase activity is indicated by increased Pi levels in the test; it is often 
observed for transporter substrates (Sarkadi et al., 1992). In contrast, inhibition of the 
basal and/or stimulated ATPase activities indicates a compound’s property as transporter 
inhibitor and is indicated by decreasing Pi levels (von Richter et al., 2009). Production of 
recombinant Abcb4 with the baculovirus expression system and performance of the 
ATPase assay were according to Fischer et al. (2013). Briefly, abcb4 baculovirus was 
produced with the Bac-to-Bac Baculovirus Expression System (Invitrogen). To produce 
recombinant Abcb4, 200 mL of Sf (Spodoptera frugiperda) 9 cell suspension with 2 x 106 
cells/ml were infected with abcb4 baculoviral particles at a multiplicity of infection (MOI) of 
2.5. Cells were incubated for 72 hours, then harvested, disrupted by nitrogen cavitation 
and cell membranes were pelleted by centrifugation and ultracentrifugation steps. 
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Table 7.1: Names, molecular weights, CAS numbers, log Kow values, aqueous solubility and environmental concentrations of test compounds.
Compound MW CAS number Log Kow Aqueous solubility 
(mg/L) 
[chemspider.com] 
Environmental concentrations 
diclofenac 318.1 15307-79-6 0.7 15906.5 Effluents: 69.2 - 382.5 ng/L (Kosma et al., 2014; Langford and Thomas, 2010) 
Influents: 12 – 3600 ng/L (Santos et al., 2010) 
Groundwater: 590 ng/L (Santos et al., 2010) 
Freshwater: 0.3 – 72 ng/L (Santos et al., 2010) 
fluoxetine 345.8 56296-78-7 4.17 3457.9 Freshwater: 12 to 157.4  ng/L (Kolpin et al., 2002;  Silva et al., 2014) 
Effluents: 99 to 929 ng/L ( Brook et al., 2003; Metcalfe et al., 2010; Silva et al., 2012, 
Styrishave et al., 2011; Metcalfe et al., 2003) 
sertraline 342.7 79559-97-0 5.15 1713.5 Surface water: 0.84 to 2.4 ng/L (Santos et al., 2010) 
Seawater:  < 0.52 ng/L (Santos et al., 2010) 
Effluents: 80 to 87 ng/L (Metcalfe et al., 2010; Silva et al., 2012   Styrishave et al., 2011) 
simvastatin 418.6 79902-63-9 4.68 0.7653 Effluents: 0.2 to 110 ng/L ( Miao and Metcalfe, 2003;  Santos et al., 2010; Ottmar et al., 
2012) 
Influent: 1560 ng/L (Ottmar et al., 2012) 
Surface water:  0.1 ng/L  (Miao and Metcalfe, 2003) 
propylparabene 180.2 94-13-3 2.71 529.3 Surface water:  9.2 ng/L (Renz et al., 2013) 
Freshwater: 900 to 1820  ng/L (Haman et al., 2015) 
Marine water: 7.9  ng/L (Haman et al., 2015) 
Influent: 20000 ng/L (Haman et al., 2015) 
α-amylcinnamaldehyde 202.2 122-40-7 4.33 9 Not found 
α-hexylcinnamaldehyde 216.3 101-86-0 4.82 2.75 Influent : 35 to 1201 ng/L (Švestková, 2014) 
citronellol 156.3 106-22-6 3.91 105.5 Influent : 784 to 4748 ng/L (Švestková and Vávrová (2015)  
camphene 136.2 79-92-5 4.22 6 Surface water: 0.38 to 837 ng/L (Button and Juttner, 1989) 
isouegenol 164.2 97-54-1 3.04 165.9 Effluents:  10 x 10
3
ng/L and 121x 10
3
 ng/L (Belknap et al., 2006) 
nerol 154.2 106-25-2 3.47 255.8 Not found 
musk xylene 297.3 81-15-2 2.25 61.35 Surface water:   0.049 - 0.62 ng/L (Peck and Hornbuckle, 2004;  Muller et    al., 1996) 
Seawater:  <0.02 to 0.17 ng/L (Gatermann et al.,1995) 
Effluents:   <1 to 162 ng/L (Simonich et al., 2002;  Díaz-Cruz Barceló, 2015) 
musk ketone 294.3 81-14-1 2.11 83.59 Influents: 812 to 5000  ng/L (Chase et al., 2012; Paxeus, 1996 ) 
Effluents:  19 to 705 ng/L (Simonich et al., 2002) 
Surface water:  < 2 to 10 ng/L (Muller et al.,1996; Peck  and Hornbuckle, 2004)             
celestolide 244.4 13171-00-1 5.93 0.22 Influent: 45 ng/L (Chase et al., 2012) 
Effluents: 620 ng/L (Chen et al., 2007) 
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The pellet containing the membrane fractions was dissolved in ice cold TMEP buffer 
(Germann, 1998; Sarkadi et al., 1992), homogenized using syringes and total protein was 
determined with the BCA™ Protein Assay Kit (Thermo Scientific). ATPase-assays were 
performed in 96-well plates and 20 µg of total protein was used per well. Liberated Pi was 
colorimetrically quantified by measuring the absorption at 750 nm using a detection 
reagent with 7.5 % ascorbic acid (Applichem, Germany), 8.75 mM ammoniummolybdate 
tetrahydrate (Sigma, Germany) and 3.75 mM zinc acetate (Sigma). The Abcb4 ATPase 
activity is orthovanadate-sensitive and test series were performed with and without 
sodium orthovanadate (Sigma) to determine the Abcb4 ATPase activity within the total 
ATPase activity in the membrane preparations. Abcb4 ATPase activities in each test were 
determined by subtracting the values from tests with orthovanadate from those from tests 
without orthovanadate (Sarkadi et al., 1992). 
Concentration response curves were modelled in GraphPad Prism using the four 
parameter logistic equation.  
                           
Where V(S) is the enzyme activity, Bottom is the activity at the bottom plateau, Top 
is the activity at the top plateau, log EC50 is the concentration at half-maximal activity, 
Hillslope describes the slope of the curve, S is the chemical concentration. Versions of 
this equation were used by Glavinas et al. (2007); Bircsak et al. (2013), and Zaja et al. 
(2011).  
7.3.3 Maintenance of zebrafish and egg production  
Adult wild-type zebrafish, obtained from local suppliers, were used as breeding 
stocks. Fish were kept at a water temperature of 27±1 ºC and in a photoperiod of 12:12 h 
(light:dark) in 60 L aquaria with dechlorinated and aerated water in a recirculation system 
with both mechanical and biological filters. The fish were fed ad libitum twice a day with a 
commercial fish diet Tetramin (Tetra, Melle, Germany), supplemented once a day with live 
brine shrimp (Artemia spp.) For reproduction, females and males (ratio 1:2) were 
transferred to a maternity, and submitted to acclimatization for 12 h in a cage with a net 
bottom covered with glass marbles within a 30 L aquarium. After spawning on the 
following day, the breeders were removed after the beginning of the light period. 
The freshly spawned eggs were collected and cleaned by rinsing. Fertilized eggs 
were transferred to aquaria (3.5 L) and kept at 26 ± 1 ºC with aeration. 
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Maintenance of adult zebrafish and egg production were according to standard 
protocols (e.g. Kimmel et al., 1988; Lammer et al., 2009; Machado et al., 2014). 
Experiments with zebrafish embryos were performed in reconstituted water as specified in 
ISO 7346-1 (ISO, 1996; 294.0 mg/L CaCl2×2 H2O; 123.3 mg/L MgSO4×7 H2O; 63.0 mg/L 
NaHCO3; 5.5 mg/L KCl). Prior to use, the artificial water was aerated to attain oxygen 
saturation. 
7.3.4 Rhodamine 123 dye accumulation assay 
The amount of RH123 accumulated in zebrafish embryo tissue upon exposure to 
the dye served as measure for MXR transporter activity. Prior to conducting dye 
accumulation assays with the test substances the RH123 concentration to be used in the 
assays was determined. These preliminary assays aimed to identify the RH123 
concentration at which effects of test compounds on RH123 accumulation in zebrafish 
embryos are clearly detected. Different concentrations of RH123 (1, 2, 5, 8, 10 µM) were 
tested in a 2 h incubation with standard MXR transporter inhibitors (MK571 and VER). 
Data is presented in arbitrary fluorescence units and in percentage (%) of RH123 
fluorescence in relation to the water control measured in each assay (Fig. 7.1a, b). At 8 
µM RH123 effects of MK571 and VER were most pronounced (MK571: +44% and VER: 
+23% vs. controls) and this RH123 concentration was therefore applied in subsequent 
experiments. 
The dye accumulation assays were performed with 24 hpf embryos (10 per well in 
a 2 ml media volume) exposed to different concentrations of the tested PPCPs 
(celestolide, musk ketone, musk xylene, propylparaben, nerol, citronellol, isouegenol, 
camphene, α-amylcinnamaldehyde, α-hexylcinnamaldehyde, sertraline, fluoxetine, 
diclofenac and simvastatin) (Table 7.2)and standard MXR transporter inhibitors (MK571, 
VER and VIN (10 µM)) along with 8 µM RH123 for 2 h at 26 ± 1 ºC in the dark. After a 2 h 
incubation period embryos were washed 3 times with ice-cold water and mechanically 
disrupted. The RH123 accumulated inside the embryos was measured in the homogenate 
of 10 embryos using a fluorescent microplate reader (Fluoroskan Ascent, Labsystems) at 
excitation/emission - 485/538 nm. Each assay was replicated at least four times. In each 
batch of chemical tests, water and positive controls (MXR inhibitors) were also measured 
and data is presented in percentage (%) of RH123 fluorescence in relation to the water 
control measured in each assay.  
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Table 7.2: Celestolide, musk ketone, musk xylene, propylparaben, nerol, citronellol, isouegenol, camphene, α-amylcinnamaldehyde, α-hexylcinnamaldehyde, sertraline, 
fluoxetine, diclofenac, simvastatin test concentrations. Environmentally relevant concentrations are marked in grey (related to Table 7.1). 
 
Compound Compound concentrations µM   
[ng/L] 
celestolide 
0.0004  0.001  0.01  0.03  0.3  0.9  
[97.7] [244.4] [2.4 x 10
3
] [7.3 x 10
3
] [7.3 x 10
4
] [2.2 x 10
5
] 
musk ketone 
0.1  0.4  3.5  10.5  94.7  284  
[2.7 x 10
4
] [8.9 x 10
4
] [7.4 x 10
5
] [2.3 x 10
6
] [2.0 x 10
7
] [6.1 x 10
7
] 
musk xylene 
0.09  0.3  2.5  7.6  68  206  
[2.9 x 10
4
] [1.2 x 10
5
] [1.0 x 10
6
] [3.1 x 10
6
] [2.8 x 10
7
] [8.4 x 10
7
] 
propylparabene 
0.001 0.004 0.04 0.1 0.9 2.9 
[180.2] [720.8] [7.2 x 10
3
] [2.0 x 10
4
] [1.5 x 10
5
] [5.3 x 10
5
] 
nerol 
0.45  1.37  12  37  333  1000  
[7.7 x 10
4
] [2.2 x 10
5
] [1.9 x 10
6
] [5.7 x 10
6
] [5.1 x 10
7
] [1.5 x 10
8
] 
citronellol 
0.3  0.9  8.3  25  225  675  
[3.1 x 10
4
] [1.4 x 10
5
] [1.3 x 10
6
] [3.9 x 10
6
] [3.5 x 10
7
] [1.1 x 10
8
] 
isoeugenol 
0.45  1.37  12  37  333  1000  
[8.2 x 10
4
] [2.3 x 10
5
] [1.9 x 10
6
] [6.1 x 10
6
] [5.5 x 10
7
] [1.6 x 10
8
] 
camphene 
0.02  0.06  0.6  1.7  15.4  46  
[2.7 x 10
3
] [8.2 x 10
3
] [8.2 x 10
4
] [2.3 x 10
5
] [2.1 x 10
6
] [6.3 x 10
6
] 
α-amylcinnamaldehyde 
0.02  0.06  0.6  1.7  15.4  46  
[4.0 x 10
3
] [1.2 x 10
4
] [1.0 x 10
5
] [3.2 x 10
5
] [2.9 x 10
6
] [8.5 x 10
6
] 
α-hexylcinnamaldehyde 
0.006  0.02 0.2 0.5 4 12.7 
[1.2 x 10
3
] [4.3 x 10
3
] [4.3 x 10
4
] [1.1 x 10
5
] [9.1 x 10
5
] [2.7 x 10
6
] 
diclofenac 
0.45  1.37  12  37  333  1000  
[1.4 x 10
5
] [4.3 x 10
5
] [3.9 x 10
6
] [1.2 x 10
7
] [1.1 x 10
8
] [3.18 x 10
8
] 
simvastatin 
0.007 0.02 0.07 0.2 0.61 1.83 
[2.9 x 10
3
] [8.3 x 10
3
] [2.5 x 10
4
] [8.3 x 10
4
] [2.5 x 10
5
] [7.6 x 10
5
] 
sertraline 
0.45  1.37  12  37 333  1000  
[1.5 x 10
5
] [4.6 x 10
5
] [4.2 x 10
6
] [1.3 x 10
7
] [1.1 x 10
8
] [3.4 x 10
8
] 
fluoxetine 
0.45  1.37  12  37  333  1000  
[1.6 x 10
5
] [4.7 x 10
5
] [4.3 x 10
6
] [1.3 x 10
7
] [1.1 x 10
8
] [3.4 x 10
8
] 
 
 
Effects of pharmaceuticals and personal care products (PPCPs) on multixenobiotic resistance 
(MXR) related efflux transporter activity in zebrafish (Danio rerio) embryos 
 
177 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7.3.5 Statistical analysis 
Differences between treatments/controls in the dye accumulation assay were 
evaluated by means of a one-way ANOVA, followed by a multiple comparison test 
(Dunnett’s test) at a 5% significance level to identify significant changes in treatments 
versus controls. Data were square root transformed in order to fit ANOVA assumptions. 
All tests were performed using the software Statistica 7 (Statsoft, Inc). Data is presented 
as mean ± standard error.  
7.4 Results 
7.4.1 Abcb4 ATPase assays 
Effects of test compounds on the ATPase activity of recombinant Abcb4 in 
membrane preparations as a measure of interaction of the compounds with zebrafish 
Abcb4 are shown in Fig 7.2. Abcb4 ATPase baseline activities, i.e., activities in solvent 
controls, were between 3 and 9 nmol Pi/mg protein/min. In the stimulated state achieved 
by the addition of 40 µM verapamil to the reaction mix, ATPase activities ranged between 
Figure 7.1: Accumulation of rhodamine 123 at different concentrations (1, 2, 5, 8 and 16 µM) in D. rerio 
embryos exposed to ABC transporters inhibitors (MK571 (10 µM), VER (10 µM) for 2 h. Data are presented in 
arbitrary fluorescence units (a) and in percentage (%) of RH123 fluorescence in relation to the water control 
(b) measured in each assay. Results are given as mean ± SE, n=4. 
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8 and 20 nmol Pi/mg protein/min (Fig. 7.2). Fold changes of stimulated vs. basal ATPase 
activities were between 2 and 9-fold. Replicate experiments were performed for all test 
compounds and generally values for basal and stimulated ATPase activities in replicate 
experiments were consistent.  
None of the tested compounds caused clear dose-dependent stimulation of the 
basal Abcb4 ATPase activity. However, in nerol and musk xylene treatments ATPase 
activities were slightly increased at the highest applied concentrations (206 and 1000 μM, 
respectively). ATPase activities were also elevated in the experiment with α-
amylcinnamaldehyde and simvastatin at the lowest concentration tested (0.02 μM in each 
case) (Fig. 7.2I, L). Although not showing an increasing trend across the tested 
concentration range, Abcb4 ATPase activities appeared to be generally higher than 
baseline levels in experiments with isoeugenol and α-hexylcinnamaldehyde (Fig. 7.2G, J). 
At higher concentrations of diclofenac, sertraline and fluoxetine basal ATPase activities 
showed decreasing trends which was particularly pronounced in the sertraline treatment 
(Fig. 7.2K, M, N). All three compounds led to a decrease in the verapamil-stimulated 
Abcb4 ATPase activities at 333 and 1000 µM (Fig. 7.2K, M, N). In addition, at higher 
concentrations (> 37 µM) of isoeugenol, decreased activity was recorded in stimulated 
Abcb4 ATPase (Fig. 7.2G). For celestolide, musk ketone, propylparabene, citronellol and 
camphene no effects on baseline or stimulated Abcb4 ATPase activities were found (Fig. 
7.2A, B, D, H). In summary, musk xylene, nerol, isoeugenol, α-amylcinnamaldehyde, α-
hexylcinnamaldehyde and simvastatin demonstrated substrate properties, while 
diclofenac, sertraline, fluoxetine and isoeugenol exhibited inhibitor properties.  
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Figure 7.2: Effects of PCPs (celestolide, musk ketone, musk xylene, propylparaben, nerol, citronellol, 
isouegenol, camphen, α-amylcinnamaldehyde, α-hexylcinnamaldehyde (A to J)) and pharmaceuticals 
(sertraline, fluoxetine, diclofenac, simvastatin (K to N)) on ATPase activities of recombinant zebrafish Abcb4. 
Compounds were tested for stimulation (open circles) of the basal Abcb4 ATPase and inhibition of the 
verapamil-stimulated Abcb4 ATPase activities (closed squares). Basal activity (closed triangle) and stimulated 
activity (inverted closed triangle) were also measured. Data from single experiments are shown, n = 2.  
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7.4.2 Dye accumulation assays 
Effects of standard ABC transporter inhibitors: 
The three standard inhibitors at 10 µM caused an increase in RH123 accumulation 
in zebrafish embryos (Fig. 7.3). MK571 exerted the most pronounced effects leading to 
RH123 increases that ranged between 19 and 40 % in the different test series. RH123 
accumulation was also enhanced by verapamil by 12 to 20 % and by vinblastine from 10 
to 18 %. The differences in fluorescence between treatments and respective controls were 
statistically significant (p < 0.05) for MK571 in all test series except for test series C; for 
verapamil in test series L; and in none of the test series for vinblastine (Fig. 7.3).  
 
Effects of test compounds: 
In embryos exposed to PPCPs, dose-dependent increases in RH123 accumulation 
were observed for nerol and fluoxetine (Fig. 7.3E, N). The most pronounced increases (p 
< 0.05) were also observed for these compounds (nerol: +40 % at 1000 μM; fluoxetine: 
+25 – 30 % at ≥ 333 µM); the effect of 1000 µM nerol even exceeded that of MK571 which 
generally showed comparatively strong effects (Fig. 7.3E). A dose-dependent decrease in 
RH123 accumulation was also detected for celestolide (Fig. 7.3A). Musk xylene exposure 
enhanced RH123 accumulation from 20 to 42 % at the lower concentrations (0.09 to 2.5 
µM) (p < 0.05) (Fig. 7.3C). Exposure to diclofenac, simvastatin and sertraline also 
increased RH123 accumulation for all concentration (Fig. 7.3K, L, M), being significant at 
the highest concentration of diclofenac (+26 %) and at lower sertraline concentrations 
(+24 to 29 %) (p < 0.05). Sertraline was tested up to 1000 µM, but as mortality was 100 % 
at 1000 µM sertraline, no RH123 fluorescence data are shown for this concentration. 
Embryos exposed to propylparaben exhibited RH123 accumulation below the control (100 
%), with a decrease ranging from 6 to 15 % (Fig. 7.3D); similarly, the citronellol exposure 
showed the same effect in concentrations below 25 µM (from 8 to 11 % decrease) (Fig. 
7.3F). Other compounds demonstrate non-monotonic RH123 accumulation changes 
throughout the different concentrations, exhibiting levels above and below the control. 
Musk ketone increased RH123 accumulation by 2 to 29 % at concentrations lower than 
10.5 µM and at higher concentrations it decreased the accumulation (Fig. 7.3B). Embryos 
exposed to isoeugenol increased the RH123 accumulation at lower concentrations, 
including environmentally relevant concentrations (p < 0.05) and at the higher 
concentrations (≥ 333 µM) ranging from 3 to 41 %, but also diminished the accumulation 
at 12 and 37 µM (by 2 and 17 % decrease) (Fig. 7.3G). Camphene decreased Rh123 
accumulation at a concentration of 0.06 µM (p < 0.05) by 14 %, but enhanced RH123 
accumulation up to 10 % at 1.7 µM (Fig. 7.3H). In embryos exposed to α- 
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amylcinnamaldehyde RH123, accumulation was lower at 42 and  0.02 µM (by 9 and 15 % 
respectively) and increased 3 to 18 % at 0.06 to 14 µM (Fig. 7.3I). RH123 was enhanced 
by α-hexylcinnamaldehyde from 2 to 28 % (0.2 to 4 µM, significant for 0.2 µM (p < 0.05)) 
and decreased by 1 and 10 % (0.02 and 13 µM) (Fig. 7.3J) 
7.5 Discussion 
Chemicals present in everyday personal care products (PCPs), such as 
shampoos, lotions and pharmaceuticals, are continuously released into the aquatic 
environment. Given their potentially toxic effects to aquatic organisms further studies are 
needed to improve risk assessment. Hence, the aim of this work was to evaluate the 
chemosensitisation potential of some of these emerging compounds using two 
complementary experimental approaches, the ATPase assay with recombinant Abcb4 
protein and the RH123 dye accumulation assay with whole zebrafish embryos. ATPase 
assay with recombinant Abcb4 enabled us to determine specific interactions of chemicals 
with this transporter. Nonetheless, the obtained effect concentrations are not necessarily 
informative about effective concentrations in a real world in vivo situation. Therefore, one 
cannot draw any conclusions on effective concentrations in vivo with this assay. In 
contrast to ATPase assay, the use of zebrafish embryos as an experimental model 
enabled us to determine chemical concentrations affecting the MXR system in vivo, thus 
providing information on the range of concentrations that are likely to be biologically active 
in fish considering the several transporter types that may contribute to MXR efflux 
transporter activity. Cells expressing zebrafish Abcb4 were able to efflux RH123 (Lu et al., 
2015) which is a known substrate of mammalian ABCB1 and also of fish Abcb1 (Forster et 
al., 2012; Sturm et al., 2001; Ferreira et al., 2014), a functional homolog of zebrafish 
Abcb4. RH123 was shown to act as substrate not only of ABCB1 but also of ABCC 
transporters in mammalian systems (Minderman et al., 1996; Daoud et al., 2000). MK571 
is a classical inhibitor of ABCC transporters (Gekeler et al., 1995) although interacting 
also with zebrafish Abcb4 (Fischer et al., 2013), and the inhibitors verapamil and 
vinblastine were also found to interfere with several transporter types in mammals 
(Sharom, 2008) and are therefore not specific to any type of ABC protein.   
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Figure 7.3: RH123 levels in zebrafish embryos from different treatments in % to control set to 100%. 
Accumulation of rhodamine 123 in D. rerio embryos upon exposure to ABC transporters inhibitors 
(MK571 (10 µM), VER (10 µM) and VIN (10 µM), PCPs (celestolide (A), musk ketone (B), musk xylene 
(C), propylparaben (D), nerol (E), citronellol (F), isouegenol (G), camphene (H), α-amylcinnamaldehyde 
(I), α-hexylcinnamaldehyde (J)) and pharmaceuticals (sertraline (K), fluoxetine (L), diclofenac (M) and 
simvastatin (N)) for 2 h in dye accumulation assays. Data are depicted as means ± SE (n=4). 
Significant differences between treatments and respective controls are marked by an asterisk (p<0.05). 
“ec” indicates concentrations that based on literature data are environmentally relevant (refer to Table 
7.1). 
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Effects of test compounds on the Abcb4 ATPase activity 
The ATPase assay with recombinant Abcb4 enabled us to study different modes of 
chemical interactions with the transporter protein. If a chemical increases basal ATPase 
activity or additionally decreases verapamil-stimulated ATPase activity, it is considered an 
ATPase activity stimulator and could be a transported substrate of Abcb4 (Fischer et al., 
2013). A compound that decreases basal and or verapamil co-exposed ATPase activity 
acts as ATPase inhibitor (von Richter et al., 2009) and probably is inhibiting translocation 
(Fekete et al., 2015).  Therefore, the inhibition of the stimulated Abcb4 ATPase activity is 
seen with compounds that act as competitive and non-competitive inhibitors. ATPase is a 
highly specific assay in terms of chemical interaction with the protein and do not mimic in 
vivo interactions. The chemical concentrations tested in the assay were used to test their 
effectiveness on the protein (Abcb4) and for that reason do not pretend to simulate 
environmental concentrations, although some of the lower concentrations are in the 
environmentally relevant range. ATPase assays were used previously to analyse and 
detect compounds present in environmental samples that can interact with Abcb1 of 
Poeciliopsis lucida (Zaja et al., 2013). Our results showed that the pharmaceuticals 
(diclofenac, simvastatin, sertraline and fluoxetine) and isoeugenol demonstrated 
chemosensitisation towards Abcb4 at higher concentrations. Musk xylene, nerol, 
isoeugenol, α-amylcinnamaldehyde and α-hexylcinnamaldehyde and simvastatin 
stimulated Abcb4 ATPase activity, showing properties that can be described as Abcb4 
substrates, even though not all chemicals that stimulate ATPase activity are transported 
substrates, for example very lipophilic chemicals (Stein and Litman 2014). Verapamil, for 
example, stimulates ATPase activity but it is not transported, notwithstanding doxorubicin 
is a known transporter substrate but it does not stimulate (Polli et al., 2001; Stein and 
Litman 2014). Hence, our results showed a direct interaction between some of the tested 
chemicals (musk xylene, nerol, isoeugenol, α-amylcinnamaldehyde, α-
hexylcinnamaldehyde, diclofenac, simvastatin, sertraline and fluoxetine) and the zebrafish 
Abcb4. 
Effects of test compounds in the dye accumulation assay 
The RH123 accumulation assay enables the identification of chemicals interacting 
with the MXR system. The substrate (dye compound, RH123) enters the cell and is 
effectively effluxed by ABC pumps. When efflux protein inhibitors are present, RH123 is 
retained inside the cells and the measured fluorescence increases. Our results show 
amplitude changes in fluorescence up to 40% that was less than other dye assays 
studies, which use rhodamine B, and observed changes ranging from 80 % to 200 % for 
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some compounds (Fischer et al., 2013). RH123 seem to be less efficiently efflux than 
rhodamine B, which can raise some questions about the evaluation of chemosensitisation 
with less efficient substrates. However, all of our assays were performed with positive 
controls (known ABC protein inhibitors) that consistently showed increase in fluorescence 
versus water controls, demonstrating the validity of the assay. Furthermore, the 
fluorescence levels of some compounds were consistently below the control, indicating a 
stimulation of MXR activity. This effect was observed in previous studies for  rhodamine B 
and rhodamine 123 (Pessatti et al., 2002; Jeon et al., 2011; Liu et al., 2012; Kaewpiboon 
et al., 2014). Although the underlying mechanism still needs to be more thoroughly 
investigated, it was suggested that it could result from an up-regulation and increased 
activity of the MXR components (Pessatti et al., 2002; Jeon et al., 2011). It has previously 
been shown that certain PPCPs (like galaxolide and tonalide) can inhibit the MXR system, 
impairing its ability to efflux other toxic pollutants (Caminada et al., 2008; Fischer et al., 
2013). Our results demonstrated that depending on the concentrations, polycyclic 
(celestolide) and nitromusk (musk ketone and musk xylene) fragrances and essential oils 
(nerol, citronellol, isoeugenol, camphene, α-amylcinnamaldehyde and α-
hexylcinnamaldehyde) can also inhibit the MXR mechanism increasing the number of 
emerging contaminants acting as chemosensitisers Furthermore, our results also even 
showed that the essential oil isoeugenol can inhibit the MXR system at environmentally 
relevant concentrations. Inhibitory effects of synthetic musks (celestolide, musk xylene 
and musk ketone) on efflux proteins was already reported in mussels (Luckenbach and 
Epel, 2005; Faria et al., 2011) and in mammalian in vitro studies for citronellol (Yoshida et 
al., 2005, 2006, 2008). In contrast to musks and essential oils, propylparaben did not 
inhibit the MXR system and like other compounds (e.g. lead or phenylthiocarbamide) 
seems to decrease RH123 accumulation, which may indicate an increase of activity and 
expression of MXR transporters. (Pessatti et al., 2002; Jeon et al., 2011; Liu et al., 2012; 
Kaewpiboon et al., 2014). Pharmaceuticals (diclofenac, simvastatin, sertraline and 
fluoxetine) also inhibited the MXR mechanism. Accordingly, previous in vitro studies 
demonstrated the inhibitory effect of diclofenac on ABC proteins (Lagas et al., 2009; 
Wassmur et al., 2013) and in mammalian in vitro studies was described the inhibition of 
efflux proteins by sertraline and fluoxetine (Peer and Margalit, 2006; O’Brien et al., 2013; 
Drinberg et al., 2014). The chemosensitisation potential of simvastatin was also observed 
in cell lines (Wang et al., 2001; Caminada et al., 2008; Sieczkowski et al., 2010). In 
zebrafish embryos, RH123 accumulation assay showed to be sensitive to the PPCPs as 
in other biological systems.  
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Comparison of the results obtained with the dye accumulation and the ATPase assays 
An overview of the dye accumulation and the ATPase assays is summarized in 
Table 7.3.  
Isoeugenol, α-amylcinnamaldehyde, α-hexylcinnamaldehyde stimulated the basal 
ATPase activity and their fluorescence levels were found to be both lower and higher than 
controls. Hence, Abcb4 ATPase stimulation by these compounds may have resulted in the 
decrease efflux of RH123, demonstrating their property as Abcb4 substrate. Other 
PPCPs, musk xylene, nerol and simvastatin also stimulated the basal ATPase activity but 
only increased RH123 accumulation. As Abcb4 substrates the test compounds may act by 
competitive inhibition, disrupting RH123 efflux increasing its accumulation inside the cell. 
The pharmaceuticals diclofenac, sertraline and fluoxetine inhibited ATPase activity and 
increased RH123 accumulation, therefore these chemicals can be potential 
chemosensitisers; and the increased accumulation of the dye in fish embryos is due to 
Abcb4 inhibition. For other compounds such as celestolide, musk ketone, citronellol and 
camphene the inhibition effects were only found in the accumulation assay. These results 
suggest that these chemicals are inhibiting the MXR system by other mechanisms that 
can include inhibition of ABC proteins other than Abcb4, such as Abcc and Abcg2 
orthologues. Given that ABCC transporters and ABCG2 can efflux non-metabolized and 
also biotransformed compounds (Leslie et al., 2005), the observed inhibition can perhaps 
be associated with metabolites as well as the parent compounds.  
The PPCPs can be at the same time substrate for certain efflux proteins and 
inhibitors of others thus making the chemosensitising potential complex to evaluate. The 
dye assay is an easy and fast method for preliminary testing of compounds and their 
interaction with MXR. The ATPase assay does not allow any conclusions on relevant 
concentrations in vivo, however it offers a specific interaction that can distinguish between 
substrates and non-competitive inhibitors of environmentally relevant contaminants. 
Overall, our results show that depending of the concentration ubiquitous environmental 
pharmaceuticals and personal care products might be able to modulate ABC transporters 
activity. In conclusion, the described results represent an insight into substrate and 
inhibitors specificities of chemicals efflux transporter in fish. 
7.6 Conclusions 
In conclusion, accumulation assay and ATPase assay should be used together, 
since ATPase assay shows the interaction of a compound with a specific transporter and 
the dye assay demonstrate an in vivo interference with MXR system... Emerging 
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pollutants like diclofenac, sertraline and fluoxetine can be recognised as potential 
chemosensitisers and interact with the zebrafish Abcb4 protein. The chemosensitisation 
potential found for most of the tested chemicals can therefore enhance the bioavailability 
of other compounds that are normally effluxed by the ABC proteins. Hence monitoring of 
their presence in the aquatic systems is an important issue and should be considered in 
risk evaluation. 
Table 7.3: Overview of the RH123 accumulation assay with zebrafish embryos and with the Abcb4 ATPase 
assay. The occurrence of effects is marked with +. 
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 Dye accumulation assay  ATPase assay 
Compound Above 
100% 
Below 
100%  
Stimulation of 
basal activity 
Inhibition of 
basal activity 
Inhibition of 
stimulated 
activity 
Celestolide + +    
musk ketone + +    
musk xylene +  +   
Propylparabene  +    
Nerol +  +   
Citronelol + +    
Isoeugenol + + +  + 
Camphene + +    
α-amylcinnamaldehyde + + +   
α-
hexylcinnamaldehyde 
+ + +   
Diclofenac +    + 
Simvastatin +  +   
Sertraline +   + + 
Fluoxetine +    + 
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8.1 Integrated discussion 
Aquatic pollution is an increasing global problem endangering the aquatic 
ecosystems. New chemicals reach water systems daily, including everyday use 
compounds such as pharmaceuticals and PCPs. These xenobiotics enter in the aquatic 
environment from diverse sources and pathways. Despite treatment in WWTPs, these are 
not efficient in the removal of all classes of compounds, therefore significant 
concentrations of PPCPs are detected in effluents, groundwater and surface waters. 
Since there is no perfect and effective way to eliminate PPCPs from reaching the aquatic 
environment, information on risk assessment and underlying cellular and molecular 
parameters have to be understood to better evaluate and maintain a sustainable 
environment. An important and relevant parameter to be considered is the detoxification 
system of the organisms and how the different chemicals can disrupt these pathways. 
Changes in this system are a clear indication of the interaction of a contaminant with an 
organism and can be further used in risk evaluation. Emerging contaminants need 
biomarkers to be established as indicators of their presence and interaction with aquatic 
organisms. The detoxification system include the biotransformation of toxic molecules into 
more easily excreted metabolites by phase I and phase II enzymes and their efflux by 
ABC proteins. To understand the molecular role of these defences we performed this 
study with zebrafish embryos a recognised model for molecular and ecotoxicological 
studies. To accomplish our goals, in vivo assays involving the exposure of zebrafish 
embryos to two different pharmaceuticals (SIM and FLU) and in vitro assays with different 
classes of PPCPs were conducted. Subsequently, transcription and activity responses of 
ABC transporters, biotransformation and antioxidant enzymes and mRNA expression of 
NRs were evaluated. Additionally, to evaluate if SIM and FLU act in conserved pathways 
between fish and mammals, specific interactions with lipid and neurotransmitters systems 
were evaluated in zebrafish embryos.  
To identify which NRs may be involved in the regulatory pathways of detoxification 
system and the effects of emerging contaminants on this regulation, zebrafish embryos 
were exposed to SIM and FLU. The transcription pattern of NRs as well as the 
transcription and activity of biotransformation and antioxidant enzymes and ABC 
transporters were evaluated after exposure to these emerging contaminants (Chapter III 
to V). In addition, disruption of embryo development was also evaluated in the presence of 
these pollutants. The results showed that zebrafish embryo development was affected by 
the exposure of SIM and FLU, and the last producing severe effects at environmental 
relevant concentrations. Embryos presented development delays and abnormalities that in 
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the case of SIM exposure resulted in mortality at the higher concentration. Both 
pharmaceuticals exerted an effect in the transcription as well as the activity of proteins 
involved in detoxification mechanism. SIM up regulated abcb4, abcc1, gstπ and Cu/Zn 
sod mRNA levels and increased EROD and GST activity while cyp3a65 and cat were 
down regulated and CAT and SOD activity were decreased (Chapter III). A general 
pattern of down regulation of genes involved in detoxification mechanisms was observed 
in the embryos after exposure to FLU, with exception of cat (Chapter V). The disruption of 
the biotransformation and antioxidant enzymes and efflux proteins seem to have 
contribute to the observed embryo toxicity effects for both pharmaceuticals. In mammals, 
pharmaceuticals (such as clofibrate or oltipraz) have been found to modulate gene 
expression of Pxr, Ppars and Ahr, and consequently affect the transcription of genes 
belonging to the detoxification mechanism (Aleksunes and Klaassen, 2012). In embryos 
exposed to SIM, the transcription of pxr and ahr was down regulated alongside with 
cyp3a65 and cat (Chapter IV). Moreover, FLU also down regulated the expression of NRs 
with exception of pxr and rxrga (Chapter V). Overall, these results seem to demonstrate 
that SIM and FLU modulate the transcription of NRs, mainly pxr and ahr which ultimately 
affect the transcription of genes involved in the detoxification mechanism. Furthermore, in 
mammalian models AhR and PXR are known to regulate CYPs (such as CYP1, CYP2, 
CYP3A) mRNA and proteins (Xu et al., 2005, Aleksunes and Klaassen, 2012). Although 
more studies have to be performed, the results of this study are in agreement with 
previous studies with fish species (which used pharmacologic concentrations unlike our 
studies that involved some environmentally relevant concentrations) where pxr and ahr 
expression levels were affected by pharmaceuticals and related with the changes in 
transcription of cyp1a and cyp3a (Wassmur et al., 2010; Mortensen and Arukwe, 2007). 
To evaluate if SIM and FLU acted on the same pathways in fish as in mammals, 
specific interactions were targeted, such as the lipid regulation by SIM and transcriptional 
levels of genes involved in the neurotransmitter system in embryos exposed to FLU 
(Chapter IV and VI). In mammals SIM affects the lipid metabolism pathway reducing the 
Chol levels and regulate lipid proteins through the modulation of PPARs (Wang et al., 
2011; Zou et al., 2013). In zebrafish embryos SIM changed the transcription of ppars 
however it did not affect the total Chol levels. FLU interacts with the serotonergic system 
by inhibiting the reuptake of serotonin by SERT (Bisesi et al., 2011) but also regulate the 
transcription of genes belonging to the dopaminergic and adrenergic systems (Gomez et 
al., 2015; Lesemann et al., 2012; Kreke and Dietrich, 2008). In zebrafish embryos, FLU 
affected the neurotransmitter system in a similar way by down regulating genes encoding 
for proteins belonging to the different neurotransmitter systems. Thus, given the 
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phylogenetic proximity between fish and mammals, SIM and FLU can impact conserved 
pathways to which they were design to act in mammals, and consequently be deleterious 
for healthy non-target organisms.  
To assess chemosensitisation potential of different PPCPs classes, accumulation 
and ATPase activity assays were performed in in vivo zebrafish embryos and in in vitro 
membranes containing zebrafish recombinant Abcb4 (Chapter III, V, VII). ABC proteins 
can be inhibited by chemosensitisers increasing the accumulation of normally effluxed 
compounds possibly increasing toxicity (Epel et al. 2008). The chemosensitisation effect 
can be significant since there are a variety of relatively innocuous compounds present in 
the aquatic environment that can inhibit the MXR mechanism. Our results demonstrated, 
that depending on the concentration PPCPs such as musk ketone, musk xylene, nerol, 
isoeugenol, α-hexylcinnamaldehyde, diclofenac, sertraline and fluoxetine have 
chemosensitisation potential. Furthermore, isoeugenol inhibited the MXR system at 
environmentally relevant concentrations. Abcb4 ATPase activity assays were performed 
to assess which compounds inhibit Abcb4. Sertraline, fluoxetine, diclofenac, simvastatin 
and isoeugenol inhibited Abcb4 ATPase activity while musk xylene, nerol, isoeugenol, α-
amylcinnamaldehyde and α-hexylcinnamaldehyde and simvastatin demonstrated Abcb4 
substrates properties. These results indicate the MXR chemosensitisation observed for 
musk xylene, nerol, α-hexylcinnamaldehyde is probably due to the inhibition of other ABC 
proteins rather than Abcb4. These results demonstrate the importance of including ABC 
transporters as biomarkers in monitoring and risk assessment in the aquatic environment.  
 
8,2 Conclusions 
After an overall analysis of this thesis results, several conclusion can be drawn: 
 
a) ABC transporters, biotransformation, antioxidant enzymes and NRs are present since 
very early development stages and important in the defence and the survival of fish; 
b) In the presence of efflux transporters inhibitors, SIM may be more toxic to zebrafish 
embryos therefore impacting their development; 
c) FLU impairs zebrafish embryo development at environmentally relevant concentrations; 
d) SIM and FLU can alter the transcription and activity of efflux proteins, biotransformation 
and antioxidant enzymes; 
e) Both pharmaceuticals modulate NRs transcription, mainly pxr and ahr that may regulate 
transcription of genes involved in the detoxification mechanism, mainly phase I cyp1a and 
cyp3a65, similar to mammalian models; 
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f) SIM affects ppars transcription however it does not impact the total Chol levels in early 
embryo development; 
g) FLU decreases the transcription of important neurotransmitters transporters and 
receptors, at concentrations found in the aquatic environment; 
h) Accumulation and ATPase assays should be used together to better assess the 
chemosentisation potential and better identify which ABC proteins are being inhibited; 
i) Certain PPCPs can disrupt zebrafish MXR activity; 
j) Isoeugenol inhibited MXR activity at environmentally relevant concentrations; 
k) Sertraline, fluoxetine, diclofenac, simvastatin and isoeugenol inhibited Abcb4 ATPase 
activity; 
l) Musk xylene, nerol, isoeugenol, α-amylcinnamaldehyde and α-hexylcinnamaldehyde 
and simvastatin demonstrated Abcb4 substrates properties. 
8.3 Future perspectives 
This work focused on the chemosensitisation potential of emergent compounds in ABC 
proteins and the response patterns of MXR system, biotransformation enzymes and 
nuclear receptors.  
After exposure to the pharmaceuticals embryo development impairment was observed in 
this study which could be related to the alter transcription of the target genes. In future 
studies this can be confirmed by testing embryo development using knockdowns of genes 
belonging to the detoxification mechanism. 
To better understand the possible regulation pathways of detoxification mechanism 
proteins, morpholinos or an alternative knockdown approach should target several nuclear 
receptors genes studied here to demonstrate their role in detoxification and the impact of 
the studied PPCPs. 
Future studies are required in order to confirm and understand which ABC proteins are in 
fact being inhibited by the selected PPCPs. This can be approached through the 
production of recombinant zebrafish Abcc1, Abcc2 and Abcg2 proteins and ATPase 
activity, because until now only recombinant zebrafish Abcb4 was produced and 
evaluated. 
In this study, MXR activity was performed in embryos with chorion, however even with 
short term exposures transcription and activity of detoxification proteins was altered by 
different compounds. Therefore, assays involving microinjection of compounds inside the 
chorion cavity most be performed in order to evaluate the true protection role of this 
membrane.  
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Since the removal of PPCPs in WWTPs is not efficient for all PPCPs, future studies 
should evaluate the effluents chemical composition and test their toxicity in fish and other 
aquatic species development and chemosensitisation potential. 
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